N-(1,3,4-OXADIAZOL-2-YL)ARYLCARBOXAMIDES OR SALTS THEREOF, PREPARATION METHODS, HERBICIDAL COMPOSITIONS AND USES THEREOF

Information

  • Patent Application
  • 20230041563
  • Publication Number
    20230041563
  • Date Filed
    November 27, 2019
    4 years ago
  • Date Published
    February 09, 2023
    a year ago
Abstract
The invention belongs to the technical field of agricultural chemicals, and particularly relates to an N-(1,3,4-oxadiazol-2-yl)arylcarboxamide compound or a salt thereof, a preparation method, a herbicidal composition and a use thereof. The compound is as shown in the following Formula I:
Description
TECHNICAL FIELD

The invention belongs to the technical field of agricultural chemicals, and particularly relates to an N-(1,3,4-oxadiazol-2-yl)arylcarboxamide or a salt thereof, a preparation method, a herbicidal composition and a use thereof.


BACKGROUND ART

The prevention and control of weeds is a crucial step in the realization of high-efficiency agricultural processes. On the market, there are a wide variety of herbicides, for example, WO2014086746A1, WO2016146561A1, WO2014086734A1, WO2013017559A1, WO2017144402A1, WO2012126932A1, WO2012028579A1, etc., disclose certain arylcarboxamides and their use as herbicides. However, due to the continuous expansion of the market, the resistance of weeds, the service life of chemicals and the economical efficiency of chemicals, as well as the increasing emphasis on the environment, especially the serious occurrence of resistance to mainstream weed herbicides (e.g., herbicides with the inhibition mechanism of ALS such as Penoxsulam, Bispyribac-sodium, Pyribenzoxim, and Nicosulfuron, herbicides with ACCe-based inhibition mechanism such as Cyhalofop-butyl, Clethodim, Quizalofop-p-ethyl, and Metamifop, as well as Glyphosate and the like) in the market, crops such as wheat, corn, rice, cotton and soybean encounter a serious challenge and lack effective chemicals to control weeds with resistance. This requires scientists to continuously research and develop new high-efficiency, safe, economic herbicides with different action modes.


In addition, many chiral herbicides have been developed in the market, such as aryloxyphenoxypropionic acid herbicides including Quizalofop-p-ethyl, Fluazifop-p-butyl, Cyhalofop-butyl, Metamifop, and Fenoxaprop-p-ethyl, aryloxypropionic acid herbicides including MCPA propionic acid and 2,4-D propionic acid, chloroamide herbicides including S-metolachlor), and the development of these chiral herbicides has greatly reduced the use of ineffective isomers, and provided better protection to environmental safety. However, there is not a sulfur-containing chiral herbicide that has been commercialized. The present application surprisingly finds an arylcarboxamide compound, a sulfur-containing chiral herbicide, which will has great commercial values.


CONTENTS OF THE INVENTION

The present invention provides an N-(1,3,4-oxadiazol-2-yl)arylcarboxamide compound or a salt thereof, a preparation method, a herbicidal composition and a use thereof, wherein the compound has advantages of a low dosage for use, excellent herbicidal activity, higher crop safety, and especially good selectivity for key crops such as rice.


The technical solution adopted by the present invention is as follows:


The present invention provides an N-(1,3,4-oxadiazol-2-yl)arylcarboxamide compound or a salt thereof, which has the following structural formula:




embedded image


wherein, X represents O, S, SO, SO2 or NR1;


Y represents halogen, cyano, cyanoalkyl, carboxy, nitro, N(R2)2, -alkyl-N(R2)2, CON(R2)2, -alkyl-CON(R2)2, -alkyl-N(R2)3+I, hydroxyalkyl, alkyl substituted by amino and carboxy, OR3, SR3, -alkyl-SOR3, -alkyl-OR3, -alkyl-SR3, COR3, COOR3, -alkyl-COR4, -alkyl-COOR4, -alkyl-OCOR3, Si(R3)3, -alkyl-O—Si(R3)3, -alkyl-O—N═C(R3)2, alkyl, haloalkyl, unsubstituted or substituted alkenyl, unsubstituted or substituted alkynyl, unsubstituted or substituted cycloalkyl, unsubstituted or substituted cycloalkylalkyl, unsubstituted or substituted heterocyclyl, unsubstituted or substituted aryl, unsubstituted or substituted heteroaryl, unsubstituted or substituted heterocyclylalkyl, unsubstituted or substituted arylalkyl, or unsubstituted or substituted heteroarylalkyl, wherein the substituted alkenyl or the substituted alkynyl is alkenyl or alkynyl substituted by at least one group selected from the group consisting of halogen, cyano, cycloalkyl, alkylcarbonyl, alkoxycarbonyl, alkoxy, alkylthio, alkylsulfinyl, alkylsulfonyl, and trialkylsilyl;


or, —X—Y represents an unsubstituted or substituted five- or six-membered heterocyclyl or heteroaryl, wherein the heterocyclyl or heteroaryl contains, besides C atom and N atom at 1-position, 0 to 3 of the following atoms or groups as a component of the ring: O, N, NR1, SO2, C═O;


Z represents hydrogen, halogen, cyano, OR4, -alkyl-OR4, —O-alkyl-N(R5)2, -alkyl-O-alkyl-N(R5)2, N(R5)2, -alkyl-(C═O)m—N(R5)2, —NH-alkyl-N(R5)2, halogen-free or halogen-containing alkyl, halogen-free or halogen-containing alkenyl, halogen-free or halogen-containing alkynyl, halogen-free or halogen-containing alkoxycarbonyl, halogen-free or halogen-containing alkoxycarbonylalkyl, halogen-free or halogen-containing alkylcarbonyl, halogen-free or halogen-containing alkylcarbonylalkyl, halogen-free or halogen-containing alkylcarbonyloxyalkyl, halogen-free or halogen-containing alkylthio, halogen-free or halogen-containing alkylsulfinyl, halogen-free or halogen-containing alkyl sulfonyl, unsubstituted or substituted cycloalkyl, unsubstituted or substituted heterocyclyl, unsubstituted or substituted aryl, unsubstituted or substituted heteroaryl, unsubstituted or substituted heterocyclylalkyl, unsubstituted or substituted arylalkyl, unsubstituted or substituted heteroarylalkyl, unsubstituted or substituted heterocyclylcarbonylalkyl, unsubstituted or substituted arylcarbonylalkyl, unsubstituted or substituted heteroarylcarbonylalkyl, unsubstituted or substituted heterocyclylcarbonyloxyalkyl, unsubstituted or substituted arylcarbonyloxyalkyl, or unsubstituted or substituted heteroarylcarbonyloxyalkyl;


M represents hydrogen, OR6, SR6, COR6, COOR6, OCOR6, CON(R7)2, N(R7)2, NR8COOR6, NR8CON(R7)2, -alkyl-R, halogen-free or halogen-containing alkyl, halogen-free or halogen-containing alkenyl, halogen-free or halogen-containing alkynyl, halogen-free or halogen-containing cycloalkyl, unsubstituted or substituted arylalkyl, or unsubstituted or substituted heteroarylalkyl;


R represents halogen-free or halogen-containing alkenyl, halogen-free or halogen-containing alkynyl, halogen-free or halogen-containing cycloalkyl, CN, OR11, OCOR11, COOR11, COR11, —O—(C═O)—O—R11, OSO2R12, SO2OR11, —S(O)nR12, N(R13)2, CON(R13)2, SO2N(R13)2, NR14COR11, NR14SO2R12, —O—(C═O)—N(R13)2;


R4, R6, and R11 each independently represent hydrogen, halogen-free or halogen-containing alkyl, halogen-free or halogen-containing alkenyl, halogen-free or halogen-containing alkynyl, halogen-free or halogen-containing cycloalkyl, halogen-free or halogen-containing cycloalkylalkyl, halogen-free or halogen-containing cycloalkenyl, halogen-free or halogen-containing alkoxyalkyl, unsubstituted or substituted heterocyclyl, unsubstituted or substituted heterocyclylalkyl, unsubstituted or substituted heterocyclyloxyalkyl, unsubstituted or substituted aryl, unsubstituted or substituted arylalkyl, unsubstituted or substituted aryloxyalkyl, unsubstituted or substituted heteroaryl, unsubstituted or substituted heteroarylalkyl, or unsubstituted or substituted heteroaryloxyalkyl;


R3 and R12 each independently represent halogen-free or halogen-containing alkyl, halogen-free or halogen-containing alkenyl, halogen-free or halogen-containing alkynyl, halogen-free or halogen-containing cycloalkyl, halogen-free or halogen-containing cycloalkylalkyl, halogen-free or halogen-containing cycloalkenyl, halogen-free or halogen-containing alkoxyalkyl, unsubstituted or substituted heterocyclyl, unsubstituted or substituted heterocyclylalkyl, unsubstituted or substituted aryl, unsubstituted or substituted arylalkyl, unsubstituted or substituted heteroaryl, or unsubstituted or substituted heteroarylalkyl;


R1, R2, R5, R7, R8, R13, and R14 each independently represent hydrogen, nitro, alkoxyaminocarbonyl, trialkylsilyl, dialkylphosphonyl, N(R21)2, CON(R21)2, OR21, COR21, CO2R21, COSR21, OCOR21, S(P)rR22, alkyl, haloalkyl, alkenyl, haloalkenyl, alkynyl, haloalkynyl, cycloalkyl, cycloalkenyl, halocycloalkyl, alkoxyalkyl, cycloalkylalkyl, aryl, arylalkyl, aryloxy, aryloxyalkyl, arylalkyloxy, arylcarbonyl, aryl sulfonyl, heteroaryl, heteroarylalkyl, heteroaryloxy, heteroaryloxyalkyl, heteroarylalkyloxy, heteroarylcarbonyl, heteroarylsulfonyl, heterocyclyl, heterocyclylalkyl, heterocyclyloxy, heterocyclyloxyalkyl, heterocyclylalkyloxy, heterocyclylcarbonyl, heterocyclylsulfonyl, aryl-NR21-alkyl, heteroaryl-NR21-alkyl, heterocyclyl-NR21-alkyl, wherein the last 35 groups as mentioned are each substituted by 0, 1, 2 or 3 groups selected from the group consisting of cyano, halogen, nitro, cyanothio, OR21, S(O)rR22, N(R21)2, NR21OR21, COR21, OCOR21, SCOR22, NR21COR21, NR21SO2R22, CO2R21, COSR21, CON(R21)2 and alkoxyalkoxycarbonyl;


R21 independently represents hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, or cycloalkylalkyl;


R22 independently represents alkyl, alkenyl, alkynyl, cycloalkyl, or cycloalkylalkyl;


m represents 0 or 1;


n and r each independently represent 0, 1 or 2; and


when X represents S or SO, Y is not methyl.


Preferably, X represents O, S, SO, SO2 or NR1;


Y represents halogen, cyano, cyano-(C1-C8)alkyl, carboxy, nitro, N(R2)2, —(C1-C8)alkyl-N(R2)2, CON(R2)2, —(C1-C8)alkyl-CON(R2)2, —(C1-C8)alkyl-N(R2)3+I, hydroxy(C1-C8)alkyl, (C1-C8)alkyl substituted by amino and carboxy, OR3, SR3, —(C1-C8)alkyl-SOR3, —(C1-C8)alkyl-OR3, —(C1-C8)alkyl-SR3, COR3, COOR3, —(C1-C8)alkyl-COR4, —(C1-C8)alkyl-COOR4, —(C1-C8)alkyl-OCOR3, Si(R3)3, —(C1-C8)alkyl-O—Si(R3)3, —(C1-C8)alkyl-O—N═C(R3)2, C1-C8alkyl, haloC1-C8alkyl; unsubstituted or substituted C2-C8 alkenyl, unsubstituted or substituted C2-C8 alkynyl, unsubstituted or substituted C3-C8 cycloalkyl, unsubstituted or substituted C3-C8cycloalkyl C1-C8alkyl, unsubstituted or substituted heterocyclyl, unsubstituted or substituted aryl, unsubstituted or substituted heteroaryl, unsubstituted or substituted heterocyclyl C1-C8alkyl, unsubstituted or substituted aryl C1-C8alkyl, unsubstituted or substituted heteroaryl C1-C8alkyl, wherein the substituted C2-C8 alkenyl or the substituted C2-C8 alkynyl is C2-C8 alkenyl or C2-C8 alkynyl substituted by at least one group selected from the group consisting of halogen, cyano, C3-C8 cycloalkyl, C1-C8 alkylcarbonyl, C1-C8 alkoxycarbonyl, C1-C8 alkoxy, C1-C8 alkylthio, C1-C8 alkylsulfinyl, C1-C8 alkylsulfonyl and tri(C1-C8)alkylsilyl, the substituted C3-C8 cycloalkyl or the substituted (C3-C8)cycloalkyl(C1-C8)alkyl is C3-C8 cycloalkyl or (C3-C8)cycloalkyl(C1-C8)alkyl substituted by at least one group selected from the group consisting of C1-C8 alkyl, halogen and phenyl;


or, —X—Y represents




embedded image


which is unsubstituted or substituted by at least one group selected from the group consisting of halogen, nitro, cyano, hydroxy, carboxy, amino, thiol, formyl, unsubstituted or substituted phenyl, unsubstituted or substituted benzyl, unsubstituted or substituted phenoxy, halogen-free or halogen-containing alkyl, halogen-free or halogen-containing alkenyl, halogen-free or halogen-containing alkynyl, halogen-free or halogen-containing cycloalkyl, halogen-free or halogen-containing cycloalkylalkyl, halogen-free or halogen-containing alkoxy, halogen-free or halogen-containing alkylthio, halogen-free or halogen-containing alkoxyalkyl, halogen-free or halogen-containing alkylthioalkyl, halogen-free or halogen-containing alkylcarbonyl, halogen-free or halogen-containing alkoxycarbonyl, halogen-free or halogen-containing alkylsulfinyl, halogen-free or halogen-containing alkylsulfonyl, halogen-free or halogen-containing alkylamino, halogen-free or halogen-containing dialkylamino, halogen-free or halogen-containing alkylacyloxy, wherein the substituted phenyl, the substituted benzyl or the substituted phenoxy is phenyl, benzyl or phenoxy substituted by at least one group selected from the group consisting of halogen, alkyl and alkoxy;


Z represents hydrogen, halogen, cyano, OR4, —(C1-C8)alkyl-OR4, —O—(C1-C8)alkyl-N(R5)2, —(C1-C8)alkyl-O—(C1-C8)alkyl-N(R5)2, N(R5)2, —(C1-C8)alkyl-(C═O)mN(R5)2, —NH—(C1-C8)alkyl-N(R5)2, halogen-free or halogen-containing C1-C8 alkyl, halogen-free or halogen-containing C2-C8 alkenyl, halogen-free or halogen-containing C2-C8 alkynyl, halogen-free or halogen-containing C1-C8 alkoxy carbonyl, halogen-free or halogen-containing C1-C8alkoxycarbonyl C1-C8alkyl, halogen-free or halogen-containing C1-C8alkyl carbonyl, halogen-free or halogen-containing C1-C8alkyl carbonyl C1-C8alkyl, halogen-free or halogen-containing C1-C8alkyl carbonyloxy C1-C8alkyl, halogen-free or halogen-containing C1-C8 alkylthio, halogen-free or halogen-containing C1-C8alkylsulfinyl, halogen-free or halogen-containing C1-C8alkylsulfonyl, unsubstituted or substituted C3-C8 cycloalkyl, unsubstituted or substituted heterocyclyl, unsubstituted or substituted aryl, unsubstituted or substituted heteroaryl, unsubstituted or substituted heterocyclyl C1-C8alkyl, unsubstituted or substituted aryl C1-C8alkyl, unsubstituted or substituted heteroaryl C1-C8alkyl, unsubstituted or substituted heterocyclylcarbonyl C1-C8 alkyl, unsubstituted or substituted arylcarbonyl C1-C8 alkyl, unsubstituted or substituted heteroarylcarbonyl C1-C8alkyl, unsubstituted or substituted heterocyclylcarbonyloxy C1-C8 alkyl, unsubstituted or substituted arylcarbonyloxy C1-C8 alkyl, or unsubstituted or substituted heteroarylcarbonyloxy C1-C8alkyl, wherein the substituted C3-C8 cycloalkyl is C3-C8 cycloalkyl substituted by at least one group selected from the group consisting of C1-C8 alkyl, halogen and phenyl;


M represents hydrogen, OR6, SR6, COR6, COOR6, OCOR6, CON(R7)2, N(R7)2, NR8COOR6, NR8CON(R7)2, —(C1-C8)alkyl-R, halogen-free or halogen-containing C1-C8alkyl, halogen-free or halogen-containing C2-C8alkenyl, halogen-free or halogen-containing C2-C8alkynyl, halogen-free or halogen-containing C3-C8cycloalkyl, unsubstituted or substituted aryl C1-C8alkyl, or unsubstituted or substituted heteroaryl C1-C8 alkyl;


R represents halogen-free or halogen-containing C2-C8alkenyl, halogen-free or halogen-containing C2-C8alkynyl, halogen-free or halogen-containing C3-C8cycloalkyl, CN, OR11, OCOR11, COOR11, COR11, —O—(C═O)—O—R11, OSO2R12, SO2OR11, —S(O)nR12, N(R13)2, CON(R13)2, SO2N(R13)2, NR14COR11, NR14SO2R12, —O—(C═O)-MR13)2;


R4, R6 and Ru each independently represent hydrogen, halogen-free or halogen-containing C1-C8alkyl, halogen-free or halogen-containing C2-C8alkenyl, halogen-free or halogen-containing C2-C8alkynyl, halogen-free or halogen-containing C3-C8cycloalkyl, halogen-free or halogen-containing C3-C8cycloalkyl C1-C8alkyl, halogen-free or halogen-containing C3-C8cycloalkenyl, halogen-free or halogen-containing C1-C8alkoxy C1-C8alkyl, unsubstituted or substituted heterocyclyl, unsubstituted or substituted heterocyclyl C1-C8alkyl, unsubstituted or substituted heterocyclyloxy C1-C8alkyl, unsubstituted or substituted aryl, unsubstituted or substituted aryl C1-C8alkyl, unsubstituted or substituted aryloxy C1-C8alkyl, unsubstituted or substituted heteroaryl, unsubstituted or substituted heteroaryl C1-C8alkyl, unsubstituted or substituted heteroaryloxy C1-C8alkyl;


R3 and R12 each independently represent halogen-free or halogen-containing C1-C8alkyl, halogen-free or halogen-containing C2-C8alkenyl, halogen-free or halogen-containing C2-C8alkynyl, halogen-free or halogen-containing C3-C8cycloalkyl, halogen-free or halogen-containing C3-C8cycloalkyl C1-C8alkyl, halogen-free or halogen-containing C3-C8cycloalkenyl, halogen-free or halogen-containing C1-C8alkoxy C1-C8alkyl, unsubstituted or substituted heterocyclyl, unsubstituted or substituted heterocyclyl C1-C8alkyl, unsubstituted or substituted aryl, unsubstituted or substituted aryl C1-C8alkyl, unsubstituted or substituted heteroaryl, unsubstituted or substituted heteroaryl C1-C8alkyl;


R1, R2, R5, R7, R8, R13, and R14 each independently represent hydrogen, nitro, alkoxyaminocarbonyl, trialkylsilyl, dialkylphosphonyl, N(R21)2, CON(R21)2, OR21, COR21, CO2R21, COSR21, OCOR21, S(O)rR22, C1-C8alkyl, haloC1-C8alkyl, C2-C8alkenyl, haloC2-Csalkenyl, C2-C8alkynyl, haloC2-C8alkynyl, C3-C8cycloalkyl, C3-C8cycloalkenyl, haloC3-C8cycloalkyl, C1-C8alkoxy C1-C8alkyl, C3-C8cycloalkyl C1-C8alkyl, aryl, aryl C1-C8alkyl, aryloxy, aryloxy C1-C8alkyl, aryl C1-C8alkyloxy, arylcarbonyl, arylsulfonyl, heteroaryl, heteroaryl C1-C8alkyl, heteroaryloxy, heteroaryloxy C1-C8alkyl, heteroaryl C1-C8alkyloxy, heteroarylcarbonyl, heteroarylsulfonyl, heterocyclyl, heterocyclyl C1-C8alkyl, heterocyclyloxy, heterocyclyloxy C1-C8alkyl, heterocyclyl C1-C8alkyloxy, heterocyclylcarbonyl, heterocyclylsulfonyl, aryl-NR21—(C1-C8)alkyl, heteroaryl-NR21—(C1-C8)alkyl, or heterocyclyl-NR21—(C1-C8)alkyl, wherein the last 35 groups as mentioned each are independently substituted by 0, 1, 2 or 3 groups selected from the group consisting of cyano, halogen, nitro, cyanothio, OR21, S(O)rR22, N(R21)2, NR21OR21, COR21, OCOR21, SCOR22, NR21COR21, NR21SO2R22, CO2R21, COSR21, CON(R21)2 and C1-C8alkoxy C1-C8alkoxycarbonyl;


R21 independently represents hydrogen, C1-C8alkyl, C2-C8alkenyl, C2-C8alkynyl, C3-C8cycloalkyl, or C3-C8cycloalkyl C1-C8alkyl;


R22 independently represents C1-C8alkyl, C2-C8alkenyl, C2-C8alkynyl, C3-C8cycloalkyl, or C3-C8cycloalkyl C1-C8alkyl;


m represents 0 or 1;


n and r each independently represent 0, 1 or 2;


wherein, the “heterocyclyl” refers to




embedded image


which has 0, 1 or 2 oxo groups; the “aryl” refers to phenyl or naphthyl, the “heteroaryl” refers to




embedded image


embedded image


wherein the heterocyclyl, the aryl or the heteroaryl is unsubstituted or substituted by at least one group selected from the group consisting of halogen, nitro, cyano, cyanothio, hydroxy, carboxy, thiol, formyl, unsubstituted or substituted phenyl, unsubstituted or substituted benzyl, unsubstituted or substituted phenoxy, halogen-free or halogen-containing alkyl, halogen-free or halogen-containing alkenyl, halogen-free or halogen-containing alkynyl, halogen-free or halogen-containing cycloalkyl, halogen-free or halogen-containing cycloalkylalkyl, halogen-free or halogen-containing OR″, halogen-free or halogen-containing SR″, halogen-free or halogen-containing -alkyl-OR″, halogen-free or halogen-containing -alkyl-SR″, halogen-free or halogen-containing COR″, halogen-free or halogen-containing COOR″, halogen-free or halogen-containing COSR″, halogen-free or halogen-containing SOR″, halogen-free or halogen-containing SO2R″, halogen-free or halogen-containing OCOR″, halogen-free or halogen-containing SCOR″, substituted amino, substituted aminocarbonyl, —OCH2CH2—, —OCH2O—, and —OCH2CH2O—, wherein the substituted phenyl, the substituted benzyl or the substituted phenoxy is phenyl, benzyl or phenoxy substituted with at least one group selected from the group consisting of halogen, alkyl and alkoxy, the substituted amino or the substituted aminocarbonyl is amino or aminocarbonyl substituted by one or two groups selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, COR″, SO2R″, and OR″;


R′ independently represents hydrogen, nitro, hydroxy, amino, halogen-containing or halogen-free alkyl, halogen-containing or halogen-free alkenyl, halogen-containing or halogen-free alkynyl, halogen-containing or halogen-free cycloalkyl, halogen-containing or halogen-free cycloalkenyl, halogen-containing or halogen-free cycloalkylalkyl, halogen-containing or halogen-free alkoxy, halogen-containing or halogen-free alkenyloxy, halogen-containing or halogen-free alkynyloxy, halogen-containing or halogen-free cycloalkyloxy, halogen-containing or halogen-free alkoxyalkyl, halogen-containing or halogen-free alkoxycarbonyl, halogen-containing or halogen-free alkylthiocarbonyl, halogen-containing or halogen-free alkylsulfonyl, halogen-containing or halogen-free alkylsulfonylalkyl, halogen-containing or halogen-free alkylcarbonyl, halogen-containing or halogen-free alkylcarbonylalkyl, halogen-containing or halogen-free alkylacyloxy, halogen-containing or halogen-free alkylamino, halogen-containing or halogen-free alkylaminocarbonyl, halogen-containing or halogen-free alkoxyaminocarbonyl, halogen-containing or halogen-free alkoxycarbonylalkyl, halogen-containing or halogen-free alkylaminocarbonylalkyl, halogen-containing or halogen-free trialkylsilyl, or halogen-containing or halogen-free dialkylphosphonyl;


R″ independently represents hydrogen, halogen-containing or halogen-free alkyl, halogen-containing or halogen-free alkenyl, halogen-containing or halogen-free alkynyl, halogen-containing or halogen-free cycloalkyl, or halogen-containing or halogen-free cycloalkylalkyl.


More preferably, X represents O, S, SO, SO2 or NR1;


Y represents halogen, cyano, cyano C1-C6alkyl, carboxy, nitro, N(R2)2, —(C1-C6)alkyl-N(R2)2, CON(R2)2, —(C1-C6)alkyl-CON(R2)2, —(C1-C6)alkyl-N(R2)3+I, hydroxy C1-C6alkyl, C1-C6alkyl substituted by amino and carboxy, OR3, SR3, —(C1-C6)alkyl-SOR3, —(C1-C6)alkyl-OR3, —(C1-C6)alkyl-SR3, COR3, COOR3, —(C1-C6)alkyl-COR4, —(C1-C6)alkyl-COOR4, —(C1-C6)alkyl-OCOR3, Si(R3)3, —(C1-C6)alkyl-O—Si(R3)3, —(C1-C6)alkyl-O—N═C(R3)2, C1-C6alkyl, haloC1-C6alkyl, unsubstituted or substituted C2-C6 alkenyl, unsubstituted or substituted C2-C6 alkynyl, unsubstituted or substituted C3-C6 cycloalkyl, unsubstituted or substituted C3-C6cycloalkyl C1-C6alkyl, unsubstituted or substituted heterocyclyl, unsubstituted or substituted aryl, unsubstituted or substituted heteroaryl, unsubstituted or substituted heterocyclyl C1-C6alkyl, unsubstituted or substituted aryl C1-C6alkyl, unsubstituted or substituted heteroaryl C1-C6alkyl, wherein the substituted C2-C6 alkenyl or the substituted C2-C6 alkynyl is C2-C6 alkenyl or C2-C6 alkynyl substituted by at least one group selected from the group consisting of halogen, cyano, C3-C6 cycloalkyl, C1-C6 alkyl carbonyl, C1-C6 alkoxy carbonyl, C1-C6 alkoxy, C1-C6 alkylthio, C1-C6 alkyl sulfinyl, C1-C6 alkyl sulfonyl and tri(C1-C6)alkylsilyl, the substituted C3-C6 cycloalkyl or the substituted C3-C6cycloalkyl C1-C6alkyl is C3-C6 cycloalkyl or C3-C6cycloalkyl C1-C6alkyl substituted by at least one group selected from the group consisting of C1-C6 alkyl, halogen and phenyl;


or, —X—Y represents




embedded image


which is unsubstituted or substituted by 1, 2 or 3 groups selected from the group consisting of halogen, nitro, cyano, hydroxy, carboxy, amino, thiol, formyl, unsubstituted or substituted phenyl, unsubstituted or substituted benzyl, unsubstituted or substituted phenoxy, halogen-containing or halogen-free C1-C8 alkyl, halogen-containing or halogen-free C2-C8 alkenyl, halogen-containing or halogen-free C2-C8 alkynyl, halogen-containing or halogen-free C3-C8 cycloalkyl, halogen-containing or halogen-free C3-C8cycloalkyl C1-C8alkyl, halogen-containing or halogen-free C1-C8 alkoxy, halogen-containing or halogen-free C1-C8 alkylthio, halogen-containing or halogen-free C1-C8alkoxy C1-C8alkyl, halogen-containing or halogen-free C1-C8alkylthio C1-C8alkyl, halogen-containing or halogen-free C1-C8alkyl carbonyl, halogen-containing or halogen-free C1-C8alkoxy carbonyl, halogen-containing or halogen-free C1-C8alkyl sulfinyl, halogen-containing or halogen-free C1-C8alkyl sulfonyl, halogen-containing or halogen-free C1-C8alkyl amino, halogen-containing or halogen-free di(C1-C8)alkyl amino, and halogen-containing or halogen-free C1-C8alkyl acyloxy, wherein the substituted phenyl, the substituted benzyl or the substituted phenoxy is phenyl, benzyl or phenoxy substituted by 1, 2 or 3 groups selected from the group consisting of halogen, C1-C8 alkyl and C1-C8 alkoxy;


Z represents hydrogen, halogen, cyano, OR4, —(C1-C6)alkyl-OR4, —O—(C1-C6)alkyl-N(R5)2, —(C1-C6)alkyl-O—(C1-C6)alkyl-N(R5)2, N(R5)2, —(C1-C6)alkyl-(C═O)m—N(R5)2, —NH—(C1-C6)alkyl-N(R5)2, halogen-free or halogen-containing C1-C6 alkyl, halogen-free or halogen-containing C2-C6 alkenyl, halogen-free or halogen-containing C2-C6 alkynyl, halogen-free or halogen-containing C1-C6alkoxy carbonyl, halogen-free or halogen-containing C1-C6alkoxy carbonyl C1-C6alkyl, halogen-free or halogen-containing C1-C6alkyl carbonyl, halogen-free or halogen-containing C1-C6alkyl carbonyl C1-C6alkyl, halogen-free or halogen-containing C1-C6alkyl carbonyloxy C1-C6alkyl, halogen-free or halogen-containing C1-C6 alkylthio, halogen-free or halogen-containing C1-C6alkyl sulfinyl, halogen-free or halogen-containing C1-C6alkyl sulfonyl, unsubstituted or substituted C3-C6 cycloalkyl, unsubstituted or substituted heterocyclyl, unsubstituted or substituted aryl, unsubstituted or substituted heteroaryl, unsubstituted or substituted heterocyclyl C1-C6alkyl, unsubstituted or substituted aryl C1-C6alkyl, unsubstituted or substituted heteroaryl C1-C6alkyl, unsubstituted or substituted heterocyclyl carbonyl C1-C6alkyl, unsubstituted or substituted aryl carbonyl C1-C6alkyl, unsubstituted or substituted heteroaryl carbonyl C1-C6alkyl, unsubstituted or substituted heterocyclyl carbonyloxy C1-C6alkyl, unsubstituted or substituted aryl carbonyloxy C1-C6alkyl, or unsubstituted or substituted heteroaryl carbonyloxy C1-C6alkyl, wherein the substituted C3-C6 cycloalkyl is C3-C6 cycloalkyl substituted by at least one group selected from the group consisting of C1-C6 alkyl, halogen and phenyl;


M represents hydrogen, OR6, SR6, COR6, COOR6, OCOR6, CON(R7)2, N(R7)2, NR8COOR6, NR8CON(R7)2, —(C1-C6)alkyl-R, halogen-free or halogen-containing C1-C6 alkyl, halogen-free or halogen-containing C2-C6 alkenyl, halogen-free or halogen-containing C2-C6 alkynyl, halogen-free or halogen-containing C3-C6 cycloalkyl, unsubstituted or substituted aryl C1-C6alkyl, or unsubstituted or substituted heteroaryl C1-C6alkyl;


R represents halogen-free or halogen-containing C2-C6 alkenyl, halogen-free or halogen-containing C2-C6 alkynyl, halogen-free or halogen-containing C3-C6 cycloalkyl, CN, OR11, OCOR11, COOR11, COR11, —O—(C═O)—O—R11, OSO2R12, SO2OR11, —S(O)nR12, N(R13)2, CON(R13)2, SO2N(R13)2, NR14COR11, NR14SO2R12, —O—(C═O)-MR13)2;


R4, R6 and R11 each independently represent hydrogen, halogen-free or halogen-containing C1-C6 alkyl, halogen-free or halogen-containing C2-C6 alkenyl, halogen-free or halogen-containing C2-C6 alkynyl, halogen-free or halogen-containing C3-C6 cycloalkyl, halogen-free or halogen-containing C3-C6cycloalkyl C1-C6alkyl, halogen-free or halogen-containing C3-C6 cycloalkenyl, C1-C6alkoxy C1-C6alkyl, unsubstituted or substituted heterocyclyl, unsubstituted or substituted heterocyclyl C1-C6alkyl, unsubstituted or substituted heterocyclyloxy C1-C6alkyl, unsubstituted or substituted aryl, unsubstituted or substituted aryl C1-C6alkyl, unsubstituted or substituted aryloxy C1-C6alkyl, unsubstituted or substituted heteroaryl, unsubstituted or substituted heteroaryl C1-C6alkyl, or unsubstituted or substituted heteroaryloxy C1-C6alkyl;


R3 and R12 each independently represent halogen-free or halogen-containing C1-C6 alkyl, halogen-free or halogen-containing C2-C6 alkenyl, halogen-free or halogen-containing C2-C6 alkynyl, halogen-free or halogen-containing C3-C6 cycloalkyl, halogen-free or halogen-containing C3-C6cycloalkyl C1-C6alkyl, halogen-free or halogen-containing C3-C6 cycloalkenyl, halogen-free or halogen-containing C1-C6alkoxy C1-C6alkyl, unsubstituted or substituted heterocyclyl, unsubstituted or substituted heterocyclyl C1-C6alkyl, unsubstituted or substituted aryl, unsubstituted or substituted aryl C1-C6alkyl, unsubstituted or substituted heteroaryl, unsubstituted or substituted heteroaryl C1-C6alkyl;


R1, R2, R5, R7, R8, R13, and R14 each independently represent hydrogen, nitro, alkoxyaminocarbonyl, trialkylsilyl, dialkylphosphonyl, N(R21)2, CON(R21)2, OR21, COR21, CO2R21, COSR21, OCOR21, S(O)rR22, C1-C6 alkyl, halo C1-C6alkyl, C2-C6 alkenyl, halo C2-C6alkenyl, C2-C6 alkynyl, halo C2-C6alkynyl, C3-C6 cycloalkyl, C3-C6 cycloalkenyl, halo C3-C6cycloalkyl, C1-C6alkoxy C1-C6alkyl, C3-C6cycloalkyl C1-C6alkyl, aryl, aryl C1-C6alkyl, aryloxy, aryloxy C1-C6alkyl, aryl C1-C6alkyloxy, arylcarbonyl, aryl sulfonyl, heteroaryl, heteroaryl C1-C6alkyl, heteroaryloxy, heteroaryloxy C1-C6alkyl, heteroaryl C1-C6alkyloxy, heteroarylcarbonyl, heteroarylsulfonyl, heterocyclyl, heterocyclyl C1-C6alkyl, heterocyclyloxy, heterocyclyloxy C1-C6alkyl, heterocyclyl C1-C6alkyloxy, heterocyclylcarbonyl, heterocyclylsulfonyl, aryl-NR21—(C1-C6)alkyl, heteroaryl-NR21—(C1-C6)alkyl, heterocyclyl-NR21—(C1-C6)alkyl, wherein the last 35 groups as mentioned are each substituted by 0, 1, 2 or 3 groups selected from the group consisting of cyano, halogen, nitro, cyanothio, OR21, S(O)rR22, N(R21)2, NR21OR21, COR21, OCOR21, SCOR22, NR21COR21, NR21SO2R22, CO2R21, COSR21, CON(R21)2 and C1-C6alkoxy C1-C6alkoxy carbonyl;


R21 independently represents hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, or C3-C6cycloalkyl C1-C6alkyl;


R22 independently represents C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, or C3-C6cycloalkyl C1-C6alkyl;


m represents 0 or 1;


n and r each independently represent 0, 1 or 2;


wherein, the “heterocyclyl” refers to




embedded image


which has 0, 1 or 2 oxo groups, the “aryl” refers to phenyl or naphthyl, and “heteroaryl” refers to




embedded image


embedded image


which is unsubstituted or substituted by 0, 1, 2 or 3 groups selected from the group consisting of halogen, nitro, cyano, cyanothio, hydroxy, carboxy, thiol, formyl, unsubstituted or substituted phenyl, unsubstituted or substituted benzyl, unsubstituted or substituted phenoxy, halogen-containing or halogen-free C1-C8 alkyl, halogen-containing or halogen-free C2-C8 alkenyl, halogen-containing or halogen-free C2-C8 alkynyl, halogen-containing or halogen-free C3-C8 cycloalkyl, halogen-containing or halogen-free C3-C8 cycloalkyl C1-C8 alkyl, halogen-containing or halogen-free OR″, halogen-containing or halogen-free SR″, halogen-containing or halogen-free —(C1-C8)alkyl-OR″, halogen-containing or halogen-free —(C1-C8)alkyl-SR″, halogen-containing or halogen-free COR″, halogen-containing or halogen-free COOR″, halogen-containing or halogen-free COSR″, halogen-containing or halogen-free SOR″, halogen-containing or halogen-free SO2R″, halogen-containing or halogen-free OCOR″, halogen-containing or halogen-free SCOR″, substituted amino, substituted aminocarbonyl, —OCH2CH2—, —OCH2O—, and —OCH2CH2O—, wherein the substituted phenyl, the substituted benzyl or the substituted phenoxy is phenyl, benzyl or phenoxy substituted by 1, 2 or 3 groups selected from halogen, C1-C8 alkyl and C1-C8 alkoxy, the substituted amino or the substituted aminocarbonyl is amino or aminocarbonyl substituted by one or two groups selected from hydrogen, C1-C8 alkyl, C2-C8 alkenyl, C2-C8 alkynyl, C3-C8 cycloalkyl, C3-C8cycloalkyl C1-C8alkyl, COR″, SO2R″ and OR″;


R′ independently represents hydrogen, nitro, hydroxy, amino, fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing C1-C8 alkyl, fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing C2-C8 alkenyl, fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing C2-C8 alkynyl, fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing C3-C8 cycloalkyl, fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing C3-C8 cycloalkenyl, fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing C3-C8cycloalkyl C1-C8alkyl, fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing C1-C8alkoxy, fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing C2-C8 alkenyloxy, fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing C2-C8 alkynyloxy, fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing C3-C8 cycloalkyloxy, fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing C1-C8alkoxy C1-C8alkyl, fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing C1-C8alkoxy carbonyl, fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing C1-C8alkylthio carbonyl, fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing C1-C8alkylsulfonyl, fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing C1-C8alkylsulfonyl C1-C8alkyl, fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing C1-C8alkyl carbonyl, fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing C1-C8alkyl carbonyl C1-C8alkyl, fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing C1-C8alkyl acyloxy, fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing C1-C8alkylamino, fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing C1-C8alkylamino carbonyl, fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing C1-C8alkoxyamino carbonyl, fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing C1-C8alkoxy carbonyl C1-C8alkyl, fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing C1-C8alkylamino carbonyl C1-C8alkyl, fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing tri(C1-C8)alkylsilyl, or fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing di(C1-C8)alkylphosphonyl;


R″ independently represents hydrogen, halogen-free or halogen-containing C1-C8 alkyl, halogen-free or halogen-containing C2-C8 alkenyl, halogen-free or halogen-containing C2-C8 alkynyl, halogen-free or halogen-containing C3-C8 cycloalkyl or halogen-free or halogen-containing C3-C8cycloalkyl C1-C8alkyl.


Further preferably, X represents O, S, SO, SO2 or NR1;


Y represents halogen, cyano, cyano C1-C2 alkyl, carboxy, nitro, N(R2)2, —(C1-C2)alkyl-N(R2)2, CON(R2)2, —(C1-C2)alkyl-CON(R2)2, —(C1-C2)alkyl-N(R2)3+I, hydroxy C1-C2 alkyl, C1-C2 alkyl substituted by amino and carboxy, OR3, SR3, —(C1-C2)alkyl-SOR3, —(C1-C2)alkyl-OR3, —(C1-C2)alkyl-SR3, COR3, COOR3, —(C1-C2)alkyl-COR4, —(C1-C2)alkyl-COOR4, —(C1-C2)alkyl-OCOR3, Si(R3)3, —(C1-C2)alkyl-O—Si(R3)3, —(C1-C2)alkyl-O—N═C(R3)2, C1-C6 alkyl, halo C1-C6 alkyl; unsubstituted or substituted C2-C6 alkenyl, unsubstituted or substituted C2-C6 alkynyl, unsubstituted or substituted C3-C6 cycloalkyl, unsubstituted or substituted C3-C6 cycloalkyl C1-C2 alkyl, unsubstituted or substituted heterocyclyl, unsubstituted or substituted aryl, unsubstituted or substituted heteroaryl, unsubstituted or substituted heterocyclyl C1-C2 alkyl, unsubstituted or substituted aryl C1-C2 alkyl, or unsubstituted or substituted heteroaryl C1-C2 alkyl, wherein the substituted C2-C6 alkenyl or substituted C2-C6 alkynyl is C2-C6 alkenyl or C2-C6 alkynyl substituted by at least one group selected from halogen, cyano, C3-C6 cycloalkyl, C1-C6 alkyl carbonyl, C1-C6 alkoxy carbonyl, C1-C6 alkoxy, C1-C6 alkylthio, C1-C6 alkylsulfinyl, C1-C6 alkylsulfonyl, and tri(C1-C6)alkylsilyl, the substituted C3-C6 cycloalkyl or the substituted C3-C6 cycloalkyl C1-C2 alkyl is C3-C6 cycloalkyl or C3-C6 cycloalkyl C1-C2 alkyl substituted by at least one group selected from C1-C6 alkyl, halogen and phenyl;


or, —X—Y represents




embedded image


which is unsubstituted or substituted by 1, 2 or 3 groups selected from the group consisting of halogen, nitro, cyano, hydroxy, carboxy, amino, thiol, formyl, unsubstituted or substituted phenyl, unsubstituted or substituted benzyl, unsubstituted or substituted phenoxy, halogen-free or halogen-containing C1-C6 alkyl, halogen-free or halogen-containing C2-C6 alkenyl, halogen-free or halogen-containing C2-C6 alkynyl, halogen-free or halogen-containing C3-C6 cycloalkyl, halogen-free or halogen-containing C3-C6 cycloalkyl C1-C2 alkyl, halogen-free or halogen-containing C1-C6 alkoxy, halogen-free or halogen-containing C1-C6 alkylthio, halogen-free or halogen-containing C1-C6 alkoxy C1-C2 alkyl, halogen-free or halogen-containing C1-C6 alkylthio C1-C2 alkyl, halogen-free or halogen-containing C1-C6 alkyl carbonyl, halogen-free or halogen-containing C1-C6 alkoxy carbonyl, halogen-free or halogen-containing C1-C6 alkyl sulfinyl, halogen-free or halogen-containing C1-C6 alkyl sulfonyl, halogen-free or halogen-containing C1-C6 alkyl amino, halogen-free or halogen-containing di(C1-C6)alkyl amino, or halogen-free or halogen-containing C1-C6 alkyl acyloxy, wherein the substituted phenyl, the substituted benzyl or the substituted phenoxy is phenyl, benzyl or phenoxy substituted by 1, 2 or 3 groups selected from halogen, C1-C6 alkyl, and C1-C6 alkoxy;


Z represents hydrogen, halogen, cyano, OR4, —(C1-C2)alkyl-OR4, —O—(C1-C2)alkyl-N(R5)2, —(C1-C2)alkyl-O—(C1-C2)alkyl-N(R5)2, N(R5)2, —(C1-C2)alkyl-(C═O)m—N(R5)2, —NH—(C1-C2)alkyl-N(R5)2, halogen-free or halogen-containing C1-C6 alkyl, halogen-free or halogen-containing C2-C6 alkenyl, halogen-free or halogen-containing C2-C6 alkynyl, halogen-free or halogen-containing C1-C6 alkoxy carbonyl, halogen-free or halogen-containing C1-C6 alkoxy carbonyl C1-C2 alkyl, halogen-free or halogen-containing C1-C6 alkyl carbonyl, halogen-free or halogen-containing C1-C6 alkyl carbonyl C1-C2 alkyl, halogen-free or halogen-containing C1-C6 alkyl carbonyloxy C1-C2 alkyl, halogen-free or halogen-containing C1-C6 alkylthio, halogen-free or halogen-containing C1-C6 alkyl sulfinyl, halogen-free or halogen-containing C1-C6 alkyl sulfonyl, unsubstituted or substituted C3-C6 cycloalkyl, unsubstituted or substituted heterocyclyl, unsubstituted or substituted aryl, unsubstituted or substituted heteroaryl, unsubstituted or substituted heterocyclyl C1-C2 alkyl, unsubstituted or substituted aryl C1-C2 alkyl, unsubstituted or substituted heteroaryl C1-C2 alkyl, unsubstituted or substituted heterocyclylcarbonyl C1-C2 alkyl, unsubstituted or substituted aryl carbonyl C1-C2 alkyl, unsubstituted or substituted heteroaryl carbonyl C1-C2 alkyl, unsubstituted or substituted heterocyclyl carbonyloxy C1-C2 alkyl, unsubstituted or substituted aryl carbonyloxy C1-C2 alkyl, or unsubstituted or substituted heteroaryl carbonyloxy C1-C2 alkyl, wherein the substituted C3-C6 cycloalkyl is C3-C6 cycloalkyl substituted by at least one group selected from C1-C6 alkyl, halogen and phenyl;


M represents hydrogen, OR6, SR6, COR6, COOR6, OCOR6, CON(R7)2, N(R7)2, NR8COOR6, NR8CON(R7)2, —(C1-C2)alkyl-R, halogen-free or halogen-containing C1-C6 alkyl, halogen-free or halogen-containing C2-C6 alkenyl, halogen-free or halogen-containing C2-C6 alkynyl, halogen-free or halogen-containing C3-C6 cycloalkyl, unsubstituted or substituted aryl C1-C2 alkyl, or unsubstituted or substituted heteroaryl C1-C2 alkyl;


R represents halogen-free or halogen-containing C2-C6 alkenyl, halogen-free or halogen-containing C2-C6 alkynyl, halogen-free or halogen-containing C3-C6 cycloalkyl, CN, OR11, OCOR11, COOR11, COR11, —O—(C═O)—O—R11, OSO2R12, SO2OR11, —S(O)nR12, N(R13)2, CON(R13)2, SO2N(R13)2, NR14COR11, NR14SO2R12, or —O—(C═O)—N(R13)2;


R4, R6 and R11 each independently represent hydrogen, halogen-free or halogen-containing C1-C6 alkyl, halogen-free or halogen-containing C2-C6 alkenyl, halogen-free or halogen-containing C2-C6 alkynyl, halogen-free or halogen-containing C3-C6 cycloalkyl, halogen-free or halogen-containing C3-C6 cycloalkyl C1-C2 alkyl, halogen-free or halogen-containing C3-C6 cycloalkenyl, halogen-free or halogen-containing C1-C6 alkoxy C1-C2 alkyl, unsubstituted or substituted heterocyclyl, unsubstituted or substituted heterocyclyl C1-C2 alkyl, unsubstituted or substituted heterocyclyloxy C1-C2 alkyl, unsubstituted or substituted aryl, unsubstituted or substituted aryl C1-C2 alkyl, unsubstituted or substituted aryloxy C1-C2 alkyl, unsubstituted or substituted heteroaryl, unsubstituted or substituted heteroaryl C1-C2 alkyl, or unsubstituted or substituted heteroaryloxy C1-C2 alkyl;


R3 and R12 each independently represent halogen-free or halogen-containing C1-C6 alkyl, halogen-free or halogen-containing C2-C6 alkenyl, halogen-free or halogen-containing C2-C6 alkynyl, halogen-free or halogen-containing C3-C6 cycloalkyl, halogen-free or halogen-containing C3-C6 cycloalkyl C1-C2 alkyl, halogen-free or halogen-containing C3-C6 cycloalkenyl, halogen-free or halogen-containing C1-C6 alkoxy C1-C2 alkyl, unsubstituted or substituted heterocyclyl, unsubstituted or substituted heterocyclyl C1-C2 alkyl, unsubstituted or substituted aryl, unsubstituted or substituted aryl C1-C2 alkyl, unsubstituted or substituted heteroaryl, or unsubstituted or substituted heteroaryl C1-C2 alkyl;


R1, R2, R5, R7, R8, R13, and R14 each independently represent hydrogen, nitro, alkoxyaminocarbonyl, trialkylsilyl, dialkylphosphonyl, N(R21)2, CON(R21)2, OR21, COR21, CO2R21, COSR21, OCOR21, S(O)rR22, C1-C6 alkyl, halo C1-C6 alkyl, C2-C6 alkenyl, halo C2-C6 alkenyl, C2-C6 alkynyl, halo C2-C6 alkynyl, C3-C6 cycloalkyl, C3-C6 cycloalkenyl, halo C3-C6 cycloalkyl, C1-C6 alkoxy C1-C2 alkyl, C3-C6 cycloalkyl C1-C2 alkyl, aryl, aryl C1-C2 alkyl, aryloxy, aryloxy C1-C2 alkyl, aryl C1-C2 alkyloxy, arylcarbonyl, arylsulfonyl, heteroaryl, heteroaryl C1-C2 alkyl, heteroaryloxy, heteroaryloxy C1-C2 alkyl, heteroaryl C1-C2 alkyloxy, heteroaryl carbonyl, heteroaryl sulfonyl, heterocyclyl, heterocyclyl C1-C2 alkyl, heterocyclyloxy, heterocyclyloxy C1-C2 alkyl, heterocyclyl C1-C2 alkyloxy, heterocyclyl carbonyl, heterocyclyl sulfonyl, aryl-NR21—(C1-C2)alkyl, heteroaryl-NR21—(C1-C2)alkyl, heterocyclyl-NR21—(C1-C2)alkyl, wherein the last 35 groups as mentioned are each substituted by 0, 1, 2 or 3 groups selected from the group consisting of cyano, halogen, nitro, cyanothio, OR21, S(O)rR22, N(R21)2, NR21OR21, COR21, OCOR21, SCOR22, NR21COR21, NR21SO2R22, CO2R21, COSR21, CON(R21)2 and C1-C6 alkoxy C1-C2 alkoxy carbonyl;


R21 independently represents hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, or C3-C6 cycloalkyl C1-C2 alkyl;


R22 independently represents C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, or C3-C6cycloalkyl C1-C2 alkyl;


m represents 0 or 1;


n and r each independently represent 0, 1 or 2;


wherein, the “heterocyclyl” refers to




embedded image


which has 0, 1 or 2 oxo groups, the “aryl” refers to phenyl or naphthyl, and the “heteroaryl” refers to




embedded image


embedded image


which is unsubstituted or substituted by 0, 1, 2 or 3 groups selected from the group consisting of halogen, nitro, cyano, cyanothio, hydroxy, carboxy, thiol, formyl, unsubstituted or substituted phenyl, unsubstituted or substituted benzyl, unsubstituted or substituted phenoxy, halogen-containing or halogen-free C1-C6 alkyl, halogen-containing or halogen-free C2-C6 alkenyl, halogen-containing or halogen-free C2-C6 alkynyl, halogen-containing or halogen-free C3-C6 cycloalkyl, halogen-containing or halogen-free C3-C6 cycloalkyl C1-C2 alkyl, halogen-containing or halogen-free OR″, halogen-containing or halogen-free SR″, halogen-containing or halogen-free —(C1-C2)alkyl-OR″, halogen-containing or halogen-free —(C1-C2 alkyl-SR″, halogen-containing or halogen-free COR″, halogen-containing or halogen-free COOR″, halogen-containing or halogen-free COSR″, halogen-containing or halogen-free SOR″, halogen-containing or halogen-free SO2R″, halogen-containing or halogen-free OCOR″, halogen-containing or halogen-free SCOR″, substituted amino, substituted aminocarbonyl, —OCH2CH2—, —OCH2O—, and —OCH2CH2O—, wherein the substituted phenyl, the substituted benzyl or the substituted phenoxy is phenyl, benzyl or phenoxy substituted by 1, 2 or 3 groups selected from halogen, C1-C6 alkyl and C1-C6 alkoxy, the substituted amino or the substituted aminocarbonyl is amino or aminocarbonyl substituted by one or two groups selected from hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C3-C6 cycloalkyl C1-C2 alkyl, COR″, SO2R″ and OR″;


R′ independently represents hydrogen, nitro, hydroxy, amino, fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing C1-C6 alkyl, fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing C2-C6 alkenyl, fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing C2-C6 alkynyl, fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing C3-C6 cycloalkyl, fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing C3-C6 cycloalkenyl, fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing C3-C8 cycloalkyl C1-C2 alkyl, fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing C1-C6 alkoxy, fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing C2-C6 alkenyloxy, fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing C2-C6 alkynyloxy, fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing C3-C6 cycloalkyloxy, fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing C1-C6 alkoxy C1-C2 alkyl, fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing C1-C6 alkoxy carbonyl, fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing C1-C6 alkylthio carbonyl, fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing C1-C6 alkylsulfonyl, fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing C1-C6 alkylsulfonyl C1-C2 alkyl, fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing C1-C6 alkyl carbonyl, fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing C1-C6 alkyl carbonyl C1-C2 alkyl, fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing C1-C6 alkyl acyloxy, fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing C1-C6 alkylamino, fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing C1-C6 alkylamino carbonyl, fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing C1-C6 alkoxyamino carbonyl, fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing C1-C6 alkoxy carbonyl C1-C2 alkyl, fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing C1-C6 alkylamino carbonyl C1-C2 alkyl, fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing tri(C1-C6)alkylsilyl, or fluorine-, chlorine-, bromine-free or fluorine-, chlorine-, bromine-containing di(C1-C6)alkylphosphonyl;


R″ independently represents hydrogen, halogen-free or halogen-containing C1-C6 alkyl, halogen-free or halogen-containing C2-C6 alkenyl, halogen-free or halogen-containing C2-C6 alkynyl, halogen-free or halogen-containing C3-C6 cycloalkyl or halogen-free or halogen-containing C3-C6 cycloalkyl C1-C2 alkyl.


Further preferably, X represents S, SO or SO2;


Y represents C2-C8 alkyl, halo C1-C8 alkyl, C2-C8 alkenyl, C2-C8 alkynyl, C1-C8 alkoxy C1-C8 alkyl, hydroxy C1-C8 alkyl, cyano, cyano C1-C8 alkyl, amino C1-C8 alkyl, C1-C8 alkyl amino C1-C8 alkyl, C1-C8 alkyl carbonyl, C3-C8 cycloalkyl, C3-C8 cycloalkyl C1-C8 alkyl, di(C1-C8)alkylamino carbonyl C1-C8 alkyl, C1-C8 alkyl carbonyl C1-C8 alkyl, C1-C8 alkoxy carbonyl C1-C8 alkyl, C1-C8 alkyl carbonyloxy C1-C8 alkyl, C1-C8 alkyl sulfinyl C1-C8 alkyl, tri(C1-C8)alkylsiloxy C1-C8 alkyl, heterocyclyl, heterocyclyl C1-C8 alkyl, phenyl, heteroaryl, heteroaryl C1-C8 alkyl, —(C1-C8)alkyl-O—N═C(R′″)2;


wherein the heterocyclyl is




embedded image


the heteroaryl is




embedded image


which is unsubstituted or substituted by C1-C8 alkyl; and R′″ independently represents C1-C8 alkyl;


Z represents hydrogen, or C1-C8 alkyl;


M represents hydrogen, or C1-C8 alkoxy carbonyloxy C1-C8 alkyl;


preferably, X represents S, SO or SO2;


Y represents C2-C6 alkyl, halo C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 alkoxy C1-C6 alkyl, hydroxy C1-C6 alkyl, cyano, cyano C1-C6 alkyl, amino C1-C6 alkyl, C1-C6 alkylamino C1-C6 alkyl, C1-C6 alkyl carbonyl, C3-C6 cycloalkyl, C3-C6 cycloalkyl C1-C6 alkyl, di(C1-C6)alkylamino carbonyl C1-C6 alkyl, C1-C6 alkyl carbonyl C1-C6 alkyl, C1-C6 alkoxy carbonyl C1-C6 alkyl, C1-C6 alkyl carbonyloxy C1-C6 alkyl, C1-C6 alkyl sulfinyl C1-C6 alkyl, tri(C1-C6)alkylsiloxy C1-C6 alkyl, heterocyclyl, heterocyclyl C1-C6 alkyl, phenyl, heteroaryl, heteroaryl C1-C6 alkyl, —(C1-C6)alkyl-O—N═C(R′″)2;


wherein, the heterocyclyl is




embedded image


the heteroaryl is




embedded image


which is unsubstituted or substituted by C1-C6 alkyl; and R′″ independently represents C1-C6 alkyl;


Z represents hydrogen, or C1-C6alkyl;


M represents hydrogen, or C1-C6 alkoxy carbonyloxy C1-C6 alkyl.


Further preferably, the compound is preferably




embedded image


wherein Y, Z and M are as defined above.


In the definition of the compound represented by the above Formula I and all of the following structural formulas, the technical terms used, whether used alone or used in compound word, represent the following substituents: an alkyl having more than two carbon atoms may be linear or branched. For example, the alkyl in the compound word “-alkyl-N(R2)2” may be —CH2—, —CH2CH2—, —CH(CH3)—, and the like. The alkyl is, for example, C1 alkyl: methyl; C2 alkyl: ethyl; C3 alkyl: propyl such as n-propyl or isopropyl; C4 alkyl: butyl such as n-butyl, isobutyl, tert-butyl or 2-butyl; C5 alkyl: pentyl such as n-pentyl; C6 alkyl: hexyl such as n-hexyl, isohexyl and 1,3-dimethylbutyl. Similarly, the alkenyl is, for example, allyl, 1-methylprop-2-en-1-yl, 2-methylprop-2-en-1-yl, but-2-en-1-yl, butyl-3-en-1-yl, 1-methylbut-3-en-1-yl and 1-methylbut-2-en-1-yl. The alkynyl is, for example, propargyl, but-2-yn-1-yl, but-3-yn-1-yl, 1-methylbut-3-yn-1-yl. Multiple bonds may be placed at any position of each unsaturated group. The cycloalkyl is a carbocyclic saturated ring system having, for example, three to six carbon atoms, such as cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl. Similarly, the cycloalkenyl is monocycloalkenyl having, for example, three to six carbon ring members, such as cyclopropenyl, cyclobutenyl, cyclopentenyl, and cyclohexenyl, wherein double bond can be at any position. Halogen is fluorine, chlorine, bromine or iodine.


Unless otherwise specified, the “aryl” of the present invention includes, but is not limited to, phenyl, naphthyl,




embedded image


the heterocyclyl is a saturated, partially saturated or completely unsaturated cyclic group having 3 to 6 ring atoms and which may also be fused with a benzo ring, wherein 1 to 4 (for example, 1, 2, 3 or 4) heteroatoms of the ring are selected from the group consisting of oxygen, nitrogen and sulfur. For example, the heterocyclyl includes, but is not limited to,




embedded image


which has 0, 1 or 2 oxo groups. The heteroaryl is an aromatic cyclic group having, for example, 3 to 6 ring atoms and which may also be fused with a benzo ring, and 1 to 4 (for example, 1, 2, 3 or 4) heteroatoms of the ring are selected from the group consisting of oxygen, nitrogen and sulfur. For example, the heteroaryl group is




embedded image


embedded image


wherein R′ is as defined above.


If a group is substituted by a group, which should be understood to mean that the group is substituted by one or more groups, which are same or different groups, selected from the mentioned groups. In addition, the same or different substitution characters contained in the same or different substituents are independently selected, for example, the four R2 groups in “N(R2)2” and “-alkyl-N(R2)2” are independently selected from the groups represented by R2 and may be the same or different, and the three R3 groups in “Si(R3)3” are independently selected from the groups represented by R3 and may be the same or different.


In addition, unless specifically defined, the determinatives of the multiple parallel substituent (separated with “, “or” or”) of the present invention has limiting effect for each substituent, such as “alkyl, alkenyl, alkynyl or cycloalkyl, which is with or without halogen” means that “with or without halogen” has limiting effect on each group “alkyl”, “alkenyl”, “alkynyl”, “cycloalkyl”.


The salt derivative is a salt used in a common agricultural chemical, and for example, may be a metal salt, an amine salt, a sulfonium salt or a phosphonium salt, or when a molecule has a basic portion, it may be prepared into a salt such as a sulfate, a chloride, a nitrate, a phosphate. When these salts are used as herbicides for agriculture and horticulture, they are also included in the present invention. In the present invention, the “metal salt” may be, for example, an alkali metal salt, an alkaline earth metal salt, an aluminum salt or an iron salt. The “alkali metal salt” may be, for example, a sodium salt, a potassium salt or a lithium salt, preferably a sodium salt or a potassium salt. The “alkaline earth metal salt” may be, for example, a calcium salt or a magnesium salt, preferably a calcium salt. In the present invention, the “amine salt” may be, for example, an alkyl secondary amine salt, an alkyl tertiary amine salt or an alkyl quaternary ammonium salt; an alkanol primary amine salt, an alkanol secondary amine salt, an alkanol tertiary amine salt or an alkanol quaternary ammonium salt; an alkyl alkanol primary amine salt, an alkyl alkanol secondary amine salt, an alkyl alkanol tertiary amine salt or an alkyl alkanol tertiary amine salt; or an alkoxy alkanol primary amine salt, an alkoxy alkanol secondary salt, an alkoxy alkanol tertiary amine salt or an alkoxyalkanol quaternary ammonium salt, preferably wherein the alkyl, the alkanol and the alkoxy are independently saturated and independently contain 1 to 4 carbon atoms and may also be substituted by phenyl group and/or halogen. More preferably, the “amine salt” is a monoethanolamine salt, a dimethylethanolamine salt, a triethanolamine salt, a dimethylamine salt, a triethylamine salt, an isopropylamine salt, a choline salt, a diglycolamine salt,




embedded image


In the present invention, the “sulfonium salt” and “phosphonium salt” may, for example, be an alkyl sulfonium salt, an alkyl phosphonium salt or an alkanol phosphonium salt, preferably wherein the alkyl is independently saturated and independently contains 1 to 4 carbon atoms and may also be substituted by phenyl and/or halogen. More preferably, the “sulfonium salt” is




embedded image


The solvates of the compounds of the present invention are also encompassed in the invention.


Depending on the property of substituents and the linkage manner thereof, the compound of Formula I may exist as a stereoisomer. For example, if a compound has one or more asymmetric carbon or sulfur atoms, it may has enantiomers and diastereomers. The stereoisomer can be obtained from the mixtures obtained in the preparation by conventional separation methods, for example by chromatographic separation. The stereoisomer may also be prepared selectively by using stereoselective reactions and using optically active starting materials and/or auxiliaries. The present invention also relates to all stereoisomers and mixtures thereof which are included in the general Formula I but are not specifically defined.


The present invention also provides a method for preparing the N-(1,3,4-oxadiazol-2-yl)arylcarboxamide compound, comprising the steps of:


a) when X represents Q in the Formula I, the method comprises the following steps:


(1) reacting a compound represented by Formula II with a compound represented by Formula III to prepare a compound represented by Formula IV;


(2) reacting the compound represented by Formula IV with carbon dioxide to obtain a compound represented by Formula V;


(3) reacting the compound represented by Formula V with a compound represented by VI in the presence of a halogenating agent to obtain a compound represented by Formula I-1;


wherein the reaction equation is as follows:




embedded image


wherein, Q represents O, S or NR1;


preferably, wherein the reaction of step (1) is carried out in the presence of a base and a solvent; more preferably, the base is one base or two bases in combination selected from the group consisting of NaOH and KOH, the solvent is one solvent or more solvents in combination selected from the group consisting of DMF, DCM, DCE, ACN, THF, and TFA; the reaction is conducted at a temperature of 0 to 25° C.;


the reaction of step (2) is carried out in the presence of a catalyst and a solvent;


preferably, the catalyst is n-butyllithium, the solvent is one solvent or more solvents in combination selected from THF, DMF, DCM, DCE, ACN, and TFA; the reaction is conducted at a temperature of −100 to −50° C.;


the reaction of step (3) is carried out in the presence of a halogenating agent, a catalyst and a solvent; preferably, the halogenating agent is SOCl2, the catalyst is 4-dimethylaminopyridine, and the solvent is pyridine; the reaction is conducted at a temperature of 0 to 50° C.


Alternatively, b) when X represents S in the Formula I, the method comprises the following steps:


according to the above-mentioned method of the compound represented by Formula I-1, preparing the compound represented by Formula I-2, and then subjecting to a dealkylation reaction; preferably, wherein the reaction is carried out in the presence of a solvent; more preferably, the solvent is one solvent or more solvents in combination selected from DCM, DCE, ACN, DMF, THF, and TFA; the reaction is conducted at a temperature of 20 to 120° C.;


and then reacting the obtained compound represented by Formula VII with Hal-Y to prepare a compound represented by Formula I-3; preferably, wherein the reaction is carried out in the presence of a base and a solvent; more preferably, the base is one base or two bases in combination selected from the group consisting of potassium carbonate and sodium carbonate, the solvent is one solvent or more solvents in combination selected from the group consisting of DCM, DCE, ACN, THF, and DMF; the reaction is conducted at a temperature of 0 to 25° C.;


wherein the reaction equation is as follows:




embedded image


wherein, Hal represents halogen, preferably fluorine, chlorine or bromine.


Alternatively, c) when X represents SO, or SO2 in the Formula I, the method comprises the following steps:


reacting a compound represented by Formula I-3 with a peroxide to prepare a compound represented by Formula I-4 and/or I-5;


wherein the reaction equation is as follows:




embedded image


preferably, wherein the peroxide is




embedded image


the reaction is carried out in the presence of a solvent; more preferably, the solvent is one solvent or two solvents in combination selected from the group consisting of DCM and DCE; and the reaction is conducted at a temperature of 0 to 50° C.


Alternatively, d) when M is not hydrogen in Formula I, the method comprises the following steps:


reacting compounds represented by Formulas I-1, I-4 or I-5 with Hal-M to prepare compounds represented by Formulas I-6, I-7, or I-8, respectively;


wherein the reaction equation is as follows:




embedded image


preferably, wherein the reaction is carried out in the presence of a base and a solvent; more preferably, the base is one base or two bases in combination selected from the group consisting of potassium carbonate and sodium carbonate, the solvent is one solvent or more solvents in combination selected from the group consisting of DCM, DCE, ACN, THF, and DMF, the reaction is conducted at a temperature of 0 to 100° C.;


alternatively, the reaction is carried out in the presence of a catalyst and a solvent;


preferably, the catalyst is 4-dimethylaminopyridine, the solvent is pyridine, and the reaction is conducted at a temperature of 0 to 80° C.


The present invention also provides a herbicidal composition, comprising (i) an N-(1,3,4-oxadiazol-2-yl)arylcarboxamide compound represented by Formula I; preferably, further comprising (ii) one or more additional herbicides and/or safeners; more preferably, further comprising (iii) an agrochemically acceptable formulation auxiliary.


The additional herbicides include the following compounds or salt or ester derivatives thereof;


a) ALS inhibitors: Pyrazosulfuron-ethyl (cas: 93697-74-6), Penoxsulam (cas: 219714-96-2), Bispyribac-sodium (cas: 125401-92-5), Pyriminobac-methyl (cas No.: 147411-69-6), Metazosulfuron (cas number: 868680-84-6), Propyrisulfuron (cas number: 570415-88-2), Triafamone (cas number: 874195-61-6);


b) ACCase inhibitors: Cyhalofop-butyl (cas number: 122008-85-9), Metamifop (cas number: 256412-89-2);


c) Hormones inhibitors: Quinclorac (cas number: 84087-01-4), MCPA (cas number: 94-74-6), 2,4-D (cas number: 94-75-7), 2,4-D butyric acid (cas number: 94-82-6), Fluroxypyr (cas number: 69377-81-7), Florpyrauxifen-benzyl (cas number: 1390661-72-9), MCPA butyric acid (cas number: 94-81-5), Dicamba (cas number: 1918-00-9), Quintrione (cas number: 130901-36-8), Clopyralid (cas number: 1702-17-6), Trichlopyr (cas number: 55335-06-3);


d) Cell division inhibitors: Pendimethalin (cas number: 40487-42-1), Butralin (cas number: 33629-47-9);


e) Lipid synthesis (non-ACC) inhibitors: Benthiocarb (cas number: 28249-77-6), Molinate (cas number: 2212-67-1);


f) HPPD inhibitors: Sanzuohuangcaotong (custom-character) (cas number: 1911613-97-2), Shuangzuocaotong (custom-character) (cas number: 1622908-18-2), Huanbifucaotong (custom-character) (cas number: 1855929-45-1), Mesotrione (cas number: 104206-82-8), Benzobicylon (cas number: 156963-66-5), Tefuryltrione (cas number: 473278-76-1);


g) PDS inhibitors: Diflufenican (cas number: 83164-33-4), Fluorochloridone (cas number: 61213-25-0), Beflubutamid (cas number: 113614-08-7);


h) PPO inhibitors: Carfentrazone-ethyl (cas number: 128621-72-7), Pyraclonil (cas number: 158353-15-2), Oxadiazon (cas number: 19666-30-9), Oxadiargyl (cas number: 39807-15-3), Oxyfluorfen (cas number: 42874-03-3), Pentoxazone (cas number: 110956-75-7);


i) Long-chain fatty acid synthesis inhibitors: Butachlor (cas number: 23184-66-9), Pretilachlor (cas number: 51218-49-6), Mefenacet (cas number: 73250-68-7), Anilofos (cas number: 64249-01-0), Fentrazamide (cas number: 158237-07-1), Metolachlor (cas number: 51218-45-2), Piperophos (cas number: 24151-93-7), Pyroxasulfone (cas number: 447399-55-5);


j) PSII inhibitors: Simetryn (cas number: 1014-70-6), Prometryn (cas number: 7287-19-6), Amicarbazone (cas number: 129909-90-6), Isoproturon (cas number: 34123-59-6), Bromacil (cas number: 314-40-9), Pyridate (cas number: 55512-33-9), Chlortoluron (cas number: 15545-48-9), Bentazone (cas number: 25057-89-0), Propanil (cas number: 709-98-8), Metribuzin (cas number: 21087-64-9), Atrazine (cas No.: 1912-24-9), Bromoxynil (cas number: 1689-84-5), Bromoxynil octanoate (cas number: 1689-99-2), Terbuthylazine (CAS number: 5915-41-3);


k) DOXP inhibitors: Clomazone (cas number: 81777-89-1);


l) Others: Oxaziclomefone (cas number: 153197-14-9), Cinmethylin (cas number: 87818-31-3), Indanofan (cas number: 133220-30-1).


In the context of the present description, if an abbreviation of a generic name of active compound is used, it includes in each case all conventional derivatives thereof, such as esters and salts as well as isomers, in particular optical isomers, in particular one or more commercially available forms thereof. If the generic name denotes an ester or a salt, it also includes in each case all other conventional derivatives, such as other esters and salts, free acids and neutral compounds, as well as isomers, in particular optical isomers, in particular one or more commercially available forms thereof. The chemical name given to a compound means at least one compound encompassed by the generic name, and generally the preferred compound. In the case of sulfamide such as sulfonylurea, the salt thereof also includes a salt formed by exchanging a cation with a hydrogen atom in sulfonamide group. For example, 2,4-D or 2,4-D butyric acid derivatives include, but are not limited to, salts of 2,4-D or 2,4-D butyric acid, such as sodium salt, potassium salt, dimethylammonium salt, triethanol ammonium salt, isopropylamine salt, choline salt, etc., and esters of 2,4-D or 2,4-D butyric acid, such as methyl ester, ethyl ester, butyl ester, isooctyl ester, etc.; MCPA derivatives include, but are not limited to: MCPA sodium salt, potassium salt, dimethylammonium salt, isopropylamine salt, etc., and MCPA methyl ester, ethyl ester, isooctyl ester, ethyl thioester and the like.


The present invention also provides a method for controlling a weed, comprising: applying at least one of the N-(1,3,4-oxadiazol-2-yl)arylcarboxamide compound or the herbicidal composition in an herbicidally effective amount on a plant or in a weed area, preferably, wherein the plant is a rice (such as indica rice, japonica rice), the weed is a gramineous weed (such as Echinochloa phyllopogon, Leptochloa chinensis, Echinochloa crusgali, Digitaria sanguinalis, Setaria viridis), a broad-leaved weed (such as Monochoria vaginalis, Sagittaria trifolia, Abutilon theophrasti, Amaranthus retroflexus, Stellaria media), or a cyperaceae weed (such as Cyperus difformis, Scirpus juncoides).


The present invention also provides a use of at least one of the N-(1,3,4-oxadiazol-2-yl)arylcarboxamide compound or the herbicidal composition as above-described for controlling a weed, preferably, wherein the N-(1,3,4-oxadiazol-2-yl)arylcarboxamide compound is used for preventing and/or controlling a weed in a useful crop, wherein the useful crop is a transgenic crop or a crop treated by gene editing technique, the crop is a rice (such as indica rice, japonica rice), the weed is a gramineous weed (such as Echinochloa phyllopogon, Leptochloa chinensis, Echinochloa crusgali, Digitaria sanguinalis, Setaria viridis), a broad-leaved weed (such as Monochoria vaginalis, Sagittaria trifolia, Abutilon theophrasti, Amaranthus retroflexus, Stellaria media), a cyperaceae weed (such as Cyperus difformis, Scirpus juncoides).


The compounds of the formula I according to the invention have an outstanding herbicidal activity against a broad spectrum of economically important monocotyledonous and dicotyledonous harmful plants. The active compounds also act efficiently on perennial weeds which produce shoots from rhizomes, root stocks or other perennial organs and which are difficult to control. In this context, it is generally immaterial whether the substances are applied pre-sowing, pre-emergence or post-emergence. Specifically, examples may be mentioned of some representatives of the monocotyledonous and dicotyledonous weed flora which can be controlled by the compounds according to the invention, without these being a restriction to certain species. Examples of weed species on which the active compounds act efficiently are, from amongst the monocotyledons, Avena, Lolium, Alopecurus, Phalaris, Echinochloa, Digitaria, Setaria and also Cyperus species from the annual sector and from amongst the perennial species Agropyron, Cynodon, Imperata and Sorghum, and also perennial Cyperus species.


In the case of the dicotyledonous weed species, the spectrum of action extends to species such as, for example, Galium, Viola, Veronica, Lamium, Stellaria, Amaranthus, Sinapis, Ipomoea, Sida, Matricaria and Abutilon from amongst the annuals, and Convolvulus, Cirsium, Rumex and Artemisia in the case of the perennial weeds. The active compounds according to the invention also effect outstanding control of harmful plants which occur under the specific conditions of rice growing such as, for example, Echinochloa, Sagittaria, Alisma, Eleocharis, Scirpus and Cyperus. If the compounds according to the invention are applied to the soil surface prior to germination, then the weed seedlings are either prevented completely from emerging, or the weeds grow until they have reached the cotyledon stage but then their growth stops, and, eventually, after three to four weeks have elapsed, they die completely. If the compounds according to the invention are applied to the soil surface prior to germination, then the weed seedlings are either prevented completely from emerging, or the weeds grow until they have reached the cotyledon stage but then their growth stops, and, eventually, after three to four weeks have elapsed, they die completely. In particular, the compounds according to the invention exhibit excellent activity against Apera spica venti, Chenopodium album, Lamium purpureum, Polygonum convulvulus, Stellaria media, Veronica hederifolia, Veronica persica, Viola tricolor and against Amaranthus, Galium and Kochia species.


Although the compounds according to the invention have an excellent herbicidal activity against monocotyledonous and dicotyledonous weeds, crop plants of economically important crops such as, for example, wheat, barley, rye, rice, corn, sugarbeet, cotton and soya, are not damaged at all, or only to a negligible extent. In particular, they have excellent compatibility in cereals, such as wheat, barley and corn, in particular wheat. For these reasons, the present compounds are highly suitable for selectively controlling undesired plant growth in plantings for agricultural use or in plantings of ornamentals.


Owing to their herbicidal properties, these active compounds can also be employed for controlling harmful plants in crops of known or still to be developed genetically engineered plants. The transgenic plants generally have particularly advantageous properties, for example resistance to certain pesticides, in particular certain herbicides, resistance to plant diseases or causative organisms of plant diseases, such as certain insects or microorganisms such as fungi, bacteria or viruses. Other particular properties relate, for example, to the quantity, quality, storage-stability, composition and to specific ingredients of the harvested product. Thus, transgenic plants having an increased starch content or a modified quality of the starch or those having a different fatty acid composition of the harvested produce are known.


The use of the compounds of the formula I according to the invention or their salts in economically important transgenic crops of useful and ornamental plants, for example of cereal, such as wheat, barley, rye, oats, millet, rice, maniok and corn, or else in crops of sugarbeet, cotton, soya, rapeseed, potato, tomato, pea and other vegetable species is preferred. The compounds of the formula I can preferably be used as herbicides in crops of useful plants which are resistant or which have been made resistant by genetic engineering toward the phytotoxic effects of the herbicides.


Conventional ways for preparing novel plants which have modified properties compared to known plants comprise, for example, traditional breeding methods and the generation of mutants. Alternatively, novel plants having modified properties can be generated with the aid of genetic engineering methods (see, for example, EP-A 0 221 044, EP-A 0 131 624). For example, there have been described several cases of:

    • genetically engineered changes in crop plants in order to modify the starch synthesized in the plants (for example WO 92/11376, WO 92/14827, WO 91/19806),
    • transgenic crop plants which are resistant to certain herbicides of the glufosinate-(cf., for example, EP-A 0 242 236, EP-A 0 242 246) or glyphosate-type (WO 92/00377), or of the sulfonylurea-type (EP-A 0 257 993, U.S. Pat. No. 5,013,659A),
    • transgenic crop plants, for example cotton, having the ability to produce Bacillus thuringiensis toxins (Bt toxins) which impart resistance to certain pests to the plants (EP-A 0 142 924, EP-A 0 193 259),
    • transgenic crop plants having a modified fatty acid composition (WO 91/13972).


Numerous molecular biological techniques which allow the preparation of novel transgenic plants having modified properties are known in principle; see, for example, Sambrook et al., 1989, Molecular Cloning, A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.; or Winnacker “Gene and Klone” [Genes and Clones], VCH Weinheim, 2nd edition 1996, or Christou, “Trends in Plant Science” 1 (1996) 423-431). In order to carry out such genetic engineering manipulations, it is possible to introduce nucleic acid molecules into plasmids which allow a mutagenesis or a change in the sequence to occur by recombination of DNA sequences. Using the abovementioned standard processes it is possible, for example, to exchange bases, to remove partial sequences or to add natural or synthetic sequences. To link the DNA fragments with each other, it is possible to attach adaptors or linkers to the fragments.


Plant cells having a reduced activity of a gene product can be prepared, for example, by expressing at least one appropriate antisense-RNA, a sense-RNA to achieve a cosuppression effect, or by expressing at least one appropriately constructed ribozyme which specifically cleaves transcripts of the above-mentioned gene product.


To this end it is possible to employ both DNA molecules which comprise the entire coding sequence of a gene product including any flanking sequences that may be present, and DNA molecules which comprise only parts of the coding sequence, it being necessary for these parts to be long enough to cause an antisense effect in the cells. It is also possible to use DNA sequences which have a high degree of homology to the coding sequences of a gene product but which are not entirely identical.


When expressing nucleic acid molecules in plants, the synthesized protein can be localized in any desired compartment of the plant cells. However, to achieve localization in a certain compartment, it is, for example, possible to link the coding region with DNA sequences which ensure localization in a certain compartment. Such sequences are known to the person skilled in the art (see, for example, Braun et al., EMBO J. 11 (1992), 3219-3227; Wolter et al., Proc. Natl. Acad. Sci. USA 85 (1988), 846-850; Sonnewald et al., Plant J. 1 (1991), 95-106).


The transgenic plant cells can be regenerated to whole plants using known techniques. The transgenic plants can in principle be plants of any desired plant species, i.e. both monocotyledonous and dicotyledonous plants. In this manner, it is possible to obtain transgenic plants which have modified properties by overexpression, suppression or inhibition of homologous (=natural) genes or gene sequences or by expression of heterologous (=foreign) genes or gene sequences.


When using the active compounds according to the invention in transgenic crops, in addition to the effects against harmful plants which can be observed in other crops, there are frequently effects which are specific for the application in the respective transgenic crop, for example a modified or specifically broadened spectrum of weeds which can be controlled, modified application rates which can be used for the application, preferably good combinability with the herbicides to which the transgenic crops are resistant, and an effect on the growth and the yield of the transgenic crop plants. The invention therefore also provides for the use of the compounds according to the invention as herbicides for controlling harmful plants in transgenic crop plants.


In addition, the substances according to the invention have outstanding growth-regulating properties in crop plants. They engage in the plant metabolism in a regulating manner and can this be employed for the targeted control of plant constituents and for facilitating harvesting, for example by provoking desiccation and stunted growth. Furthermore, they are also suitable for generally regulating and inhibiting undesirable vegetative growth, without destroying the plants in the process. Inhibition of vegetative growth plays an important role in many monocotyledon and dicotyledon crops because lodging can be reduced hereby, or prevented completely.


The compounds according to the invention can be applied in the customary formulations in the form of wettable powders, emulsifiable concentrates, sprayable solutions, dusts or granules. The invention therefore also provides herbicidal compositions comprising compounds of the formula I. The compounds of the formula I can be formulated in various ways depending on the prevailing biological and/or chemico-physical parameters. Examples of suitable formulation options are: wettable powders (WP), water-soluble powders (SP), water-soluble concentrates, emulsifiable concentrates (EC), emulsions (EW), such as oil-in-water and water-in-oil emulsions, sprayable solutions, suspension concentrates (SC), oil dispersions (OD), oil- or water-based dispersions, oil-miscible solutions, dusts (DP), capsule suspensions (CS), seed-dressing compositions, granules for broadcasting and soil application, granules (GR) in the form of microgranules, spray granules, coating granules and adsorption granules, water-dispersible granules (WG), water-soluble granules (SG), ULV formulations, microcapsules and waxes. These individual formulation types are known in principle and are described, for example, in Winnacker-Kühler, “Chemische Technologie” [Chemical Technology], Volume 7, C. Hauser Verlag Munich, 4th. Edition 1986; Wade van Valkenburg, “Pesticide Formulations”, Marcel Dekker, N.Y., 1973; K. Martens, “Spray Drying” Handbook, 3rd Ed. 1979, G. Goodwin Ltd. London.


The necessary formulation auxiliaries, such as inert materials, surfactants, solvents and other additives, are likewise known and are described, for example, in Watkins, “Handbook of Insecticide Dust Diluents and Carriers”, 2nd Ed., Darland Books, Caldwell N.J., H. v. Olphen, “Introduction to Clay Colloid Chemistry”; 2nd Ed., J. Wiley & Sons, N.Y.; C. Marsden, “Solvents Guide”; 2nd Ed., Interscience, N.Y. 1963; McCutcheon's “Detergents and Emulsifiers Annual”, MC Publ. Corp., Ridgewood N.J.; Sisley and Wood, “Encyclopedia of Surface Active Agents”, Chem. Publ. Co. Inc., N.Y. 1964; Schonfeldt, “Grenzflüchenaktive Äthylenoxidaddkte” [Surface-active ethylene oxide adducts], Wiss. Verlagagesell. Stuttgart 1976; Winnacker-Küchler, “Chemische Technologie” [Chemical Technology], Volume 7, C. Hauser Verlag Munich, 4th Edition 1986.


Wettable powders are preparations which are uniformly dispersible in water and which contain, in addition to the active compound and as well as a diluent or inert substance, surfactants of ionic and/or nonionic type (wetting agents, dispersants), for example polyethoxylated alkyl phenols, polyethoxylated fatty alcohols, polyethoxylated fatty amines, fatty alcohol polyglycol ethersulfates, alkanesulfonates, alkylbenzenesulfonates, sodium ligninsulfonate, sodium 2,2′-dinaphthylmethane-6,6′-disulfonate, sodium dibutyinaphthalenesulfona-te or else sodium oleoylmethyltaurinate. To prepare the wettable powders, the herbicidally active compounds are finely ground, for example in customary apparatus such as hammer mills, fan mills and air-jet mills, and are mixed simultaneously or subsequently with the formulation auxiliaries.


Emulsifiable concentrates are prepared by dissolving the active compound in an organic solvent, for example butanol, cyclohexanone, dimethylformamide, xylene or else relatively high-boiling aromatic compounds or hydrocarbons or mixtures of the solvents, with the addition of one or more surfactants of ionic and/or nonionic type (emulsifiers). Examples of emulsifiers which can be used are calcium alkylarylsulfonates, such as Ca dodecylbenzenesulfonate, or nonionic emulsifiers, such as fatty acid polyglycol esters, alkylaryl polyglycol ethers, fatty alcohol polyglycol ethers, propylene oxide-ethylene oxide condensation products, alkyl polyethers, sorbitan esters, for example sorbitan fatty acid esters or polyoxyethylene sorbitan esters, for example polyoxyethylene sorbitan fatty acid esters.


Dusts are obtained by grinding the active compound with finely divided solid substances, for example talc, natural clays, such as kaolin, bentonite and pyrophyllite, or diatomaceous earth. Suspension concentrates can be water- or oil-based. They can be prepared, for example, by wet milling using commercially customary bead mills, with or without the addition of surfactants as already mentioned above, for example, in the case of the other formulation types.


Emulsions, for example oil-in-water emulsions (EW), can be prepared for example by means of stirrers, colloid mills and/or static mixers using aqueous organic solvents and, if desired, surfactants as already mentioned above, for example, in the case of the other formulation types.


Granules can be prepared either by spraying the active compound onto adsorptive, granulated inert material or by applying active-compound concentrates to the surface of carriers such as sand, kaolinites or granulated inert material, by means of adhesive binders, for example polyvinyl alcohol, sodium polyacrylate or else mineral oils. Suitable active compounds can also be granulated in the manner which is customary for the preparation of fertilizer granules, if desired as a mixture with fertilizers. Water-dispersible granules are generally prepared by the customary processes, such as spray-drying, fluidized-bed granulation, disk granulation, mixing using high-speed mixers, and extrusion without solid inert material.


For the preparation of disk, fluidized-bed, extruder and spray granules, see for example processes in “Spray-Drying Handbook” 3rd ed. 1979, G. Goodwin Ltd., London; J. E. Browning, “Agglomeration”, Chemical and Engineering 1967, pages 147 ff.; “Perry's Chemical Engineer's Handbook”, 5th Ed., McGraw-Hill, New York 1973, pp. 8-57. For further details on the formulation of crop protection products, see for example G. C. Klingman, “Weed Control as a Science”, John Wiley and Sons Inc., New York, 1961, pages 81-96 and J. D. Freyer, S. A. Evans, “Weed Control Handbook”, 5th Ed., Blackwell Scientific Publications, Oxford, 1968, pages 101-103.


The agrochemical formulations generally contain from 0.1 to 99% by weight, in particular from 0.1 to 95% by weight, of active compound of the formula I. In wettable powders the concentration of active compound is, for example, from about 10 to 99% by weight, the remainder to 100% by weight consisting of customary formulation constituents. In emulsifiable concentrates the concentration of active compound can be from about 1 to 90%, preferably from 5 to 80%, by weight. Formulations in the form of dusts contain from 1 to 30% by weight of active compound, preferably most commonly from 5 to 20% by weight of active compound, while sprayable solutions contain from about 0.05 to 80%, preferably from 2 to 50%, by weight of active compound. In the case of water-dispersible granules the content of active compound depends partly on whether the active compound is in liquid or solid form and on the granulation auxiliaries, fillers, etc. that are used. In water-dispersible granules the content of active compound, for example, is between 1 and 95% by weight, preferably between 10 and 80% by weight.


In addition, the formulations of active compound may comprise the tackifiers, wetting agents, dispersants, emulsifiers, penetrants, preservatives, antifreeze agents, solvents, fillers, carriers, colorants, antifoams, evaporation inhibitors and pH and viscosity regulators which are customary in each case.


Based on these formulations it is also possible to produce combinations with other pesticidally active substances, for example insecticides, acaricides, herbicides and fungicides, and also with safeners, fertilizers and/or growth regulators, for example in the form of a ready-mix or tank mix.


Suitable active compounds which can be combined with the active compounds according to the invention in mixed formulations or in a tank mix are, for example, known active compounds as described in for example World Herbicide New Product Technology Handbook, China Agricultural Science and Farming Techniques Press, 2010.9 and in the literature cited therein. For example the following active compounds may be mentioned as herbicides which can be combined with the compounds of the formula I (note: the compounds are either named by the “common name” in accordance with the International Organization for Standardization (ISO) or by the chemical names, if appropriate together with a customary code number): acetochlor, butachlor, alachlor, propisochlor, metolachlor, s-metolachlor, pretilachlor, propachlor, ethachlor, napropamide, R-left handed napropamide, propanil, mefenacet, diphenamid, diflufenican, ethaprochlor, beflubutamid, bromobutide, dimethenamid, dimethenamid-P, etobenzanid, flufenacet, thenylchlor, metazachlor, isoxaben, flamprop-M-methyl, flamprop-M-propyl, allidochlor, pethoxamid, chloranocryl, cyprazine, mefluidide, monalide, delachlor, prynachlor, terbuchlor, xylachlor, dimethachlor, cisanilide, trimexachlor, clomeprop, propyzamide, pentanochlor, carbetamide, benzoylprop-ethyl, cyprazole, butenachlor, tebutam, benzipram, mogrton, dichlofluanid, naproanilide, diethatyl-ethyl, naptalam, flufenacet, benzadox, chlorthiamid, chlorophthalimide, isocarbamide, picolinafen, atrazine, simazine, prometryn, cyanatryn, simetryn, ametryn, propazine, dipropetryn, SSH-108, terbutryn, terbuthylazine, triaziflam, cyprazine, proglinazine, trietazine, prometon, simetone, aziprotryne, desmetryn, dimethametryn, procyazine, mesoprazine, sebuthylazine, secbumeton, terbumeton, methoprotryne, cyanatryn, ipazine, chlorazine, atraton, pendimethalin, eglinazine, cyanuric acid, indaziflam, chlorsulfuron, metsulfuron-methyl, bensulfuron methyl, chlorimuron-ethyl, tribenuron-methyl, thifensulfuron-methyl, pyrazosulfuron-ethyl, mesosulfuron, iodosulfuron-methyl sodium, foramsulfuron, cinosulfuron, triasulfuron, sulfometuron methyl, nicosulfuron, ethametsulfuron-methyl, amidosulfuron, ethoxysulfuron, cyclosulfamuron, rimsulfuron, azimsulfuron, flazasulfuron, monosulfuron, monosulfuron-ester, flucarbazone-sodium, flupyrsulfuron-methyl, halosulfuron-methyl, oxasulfuron, imazosulfuron, primisulfuron, propoxycarbazone, prosulfuron, sulfosulfuron, trifloxysulfuron, triflusulfuron-methyl, tritosulfuron, sodium metsulfuron methyl, flucetosulfuron, HNPC-C, orthosulfamuron, propyrisulfuron, metazosulfuron, acifluorfen, fomesafen, lactofen, fluoroglycofen, oxyfluorfen, chlornitrofen, aclonifen, ethoxyfen-ethyl, bifenox, nitrofluorfen, chlomethoxyfen, fluorodifen, fluoronitrofen, furyloxyfen, nitrofen, TOPE, DMNP, PPG1013, AKH-7088, halosafen, chlortoluron, isoproturon, linuron, diuron, dymron, fluometuron, benzthiazuron, methabenzthiazuron, cumyluron, ethidimuron, isouron, tebuthiuron, buturon, chlorbromuron, methyldymron, phenobenzuron, SK-85, metobromuron, metoxuron, afesin, monuron, siduron, fenuron, fluothiuron, neburon, chloroxuron, noruron, isonoruron, 3-cyclooctyl-1, thiazfluron, tebuthiuron, difenoxuron, parafluron, methylamine tribunil, karbutilate, trimeturon, dimefuron, monisouron, anisuron, methiuron, chloreturon, tetrafluron, phenmedipham, phenmedipham-ethyl, desmedipham, asulam, terbucarb, barban, propham, chlorpropham, rowmate, swep, chlorbufam, carboxazole, chlorprocarb, fenasulam, BCPC, CPPC, carbasulam, butylate, benthiocarb, vernolate, molinate, triallate, dimepiperate, esprocarb, pyributicarb, cycloate, avadex, EPTC, ethiolate, orbencarb, pebulate, prosulfocarb, tiocarbazil, CDEC, dimexano, isopolinate, methiobencarb, 2,4-D butyl ester, MCPA-Na, 2,4-D isooctyl ester, MCPA isooctyl ester, 2,4-D sodium salt, 2,4-D dimethyla mine salt, MCPA-thioethyl, MCPA, 2,4-D propionic acid, high 2,4-D propionic acid salt, 2,4-D butyric acid, MCPA propionic acid, MCPA propionic acid salt, MCPA butyric acid, 2,4,5-D, 2,4,5-D propionic acid, 2,4,5-D butyric acid, MCPA amine salt, dicamba, erbon, chlorfenac, saison, TBA, chloramben, methoxy-TBA, diclofop-methyl, fluazifop-butyl, fluazifop-p-butyl, haloxyfop-methyl, haloxyfop-P, quizalofop-ethyl, quizalofop-p-ethyl, fenoxaprop-ethy, fenoxaprop-p-ethyl, propaquizafop, cyhalofop-butyl, metamifop, clodinafop-propargyl, fenthiaprop-ethyl, chloroazifop-propynyl, poppenate-methyl, trifopsime, isoxapyrifop, paraquat, diquat, oryzalin, ethalfluralin, isopropalin, nitralin, profluralin, prodinamine, benfluralin, fluchloraline, dinitramina, dipropalin, chlornidine, methalpropalin, dinoprop, glyphosate, anilofos, glufosinate ammonium, amiprophos-methyl, sulphosate, piperophos, bialaphos-sodium, bensulide, butamifos, phocarb, 2,4-DEP, H-9201, zytron, imazapyr, imazethapyr, imazaquin, imazamox, imazamox ammonium salt, imazapic, imazamethabenz-methyl, fluroxypyr, fluroxypyr isooctyl ester, clopyralid, picloram, trichlopyr, dithiopyr, haloxydine, 3,5,6-trichloro-2-pyridinol, thiazopyr, fluridone, aminopyralid, diflufenzopyr, triclopyr-butotyl, Cliodinate, sethoxydim, clethodim, cycloxydim, alloxydim, clefoxydim, butroxydim, tralkoxydim, tepraloxydim, buthidazole, metribuzin, hexazinone, metamitron, ethiozin, ametridione, amibuzin, bromoxynil, bromoxynil octanoate, ioxynil octanoate, ioxynil, dichlobenil, diphenatrile, pyraclonil, chloroxynil, iodobonil, flumetsulam, florasulam, penoxsulam, metosulam, cloransulam-methyl, diclosulam, pyroxsulam, benfuresate, bispyribac-sodium, pyribenzoxim, pyriftalid, pyriminobac-methyl, pyrithiobac-sodium, benzobicylon, mesotrione, sulcotrione, tembotrione, tefuryltrione, bicyclopyrone, ketodpiradox, isoxaflutole, clomazone, fenoxasulfone, methiozolin, fluazolate, pyraflufen-ethyl, pyrazolynate, difenzoquat, pyrazoxyfen, benzofenap, nipyraclofen, pyrasulfotole, topramezone, pyroxasulfone, cafenstrole, flupoxam, aminotriazole, amicarbazone, azafenidin, carfentrazone-ethyl, sulfentrazone, bencarbazone, benzfendizone, butafenacil, bromacil, isocil, lenacil, terbacil, flupropacil, cinidon-ethyl, flumiclorac-pentyl, flumioxazin, propyzamide, MK-129, flumezin, pentachlorophenol, dinoseb, dinoterb, dinoterb acetate, dinosam, DNOC, chloronitrophene, medinoterb acetate, dinofenate, oxadiargyl, oxadiazon, pentoxazone, Flufenacet, fluthiacet-methyl, fentrazamide, flufenpyr-ethyl, pyrazon, brompyrazon, metflurazon, kusakira, dimidazon, oxapyrazon, norflurazon, pyridafol, quinclorac, quinmerac, bentazone, pyridate, oxaziclomefone, benazolin, clomazone, cinmethylin, ZJ0702, pyribambenz-propyl, indanofan, sodium chlorate, dalapon, trichloroacetic acid, monochloroacetic acid, hexachloroacetone, flupropanate, cyperquat, bromofenoxim, epronaz, methazole, flurtamone, benfuresate, ethofumesate, tioclorim, chlorthal, fluorochloridone, tavron, acrolein, bentranil, tridiphane, chlorfenpropmethyl, thidiarizonaimin, phenisopham, busoxinone, methoxyphenone, saflufenacil, clacyfos, chloropon, alorac, diethamquat, etnipromid, iprymidam, ipfencarbazone, thiencarbazone-methyl, pyrimisulfan, chlorflurazole, tripropindan, sulglycapin, prosulfalin, cambendichlor, aminocyclopyrachlor, rodethanil, benoxacor, fenclorim, flurazole, fenchlorazole-ethyl, cloquintocet-mexyl, oxabetrinil, MG/91, cyometrinil, DKA-24, mefenpyr-diethyl, furilazole, fluxofenim, isoxadifen-ethyl, dichlormid, halauxifen-methyl, DOW florpyrauxifen, UBH-509, D489, LS 82-556, KPP-300, NC-324, NC-330, KH-218, DPX-N8189, SC-0744, DOWC0535, DK-8910, V-53482, PP-600, MBH-001, KIH-9201, ET-751, KIH-6127 and KIH-2023.


For use, the formulations which are present in commercially available form are, if appropriate, diluted in the customary manner, for example using water in the case of wettable powders, emulsifiable concentrates, dispersions and water-dispersible granules. Products in the form of dusts, granules for soil application or broadcasting and sprayable solutions are usually not further diluted with other inert substances prior to use. The application rate of the compounds of the formula I required varies with the external conditions, such as temperature, humidity, the nature of the herbicide used and the like. It can vary within wide limits, for example between 0.001 and 1.0 kg a.i./ha or more of active substance, but it is preferably between 0.005 and 750 g a.i./ha, in particular between 0.005 and 500 g a.i./ha.







SPECIFIC MODE FOR CARRYING OUT THE INVENTION

The following embodiments are used to illustrate the present invention in detail and should not be taken as any limit to the present invention. The scope of the invention would be explained through the Claims.


In view of economics, variety and biological activity of a compound, we preferably synthesized several compounds, part of which are listed in the following Table A1-A152. The structure and information of a certain compound are shown in Table A1 and Table 1. The compounds in Table A1-A152 are listed for further explication of the present invention, other than any limit therefor. The subject of the present invention should not be interpreted by those skilled in the art as being limited to the following compounds.









TABLE A1







Structures and 1H NMR data of compounds


I




embedded image

















Compound







No.
X
Y
Z
M

1HNMR






1-1
S
Me
Me
H

1H NMR








(500 MHz,







DMSO-d6)







12.35 (s,







1H), 7.84







(dd, J = 8.0,







7.0 Hz, 1H),







7.75 (d, J =







8.0 Hz, 1H),







2.50 (s, 3H),







2.48 (s, 3H).


1-2
SO
Me
Me
H

1H NMR








(500 MHz,







DMSO-d6)







12.37 (s,







1H), 8.04







(dd, J = 8.0,







7.0 Hz, 1H),







7.78 (d, J =







8.0 Hz, 1H),







3.35 (s, 3H),







2.50 (s, 3H).


1-3
SO2
Me
Me
H

1H NMR








(500 MHz,







DMSO-d6)







12.39 (s,







1H), 8.24







(dd, J = 8.0,







7.0 Hz, 1H),







7.98 (d, J =







8.0 Hz, 1H),







3.45 (s, 3H),







2.50 (s, 3H).


1-4
S
Et
Me
H

1H NMR








(500 MHz,







DMSO-d6)







12.39 (s,







1H), 7.88







(dd, J = 8.0,







7.0 Hz, 1H),







7.78 (d, J =







8.0 Hz, 1H),







2.98 (q, J =







7.5 Hz, 2H)







2.51 (s, 3H),







1.15 (t, J =







7.5 Hz, 3H).


1-5
SO
Et
Me
H

1H NMR








(500 MHz,







DMSO-d6)







12.37 (s,







1H), 8.04







(dd, J = 8.0,







7.0 Hz, 1H),







7.78 (d, J =







8.0 Hz, 1H),







3.47 (q, J =







7.5 Hz, 2H),







2.50 (s, 3H),







1.12 (t, J =







7.5 Hz, 3H).


1-6
SO2
Et
Me
H

1H NMR








(500 MHz,







DMSO-d6)







12.41 (s,







1H), 8.22







(dd, J = 8.0,







7.0 Hz, 1H),







7.96 (d, J =







8.0 Hz, 1H),







3.54 (q, J =







7.5 Hz, 2H),







2.49 (s, 3H),







1.20 (t, J =







7.5 Hz, 3H).





1-7
S


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.38 (s,








1H), 7.86







(dd, J = 8.0,







7.0 Hz, 1H),







7.77 (d, J =







8.0 Hz, 1H),







2.95 (t, J =







7.5 Hz, 2H),







2.50 (s, 3H),







1.25-1.20 (m,







2H), 0.90 (t,







J = 7.5 Hz,







3H).





1-8
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.57 (s,








1H), 8.07







(dd, J = 8.0,







7.0 Hz, 1H),







7.82 (d, J =







8.0 Hz, 1H),







3.57-3.47 (m,







2H), 2.48 (s,







3H), 1.70-







1.52 (m, 2H),







1.08-0.93 (m,







3H).





1-9
SO2


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.59 (s,








1H), 8.27







(dd, J = 8.0,







7.0 Hz, 1H),







3.75 (t, J =







7.5 Hz, 2H),







2.48 (s, 3H),







1.80-1.62 (m,







2H), 1.05 (t,







J = 7.5 Hz,







3H).


1-10
S


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.42 (s, 1H), 7.89








(dd, J = 8.0,







7.0 Hz, 1H),







7.80 (d, J =







8.0 Hz,







1H), 3.52







(hept., J = 7.5







Hz, 1H) 2.51







(s, 3H), 1.22







(d, J = 7.5







Hz, 6H).





1-11
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.55 (s, 1H), 8.17








7.0 Hz, 1H),







7.88 (d, J =







8.0 Hz, 1H),







3.80-3.73 (m,







1H), 2.50 (s,







3H), 1.47 (d,







J = 7.0, 3H),







0.98 (d, J =







7.0 Hz, 3H).


1-12
SO2


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.75 (s, 1H), 8.27








(dd, J = 8.0,







7.0 Hz, 1H),







8.08 (d, J =







8.0 Hz, 1H),







3.89 (hept.,







J = 7.5 Hz,







1H), 2.50 (s,







3H), 1.27 (d,







J = 7.0, 6H).





1-13
S


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.25 (s,








1H), 7.86







(dd, J = 8.0,







7.0 Hz, 1H),







7.77 (d, J =







8.0 Hz, 1H),







2.99







7.5 Hz, 2H),







2.50 (s, 3H),







1.48-1.42 (m,







2H), 1.39-







1.33 (m, 2H),







0.83 (t, J =







7.5 Hz, 3H).





1-14
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.27 (s,








1H), 8.06







(dd, J = 8.0,







7.0 Hz, 1H),







7.88 (d, J =







8.0 Hz, 1H),







3.57 (t, J =







7.5 Hz, 2H),







2.48 (s, 3H),







1.72-1.46 (m,







4H), 0.93 (t,







J = 7.5 Hz,







3H).





1-15
SO2


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.47 (s,








1H), 8.26







(dd, J = 8.0,







7.0 Hz, 1H),







8.08 (d, J =







8.0 Hz, 1H),







3.77 (t, J =







7.5 Hz, 2H),







2.48 (s, 3H),







1.82-1.56 (m,







4H), 1.02 (t,







J = 7.5 Hz,







3H).





1-16
S


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.40 (s, 1H), 7.93








(dd, J = 8.0,







7.0 Hz, 1H),







7.63 (d, J =







8.0 Hz, 1H),







3.68-3.60







(m, 1H), 2.50







(s, 3H), 1.75-







1.66 (m,







2H), 1.18 (d,







J = 7.0 Hz,







3H), 1.07 (t,







J = 7.5 Hz,







3H).





1-17
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.41 (s, 1H), 8.12








(dd, J = 8.0,







7.0 Hz, 1H),







7.83 (d, J =







8.0 Hz, 1H),







3.88-3.80







(m, 1H), 2.50







(s, 3H), 1.85-







1.73 (m,







2H), 1.23 (d,







J = 7.0 Hz,







3H), 1.10 (t,







J = 7.5 Hz,







3H).





1-18
SO2


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.43 (s, 1H), 8.32








(dd, J = 8.0,







7.0 Hz, 1H),







8.04 (d, J =







8.0 Hz, 1H),







4.08-4.00







(m, 1H), 2.50







(s, 3H), 1.95-







1.85 (m,







2H), 1.30 (d,







J = 7.0 Hz,







3H), 1.14 (t,







J = 7.5 Hz,







3H).





1-19
S


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.38 (s,








1H), 7.85







(dd, J = 8.0,







7.0 Hz, 1H),







7.59 (d, J =







8.0 Hz, 1H),







3.46 (d, J =







7.0 Hz, 2H),







2.50 (s, 3H),







1.82-1.77 (m,







1H), 1.15 (d,







J = 7.5 Hz,







6H).





1-20
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.41 (s,








1H), 8.05







(dd, J = 8.0,







7.0 Hz, 1H),







7.79 (d, J =







8.0 Hz, 1H),







3.55 (d, J =







7.0 Hz, 2H),







2.50 (s, 3H),







1.92-1.86 (m,







1H), 1.20 (d,







J = 7.5 Hz,







6H).





1-21
SO2


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 1H), 8.26








(dd, J = 8.0,







7.0 Hz, 1H),







7.99 (d, J =







8.0 Hz, 1H),







3.75 (d, J =







7.0 Hz, 2H),







2.50 (s, 3H),







1.99-1.92 (m,







1H), 1.27 (d,







J = 7.5 Hz,







6H).





1-22
S


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.36 (s,








1H), 7.94







(dd, J = 8.0,







7.0 Hz, 1H),







7.68 (d J =







8.0 Hz, 1H),







3.25 (t, J =







7.5 Hz, 2H),







2.50 (s, 3H),







1.72-1.48 (m,







6H), 1.10 (t,







J = 7.5 Hz,







3H).





1-23
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.37 (s,








1H), 8.05







(dd, J = 8.0,







7.0 Hz, 1H),







7.75 (d J =







8.0 Hz, 1H),







3.45 (t, J =







7.5 Hz, 2H),







2.50 (s, 3H),







1.82-1.56 (m,







6H), 1.12 (t,







J = 7.5 Hz,







3H).





1-24
SO2


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.37 (s,








1H), 8.25







(dd, J = 8.0,







7.0 Hz, 1H),







7.96 (d, J =







8.0 Hz, 1H),







3.66 (t, J =







7.5 Hz, 2H),







2.50 (s, 3H),







1.99-1.56 (m,







6H), 1.15 (t,







J = 7.5 Hz,







3H).





1-25
S


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.37 (s, 1H), 7.96








(dd, J = 8.0,







7.0 Hz, 1H),







7.65 (d, J =







8.0 Hz, 1H),







3.27 (t, J =







7.5 Hz, 2H),







2.50 (s, 3H),







1.75-1.66 (m,







3H), 1.18 (d,







J = 7.5 Hz,







6H).





1-26
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.37 (s, 1H), 8.04








(dd, J = 8.0,







7.0 Hz, 1H),







3.49 (t, J =







7.5 Hz, 2H),







2.50 (s, 3H),







1.82-1.76 (m,







3H), 1.22 (d,







J = 7.5 Hz,







6H).





1-27
SO2


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.39 (s, 1H), 8.25








(dd, J = 8.0,







7.0 Hz, 1H),







3.68 (t, J =







7.5 Hz, 2H),







2.50 (s, 3H),







1.92-1.86 (m,







3H), 1.26 (d,







J = 7.5 Hz,







6H).





1-28
S


embedded image


Me
H

1H NMR DMSO-d6) 12.40 (s, 1H), 7.88








(dd, J = 8.0,







7.0 Hz, 1H),







7.61 (d, J =







8.0 Hz, 1H),







3.32 (d, J =







7.0 Hz, 2H),







2.50 (s, 3H),







1.82-1.63 (m,







3H), 1.23 (d,







J = 7.5 Hz,







3H), 1.08 (t,







J = 7.5 Hz,







3H).





1-29
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.41 (s,








1H), 8.05







(dd, J = 8.0,







7.0 Hz, 1H),







7.79 (d, J =







8.0 Hz, 1H),







3.55 (d, J =







7.0 Hz, 2H),







2.50 (s, 3H),







1.92-1.66 (m,







3H), 1.29 (d,







J = 7.5 Hz,







3H), 1.10 (t,







J = 7.5 Hz,







3H).





1-30
SO2


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.42 (s,








1H), 8.25







(dd, J = 8.0,







7.0 Hz, 1H),







7.96 (d, J =







8.0 Hz, 1H),







3.76 (d, J =







7.0 Hz, 2H),







2.50 (s, 3H),







1.99-1.69 (m,







3H), 1.36 (d,







J = 7.5 Hz,







3H), 1.17 (t,







J = 7.5 Hz,







3H).





1-31
S


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.37 (s,








1H), 7.98







(dd, J = 8.0,







7.0 Hz, 1H),







7.60 (d, J =







8.0 Hz, 1H),







3.27 (t, J =







7.5 Hz, 2H),







2.51 (s, 3H),







1.76-1.48 (m,







8H), 1.05 (t,







J = 7.5 Hz,







3H).





1-32
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.38 (s,








1H), 8.05







(dd, J = 8.0,







7.0 Hz, 1H),







7.81 (d, J =







8.0 Hz, 1H),







3.47 (t, J =







7.5 Hz, 2H),







2.51 (s, 3H),







1.85-1.55 (m,







8H), 1.10 (t,







J = 7.5 Hz,







3H).





1-33
SO2


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.39 (s,








1H), 8.25







(dd, J = 8.0,







7.0 Hz, 1H),







7.98 (d J =







8.0 Hz, 1H),







3.69 (t, J =







7.5 Hz, 2H),







2.51 (s, 3H),







1.95-1.57 (m,







8H), 1.19 (t,







J = 7.5 Hz,







3H).





1-34
S


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.37 (s,








1H), 7.87







(dd, J = 8.0,







7.0 Hz, 1H),







7.60 (d, J =







8.0 Hz, 1H),







3.28 (t, J =







7.5 Hz, 2H),







2.50 (s, 3H),







1.76 -1.51







(m, 10H),







1.08 (t, J =







7.5 Hz, 3H).





1-35
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.38 (s,








1H), 8.07







(dd, J = 8.0,







7.0 Hz, 1H),







3.48 (t, J =







7.5 Hz, 2H),







2.50 (s, 3H),







1.85-1.53







(m, 10H),







1.10 (t, J =







7.5 Hz, 3H).





1-36
SO2


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.39 (s,








1H), 8.27







(dd, J = 8.0,







7.0 Hz, 1H),







3.68 (t, J =







7.5 Hz, 2H),







2.50 (s, 3H),







1.94-1.55







(m, 10H),







1.12 (t, J =







7.5 Hz, 3H).





1-37
S


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6)








12.12 (s,







1H), 8.10







(dd, J = 8.0,







7.0 Hz, 1H),







7.99 (d, J =







8.0 Hz, 1H),







6.46-6.35 (m,







1H), 5.43-







5.32 (m, 2H),







2.50 (s, 3H).





1-38
SO


embedded image


Me
H






1-39
SO2


embedded image


Me
H






1-40
S


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.40 (s,








1H), 7.95







(dd, J = 8.0,







7.0 Hz, 1H),







7.80 (d, J =







8.0 Hz, 1H),







6.01 ?+05.92







(m, 1H), 5.21







?+05.12 (m,







2H), 3.82 ?+0







3.76 (m, 2H),







2.50 (s, 3H)





1-41
S


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.23 (s, 1H), 8.10








(dd, J = 8.0,







7.0 Hz, 1H),







7.99 (d, J =







8.0 Hz, 1H),







3.12 (s, 1H),







2.50 (s, 3H).





1-42
S


embedded image


Me
H






1-43
S


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.40 (s,








1H), 8.02







(dd, J = 8.0,







7.0 Hz, 1H),







7.86 (d, J =







8.0 Hz, 1H),







3.35 (s, 2H),







2.95 (s, 1H),







2.49 (s, 3H)





1-44
S


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.33 (s, 1H), 8.13








7.0 Hz, 1H),







8.00 (d, J =







8.0 Hz, 1H),







6.65 (t, J =







73..5 Hz,







1H), 2.50 (s,







3H).





1-45
SO


embedded image


Me
H






1-46
SO2


embedded image


Me
H






1-47
S


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.48 (s,








1H), 8.18







(dd, J = 8.0,







7.0 Hz, 1H),







8.07 (d, J =







8.0 Hz, 1H),







2.51 (s, 3H)





1-48
S


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.40 (s,








1H), 7.95







(dd, J = 8.0,







7.0 Hz, 1H),







8.0 Hz, 1H),







4.53-4.40







(m, 2H), 3.11-







3.00 (m,







2H), 2.50 (s,







3H)





1-49
S


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.41 (s,








1H), 7.97







(dd, J = 8.0,







7.0 Hz, 1H)







8.0 Hz, 1H),







5.59-5.41







(m, 1H), 3.21-







3.10 (m,







2H), 2.50 (s,







3H)





1-50
S


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.43 (s,








1H), 7.98







(dd, J = 8.0,







7.0 Hz, 1H),







7.86 (d, J =







8.0 Hz, 1H),







3.45-3, 38







(m, 2H), 2.51







(s, 3H)





1-51
S


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.40 (s,








1H), 7.95







(dd, J = 8.0,







7.0 Hz, 1H),







7.83 (d, J =







8.0 Hz, 1H),







2.93-2.80







(m, 2H), 2.21-







2.10 (m,







2H), 2.50 (s,







3H)





1-52
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.42 (s,








1H), 8.15







(dd, J = 8.0,







7.0 Hz, 1H),







8.03 (d, J =







8.0 Hz, 1H),







3.13-2.96







(m, 2H), 2.28-







2.13 (m,







2H), 2.50 (s,







3H)





1-53
SO2


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.43 (s,








1H), 8.34







(dd, J = 8.0,







7.0 Hz, 1H),







8.21 (d, J =







8.0 Hz, 1H),







3.13-3.00







(m, 2H), 2.31-







2.70 (m,







2H), 2.50 (s,







3H)





1-54
S


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.41 (s,








1H), 7.93







(dd, J = 8.0,







7.0 Hz, 1H),







7.81 (d, J =







8.0 Hz, 1H),







3.73 (t, J =







8.0 Hz, 2H),







3.11 (t, J =







8.0 Hz, 2H),







2.50 (s, 3H)





1-55
S


embedded image


Me
H






1-56
S


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.41 (s,








1H), 7.93







(dd, J = 8.0,







7.0 Hz, 1H),







7.81 (d, J =







8.0 Hz, 1H),







3.78 (t, J =







8.0 Hz, 2H),







3.31 (t, J =







8.0 Hz, 2H),







3.21 (s, 3H),







2.50 (s, 3H)





1-57
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.42 (s,








1H), 8.13







(dd, J = 8.0,







7.0 Hz, 1H),







8.01 (d, J =







8.0 Hz, 1H),







3.98 (t, J =







8.0 Hz, 2H),







3.39 (t, J =







8.0 Hz, 2H),







3.31 (s, 3H),







2.50 (s, 3H)





1-58
SO2


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.44 (s,








1H), 8.33







(dd, J = 8.0,







7.0 Hz, 1H),







8.23 (d, J =







8.0 Hz, 1H),







4.17 (t, J =







8.0 Hz, 2H),







3.48 (t, J =







8.0 Hz, 2H),







3.33 (s, 3H),







2.50 (s, 3H)





1-59
S


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6)








12.41 (s,







1H), 7.93







(dd, J = 8.0,







7.0 Hz, 1H),







7.81 (d, J =







8.0 Hz, 1H),







3.78 (t, J =







8.0 Hz, 2H),







3.31 (t, J =







8.0 Hz, 2H),







2.50 (s, 3H)





1-60
S


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.40 (s,








1H), 7.92







(dd, J = 8.0,







7.80 (d, J =







3.38 (t, J =







8.0 Hz, 2H),







2.61 (t, J =







8.0 Hz, 2H),







2.50 (s, 3H),







2, 21 (s, 6H)





1-61
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.42 (s,








1H), 8.12







(dd, J = 8.0,







7.0 Hz, 1H),







8.00 (d, J =







8.0 Hz, 1H),







3.58 (t, J =







8.0 Hz, 2H),







2.72 (t, J =







8.0 Hz, 2H),







2.50 (s, 3H),







2.23 (s, 6H)





1-62
SO2


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.44 (s,








1H), 8.32







(dd, J = 8.0,







7.0 Hz, 1H),







8.20 (d, J =







8.0 Hz, 1H),







3.77 (t, J =







8.0 Hz, 2H),







2.83 (t, J =







8.0 Hz, 2H),







2.50 (s, 3H),







2, 24 (s, 6H)





1-63
S


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 7.91 (dd, J = 8.0, 7.0 Hz,








1H), 7.80 (d,







J = 8.0 Hz,







1H), 3.80-







3.69 (m, 1H),







3.11-3.03







(m, 2H), 2.50







(s, 3H)





1-64
S


embedded image


Me
H






1-65
SO2


embedded image


Me
H






1-66
SO


embedded image


Me
H






1-67
S


embedded image


Me
H






1-68
S


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.49 (s,








1H), 8.19







(dd, J = 8.0,







7.0 Hz, 1H),







8.09 (d, J =







8.0 Hz, 1H),







2.51 (s, 3H)





1-69
S


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6)








12.43 (s,







1H), 8.05







(dd, J = 8.0,







7.0 Hz, 1H),







7.89 (d, J =







8.0 Hz, 1H),







4.22 (s, 2H),







2.50 (s, 3H)





1-70
S


embedded image


H


1H NMR (500 MHz, DMSO-d6) 12.43 (s, 1H), 8.12








(dd, J = 8.0,







7.0 Hz, 1H),







8.06 (d, J =







8.0 Hz, 1H),







2.51 (s, 3H),







2.34 (s, 3H)





1-71
S


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.43 (s,








1H), 7.97







(dd, J = 8.0,







7.0 Hz, 1H),







7.85 (d, J =







8.0 Hz, 1H),







4.17 (s, 2H),







4.10 (q, J =







8.0 Hz, 2H),







2.51 (s, 3H),







1.29 (t, J =







8.0 Hz, 3H)





1-72
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.45 (s,








1H), 8.17







(dd, J = 8.0,







7.0 Hz, 1H),







8.05 (d, J =







8.0 Hz, 1H),







4.37 (s, 2H),







4.13 (q, J =







8.0 Hz, 2H),







2.51 (s, 3H),







1.30 (t, J =







8.0 Hz, 3H)





1-73
SO2


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.46 (s,








1H), 8.37







(dd, J = 8.0,







7.0 Hz, 1H),







8.25 (d, J =







8.0 Hz, 1H),







4.57 (s, 2H),







4.19 (q, J =







8.0 Hz, 2H),







2.51 (s, 3H),







1.33 (t, J =







8.0 Hz, 3H)





1-74
S


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.40 (s, 1H), 7.90








(dd, J = 8.0,







7.0 Hz, 1H),







7.80 (d, J =







8.0 Hz,







1H), 3.69 (s,







3H), 3.57 (t,







J = 8.5 Hz,







2H), 2, 67 (t,







J = 8.5 Hz,







2H), 2.50 (s,







3H)







H





1-75
S


embedded image


Me
H






1-76
S


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.41 (s, 1H), 7.90 (dd, J = 8.0,








8.0 Hz, 1H),







2.50 (s, 3H),







1.67-1.58







(m, 1H), 1.17-







0.92 (m,







4H)





1-77
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.51 (s, 1H), 8.10 (dd, J = 8.0,








8.0 Hz, 1H),







2.50 (s, 3H),







1.78-1.69







(m, 1H), 1.20-







0.95 (m,







4H)





1-78
SO2


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.55 (s, 1H), 8.29 (dd, J = 8.0,








7.0 Hz, 1H),







8.17 (d, J =







8.0 Hz, 1H),







2.50 (s, 3H),







1.98-1.89







(m, 1H), 1.25-







0.99 (m,







4H)





1-79
S


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.37 (s, 1H), 7.86- 7.83 (m,








1H), 7.76 (d,







J = 8.0 Hz,







1H), 2.46 (s,







3H), 1.79 (d,







J = 11.5 Hz,







2H), 1.70-







1.63 (m,







2H), 1.56-







1.49 (m,







1H), 1.35-







1.15(m, 6H)





1-80
SO2


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.43 (s,








1H), 8.19







(dd, J = 8.0,







7.0 Hz, 1H),







8.07 (d, J =







8.0 Hz, 1H),







3.92-3.83 (m,







1H), 3.11-







2.99 (m, 2H),







2.50 (s, 3H).





1-81
SO2


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.47 (s,








1H), 8.22







(dd, J = 8.0,







7.0 Hz, 1H),







7.96 (d, J =







8.0 Hz, 1H),







3.55-3.48







(m, 2H), 2.49







(s, 3H), 2.41-







2.32 (m,







3H)





1-82
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.41 (s, 1H), 8.13








(dd, J = 8.0,







7.0 Hz, 1H),







8.01 (d, J =







8.0 Hz, 1H),







5.11-.5.01







(m, 4H), 4.25-







4.16 (m,







1H), 2.50 (s,







3H)





1-83
S


embedded image


Me
H






1-84
S


embedded image


Me
H






1-85
SO2


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.47 (s, 1H), 8.22 (dd, J = 8.0,








7.0 Hz 1H),







7.96 (d, J =







8.0 Hz, 1H),







3.15-3.01







(m, 4H), 2.49







(s, 3H), 1.49-







1.42 (m,







6H)





1-86
S


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.40 (s,








1H), 7.85 (t,







d, J =







7.5 Hz, 1H),







7.69 (d, J =







8.0 Hz,







1H), 7.25-







7.16 (m,







5H), 4.18 (s,







2H), 2.47 (s,







3H).





1-87
S


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.40 (s, 1H), 7.90 7.0 Hz, 1H),








7.80 (d, J =







8.0 Hz, 1H),







7.27-7.17







(m, 5H), 3.17







(t, J = 8.5 Hz,







2H), 3.07 (t,







J = 8.5 Hz,







2H), 2.50 (s,







3H)





1-88
S


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.33 (s, 1H), 8.03 (dd, J = 8.0, 7.0 Hz, 1H),








7.93 (d, J =







8.0 Hz, 1H),







7.47-7.32 (m,







5H), 2.51 (s,







3H).





1-89
S


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.39 (s, 1H), 8.82 (d, J = 5.5 Hz, 2H), 8.09 (dd,








J = 8.0, 7.0







Hz, 1H), 7.96







(d, J = 8.0







Hz, 1H), 7.45







(d, J = 5.5







Hz, 2H), 2.51







(s, 3H).





1-90
S


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.31 (s, 1H), 8.12 (s, 1H), 8.09 (dd,








J = 8.0, 7.0







Hz, 1H), 7.96







(d, J = 8.0







Hz, 1H), 7.85







(s, 1H), 3.81







(s, 3H), 2.51







(s, 3H).





1-91
S


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.47 (s, 1H), 8.22 (dd, J = 8.0, 7.0 Hz, 1H),








7.96 (d, J =







8.0 Hz, 1H),







2.65 (s, 3H),







2.49 (s, 3H)





1-92
S


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.41 (s, 1H), 8.13 (dd, J = 8.0, 7.0








Hz, 1H), 7.99







(d, J = 8.0







Hz, 1H), 3.91







(s, 3H), 2.51







(s, 3H).





1-93
S


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.41 (s, 1H), 7.95








(dd, J = 8.0,







7.0 Hz, 1H),







7.83 (d, J =







8.0 Hz, 1H),







7.50 (d, J =







2.0 Hz, 1H),







6.31 (dd, J =







2.5, 2.0 Hz,







1H), 6.15 (d,







J = 2.5 Hz,







1H), 3.97 (s,







2H), 2.50 (s,







3H)


1-94
S
Et
Me
Me



1-95
S
Et
Me
Et






1-96
S
Et
Me


embedded image








1-97
S
Et
Me


embedded image








1-98
S
Et
Me


embedded image








1-99
S
Et
Me


embedded image








1-100
S
Et
Me


embedded image








1-101
S
Et
Me


embedded image








1-102
S
Et
Me


embedded image








1-103
S
Et
Me


embedded image








1-104
S
Et
Me


embedded image








1-105
S
Et
Me


embedded image








1-106
S
Et
Me


embedded image








1-107
S
Et
Me


embedded image








1-108
S
Et
Me


embedded image








1-109
S
Et
Me


embedded image



1H NMR (500 MHz, DMSO-d6) 7.98 (dd, J = 8.0, 7.0 Hz, 1H), 7.88 (d,








J = 8.0 Hz,







1H), 6, 32 (q,







J = 7.5 Hz,







1H), 4.11 (q,







J = 8.5, 2H),







2.98 (q, J =







7.5 Hz, 2H)







2.51 (s, 3H),







1.56 (d, J =







7.5 Hz, 3H),







1.32 (t, J =







8.5 Hz, 3H),







1.15 (t, J =







7.5 Hz, 3H).





1-110
S
Et
Me


embedded image








1-111
S
Et
Me


embedded image








1-112
S
Et
Me


embedded image



1H NMR (500 MHz, DMSO-d6) 7.99 (dd, J = 8.0, 7.0 Hz,








1H), 7.85 (d,







J = 8.0 Hz,







1H), 7.31-







7.20 (m, 5H),







4.97 (s, 2H),







2.99 (q, J =







7.5 Hz, 2H)







2.51 (s, 3H),







1.15 (t, J =







7.5 Hz, 3H).





1-113
S
Et
Me


embedded image








1-114
S
Et
Me


embedded image








1-115
S
Et
Me


embedded image








1-116
S
Et
Me


embedded image








1-117
S
Et
Me


embedded image








1-118
S
Et
Me


embedded image



1H NMR (500 MHz, DMSO-d6) 8.07 (dd, J = 8.0, 7.0 Hz, 1H), 7.89 (d, J = 8.0 Hz,








1H), 3.61-







3.52 (m, 4H),







3.31-3.23







(m, 4H), 2.98







(q, J = 7.5







Hz, 2H) 2.53







(s, 3H), 1.15







(t, J = 7.5 Hz,







3H).





1-119
S
Et
Me


embedded image



1H NMR (500 MHz, DMSO-d6) 8.08 (dd, J =








8.0, 7.0 Hz,







1H), 7.89 (d,







J = 8.0 Hz,







1H), 2.98 (q,







J = 7.5 Hz,







2H) 2.51 (s,







3H), 2.27 (s,







3H), 1.15 (t,







J = 7.5 Hz,







3H).





1-120
S
Et
Me


embedded image








1-121
S
Et
Me


embedded image








1-122
S
Et
Me


embedded image








1-123
S
Et
Me


embedded image








1-124
S
Et
Me


embedded image








1-125
S
Et
Me


embedded image








1-126
O
Me
Me


1H NMR








(500 MHz,







DMSO-d6)







7.60-7.48 (m,







2H), 3.96 (s,







3H), 2.50 (s,







3H).


1-127
O
Et
Me
H

1H NMR








(500 MHz,







DMSO-d6)







12.12 (s,







1H), 7.61-







7.50 (m, 2H),







4.18 (q, J =







7.5 Hz, 2H),







2.50 (s, 3H),







1.20 (t, J =







7.5 Hz, 3H).





1-128
O


embedded image


Me
H






1-129
O


embedded image


Me
H

1H NMR (500 MHz,








DMSO-d6)







12.41 (s,







1H), 7.99-







7.88 (m, 2H),







4.51 (q, J =







13.5 Hz, 2H),







2.50 (s, 3H)





1-130
O


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.12 (s,








1H), 7.61-







7.50 (m, 2H),







4.53-4.20







(m, 4H), 2.50







(s, 3H)


1-131
NH
Me
Me
H



1-132
NMe
Me
Me
H

1H NMR








(500 MHz,







DMSO-d6)







12.12 (s,







1H), 7.61-







7.50 (m, 2H),







3.08 (s, 6H),







2.50 (s, 3H).


1-133
NMe
Et
Me
H















1-134
-X-Y represents   embedded image
Me
H

1H NMR (500 MHz, DMSO-d6) 12.32 (s, 1H), 8.10 (dd, J = 8.0, 7.0 Hz, 1H), 7.99 (d, J =


















8.0 Hz, 1H),







3.73-3.66 (m,







2H), 2.50 (s,







3H), 2.45-







2.38 (m, 2H),







1.98-1.89 (m,







2H).














1-135
-X-Y represents   embedded image
Me
H

1H NMR (500 MHz, DMSO-d6) 12.43 (s, 1H), 7.99- 7.82 (m, 2H), 7.52-7.40 (m, 3H), 2.50


















(s, 3H)





1-136
S


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.35 (s, 1H), 7.94








(dd, J = 8.0,







7.0 Hz, 1H),







7.59 (d, J =







8.0 Hz, 1H),







2.50 (s, 3H),







1.28 (s, 9H)





1-137
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.37 (s, 1H), 8.08








(dd, J = 8.0,







7.0 Hz, 1H),







7.72 (d, J =







8.0 Hz, 1H),







2.50 (s, 3H),







1.36 (s, 9H).





1-138
SO2


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.40 (s, 1H), 8.24








(dd, J = 8.0,







7.0 Hz, 1H),







7.98 (d, J =







8.0 Hz, 1H),







2.50 (s, 3H),







1.37 (s, 9H)


1-139
S
CF2CF3
Me
H

1H NMR








(500 MHz,







DMSO-d6)







12.41 (s,







1H), 8.14







(dd, J = 8.0,







7.0 Hz, 1H),







7.99 (d, J =







8.0 Hz, 1H),







2.51 (s, 3H).


1-140
S
CF2CF2CF3
Me
H

1H NMR








(500 MHz,







DMSO-d6)







12.42 (s,







1H), 8.20







(dd, J = 8.0,







7.0 Hz, 1H),







8.07 (d, J =







8.0 Hz, 1H),







2.51 (s, 3H).





1-141
S


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.41 (s, 1H), 8.22 (dd, J = 8.0,








8.09 (d, J =







8.0 Hz, 1H),







3.27 (s, 6H),







2.51 (s, 3H).





1-142
S


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.40 (s, 1H), 8.00








(dd, J = 8.0,







7.0 Hz, 1H),







7.89 (d, J =







8.0 Hz, 1H),







2.51 (s, 3H),







0.02 (s, 9H).





1-143
S


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.41 (s, 1H), 8.05








(dd, J = 8.0,







7.0 Hz, 1H),







7.93 (d, J =







8.0 Hz, 1H),







2.50 (s, 3H),







2.31 (q, J =







7.5 Hz, 2H),







1.16 (t, J =







7.5 Hz, 3H).





1-144
S


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.40 (s, 1H), 8.00








(dd, J = 8.0,







7.0 Hz, 1H),







7.89 (d, J =







8.0 Hz, 1H),







3.97 (t, J =







8.0 Hz, 2H),







3.36 (t, J =







8.0 Hz, 2H),







3.01 (s, 6H),







2.51 (s, 3H),





1-145
S


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.41 (s, 1H), 8.20 (d, J = 2.0 Hz,








1H), 8.02







(dd, J = 8.0,







7.0 Hz, 1H),







7.93 (d, J =







8.0 Hz, 1H),







7.56 (d, J =







2.5 Hz, 1H),







6.89 (dd, J =







2.5, 2.0 Hz,







1H), 2.50 (s,







3H)





1-146
S


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.41 (s, 1H), 8.08 (dd, J = 8.0,








7.0 Hz, 1H),







7.98-7.73







(m, 6H),







2.50 (s, 3H)





1-147
S


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.40 (s, 1H), 8.77 (s, 1H), 8.06 (dd, J = 8.0, 7.0 Hz, 1H),








7.92 (d, J =







8.0 Hz, 1H),







3.77 (s, 3H),







2.50 (s, 3H),







2.47 (s, 3H).





1-148
S


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.41 (s, 1H), 8.37 (s, 1H), 8.00 (dd, J = 8.0,








7.88 (d, J =







8.0 Hz, 1H),







4.35 (s, 2H),







3.75 (s, 3H),







2.50 (s, 3H),







2.10 (s, 3H).





1-149
NCOMe


embedded image


Me
H






1-150
NSO2Me
Me
Me
H



1-151
NPh
Et
Me
H



1-152
NH
CH2Ph
Me
H






1-153
NH


embedded image


Me
H






1-154


embedded image


Me
Me
H






1-155


embedded image


Me
Me
H






1-156


embedded image


Et
Me
H






1-157
S
F
Me
H



1-158
O
Cl
Me
H



1-159
SO
Br
Me
H



1-160
SO2
I
Me
H






1-161
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s,








1H), 8.03 (dd,







J = 7.5. 6.0







Hz, 1H), 7.62







(d, J = 7.5







Hz, 1H), 2.43







(s, 3H).





1-162
SO2


embedded image


Me
H






1-163
O


embedded image


Me
H






1-164
S
COOH
Me
H



1-165
S
NO2
Me
H



1-166
S
NH2
Me
H






1-167
S


embedded image


Me
H






1-168
O


embedded image


Me
H






1-169
NH


embedded image


Me
H






1-170
SO


embedded image


Me
H






1-171
SO2


embedded image


Me
H






1-172
S


embedded image


Me
H






1-173
S


embedded image


Me
H






1-174
S


embedded image


Me
H






1-175
S


embedded image


Me
H






1-176
S


embedded image


Me
H






1-177
O


embedded image


Me
H






1-178
NMe


embedded image


Me
H






1-179
NH


embedded image


Me
H






1-180
NH


embedded image


Me
H






1-181
S


embedded image


Me
H






1-182
S


embedded image


Me
H






1-183
NH


embedded image


Me
H






1-184
O


embedded image


Me
H






1-185
S


embedded image


Me
H






1-186
S


embedded image


Me
H






1-187
S


embedded image


Me
H






1-188
O


embedded image


Me
H






1-189
NH


embedded image


Me
H






1-190
SO


embedded image


Me
H






1-191
O


embedded image


Me
H






1-192
S


embedded image


Me
H






1-193
S


embedded image


Me
H






1-194
S


embedded image


Me
H






1-195
S


embedded image


Me
H






1-196
NH


embedded image


Me
H






1-197
NH


embedded image


Me
H






1-198
S


embedded image


Me
H






1-199
SO


embedded image


Me
H






1-200
SO2


embedded image


Me
H






1-201
O


embedded image


Me
H






1-202
NEt


embedded image


Me
H






1-203
NH


embedded image


Me
H






1-204
S


embedded image


Me
H






1-205
SO


embedded image


Me
H






1-206
SO2


embedded image


Me
H






1-207
S


embedded image


Me
H






1-208
SO


embedded image


Me
H






1-209
SO2


embedded image


Me
H






1-210
O


embedded image


Me
H






1-211
S


embedded image


Me
H






1-212
O


embedded image


Me
H






1-213
S


embedded image


Me
H






1-214
S


embedded image


Me
H






1-215
O


embedded image


Me
H






1-216
S


embedded image


Me
H






1-217
O


embedded image


Me
H






1-218
SO


embedded image


Me
H






1-219
SO2


embedded image


Me
H






1-220
S


embedded image


Me
H






1-221
S


embedded image


Me
H






1-222
S


embedded image


Me
H






1-223
S


embedded image


Me
H






1-224
NH


embedded image


Me
H






1-225
S


embedded image


Me
H






1-226
S


embedded image


Me
H






1-227
S


embedded image


Me
H






1-228
SO


embedded image


Me
H






1-229
SO2


embedded image


Me
H






1-230
SO


embedded image


Me
H






1-231
SO2


embedded image


Me
H






1-232
NH


embedded image


Me
H






1-233
S


embedded image


Me
H






1-234
O


embedded image


Me
H






1-235
S


embedded image


Me
H






1-236
S


embedded image


Me
H






1-237
S


embedded image


Me
H






1-238
O


embedded image


Me
H






1-239
S


embedded image


Me
H






1-240
SO


embedded image


Me
H






1-241
S


embedded image


Me
H






1-242
SO


embedded image


Me
H






1-243
SO2


embedded image


Me
H






1-244
NH


embedded image


Me
H






1-245
O


embedded image


Me
H






1-246
S


embedded image


Me
H






1-247
S


embedded image


Me
H






1-248
S


embedded image


Me
H






1-249
S


embedded image


Me
H






1-250
S


embedded image


Me
H






1-251
S


embedded image


Me
H






1-252
S


embedded image


Me
H






1-253
S


embedded image


Me
H






1-254
SO


embedded image


Me
H






1-255
SO2


embedded image


Me
H






1-256
SO


embedded image


Me
H






1-257
SO2


embedded image


Me
H






1-258
SO


embedded image


Me
H






1-259
SO2


embedded image


Me
H






1-260
S


embedded image


Me
H






1-261
S


embedded image


Me
H






1-262
S


embedded image


Me
H






1-263
S


embedded image


Me
H






1-264
O


embedded image


Me
H






1-265
S


embedded image


Me
H






1-266
SO


embedded image


Me
H






1-267
S


embedded image


Me
H






1-268
S


embedded image


Me
H






1-269
S


embedded image


Me
H






1-270
O


embedded image


Me
H






1-271
NH


embedded image


Me
H






1-272
S


embedded image


Me
H






1-273
S


embedded image


Me
H






1-274
S


embedded image


Me
H






1-275
S


embedded image


Me
H






1-276
S


embedded image


Me
H






1-277
SO2


embedded image


Me
H






1-278
SO


embedded image


Me
H






1-279
S


embedded image


Me
H






1-280
O


embedded image


Me
H






1-281
NH


embedded image


Me
H






1-282
S


embedded image


Me
H






1-283
S


embedded image


Me
H






1-284
S


embedded image


Me
H






1-285
S


embedded image


Me
H






1-286
S


embedded image


Me
H






1-287
S


embedded image


Me
H






1-288
S


embedded image


Me
H






1-289
S


embedded image


Me
H






1-290
S


embedded image


Me
H






1-291
S


embedded image


Me
H






1-292
S


embedded image


Me
H






1-293
SO2


embedded image


Me
H






1-294
SO


embedded image


Me
H






1-295
S


embedded image


Me
H






1-296
S


embedded image


Me
H






1-297
S


embedded image


Me
H






1-298
S


embedded image


Me
H






1-299
S


embedded image


Me
H






1-300
S


embedded image


Me
H






1-301
S


embedded image


Me
H






1-302
O


embedded image


Me
H






1-303
NH


embedded image


Me
H






1-304
S


embedded image


Me
H






1-305
S


embedded image


Me
H






1-306
SO2


embedded image


Me
H






1-307
SO


embedded image


Me
H






1-308
SO2


embedded image


Me
H






1-309
SO


embedded image


Me
H






1-310
S


embedded image


Me
H






1-311
S


embedded image


Me
H















1-312


embedded image


Me
H






1-313


embedded image


Me
H






1-314


embedded image


Me
H






1-315


embedded image


Me
H






1-316


embedded image


Me
H






1-317


embedded image


Me
H









1-318


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.36 (s, 1H), 7.72- 7.65 (m,


















2H), 3.12-







3.09 (m,







4H), 2.47 (s,







3H), 1.74-







1.64 (m, 6H).














1-319


embedded image


Me
H






1-320


embedded image


Me
H






1-321


embedded image


Me
H






1-322


embedded image


Me
H






1-323


embedded image


Me
H






1-324


embedded image


Me
H






1-325


embedded image


Me
H






1-326


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.27 (s, 1H), 7.96- 7.82 (m, 2H), 7.65 (s, 1H), 7.42 (s,


















1H), 2.47 (s,







3H), 2.08 (s,







3H).














1-327


embedded image


Me
H






1-328


embedded image


Me
H






1-329


embedded image


Me
H






1-330


embedded image


Me
H






1-331


embedded image


Me
H






1-332


embedded image


Me
H






1-333


embedded image


Me
H






1-334


embedded image


Me
H






1-335


embedded image


Me
H






1-336


embedded image


Me
H






1-337


embedded image


Me
H






1-338


embedded image


Me
H






1-339


embedded image


Me
H
















1-340
S
Et
Me
OMe






1-341
O
Me
Me


embedded image








1-342
NMe
Me
Me


embedded image








1-343
S
Et
Me


embedded image








1-344
S
Et
Me


embedded image








1-345
O
Me
Me


embedded image








1-346
NMe
Me
Me


embedded image








1-347
S
Et
Me


embedded image








1-348
O
Me
Me


embedded image








1-349
S
Et
Me


embedded image








1-350
NMe
Me
Me


embedded image








1-351
S
Et
Me


embedded image








1-352
S
Et
Me


embedded image








1-353
O
Me
Me


embedded image








1-354
S
Et
Me


embedded image








1-355
NMe
Me
Me


embedded image








1-356
S
Et
Me


embedded image








1-357
S
Et
Me


embedded image








1-358
S
Et
Me


embedded image








1-359
O
Me
Me


embedded image








1-360
S
Et
Me


embedded image








1-361
S
Et
Me


embedded image








1-362
S
Et
Me


embedded image








1-363
O
Me
Me


embedded image








1-364
NMe
Me
Me


embedded image








1-365
S
Et
Me


embedded image








1-366
S
Et
Me


embedded image








1-367
NMe
Me
Me


embedded image








1-368
S
Et
Me


embedded image








1-369
SO2
Et
Me


embedded image








1-370
O
Me
Me


embedded image








1-371
S
Et
Me


embedded image








1-372
S
Et
Me


embedded image








1-373
SO
Et
Me


embedded image








1-374
NMe
Me
Me


embedded image








1-375
S
Et
Me


embedded image








1-376
O
Me
Me


embedded image








1-377
NMe
Me
Me


embedded image








1-378
S
Et
Me


embedded image








1-379
O
Me
Me


embedded image








1-380
S
Et
Me


embedded image








1-381
S
Et
Me


embedded image








1-382
SO2
Et
Me


embedded image








1-383
NMe
Me
Me


embedded image








1-384
O
Me
Me


embedded image








1-385
S
Et
Me


embedded image








1-386
SO
Et
Me


embedded image








1-387
SO2
Et
Me


embedded image








1-388
S
Et
Me


embedded image








1-389
S
Et
Me


embedded image








1-390
S
Et
Me


embedded image








1-391
S
Et
Me


embedded image








1-392
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s,








1H), 8.33 (dd,







J = 8.0, 7.0







Hz, 1H), 7.59







(d, J = 8.0







Hz, 1H), 2.64







(s, 2H), 2.46







(s, 3H), 0.94







(s, 9H).





1-393
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s, 1H), 8.34








(dd, J =







7.5, 6.0 Hz,







1H), 7.61 (d,







J = 7.5 Hz,







1H), 2.76 (t,







J = 8.0 Hz,







2H), 2.46 (s,







3H), 1.49 (t,







J = 8.0 Hz,







2H), 0.86 (s,







9H).





1-394
SO


embedded image


Me
H

1H NMR (500











MHz,







DMSO-d6) δ







12.55 (s,







1H), 8.10 (d,







J = 7.5 Hz,







1H), 7.89-







7.86 (m,







1H), 2.47







(s, 3H),







2.21-2.19







(m, 1H),







1.90-1.79







(m, 1H),







1.71-1.63







(m, 1H),







1.62-1.56







(m, 1H),







1.49-1.41







(m, 1H),







1.38-1.10







(m, 6H).





1-395
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s, 1H), 8.34 (dd,








Hz, 1H), 7.59







(d J= 7.5 Hz,







1H), 2.76 (t,







J = 8.1 Hz,







2H), 2.46 (s,







3H), 1.55-







1.46 (m, 2H),







0.98-0.87 (m,







1H), 0.42-







0.31 (m, 2H),







0.24-0.18 (m,







2H).





1-396
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s, 1H), 8.33 (dd, J = 7.5, 6.0








Hz, 1H), 7.59







(d, J = 7.5,







1H), 2.76 (t,







J = 5.2 Hz,







2H), 2.46 (s,







3H), 1.72-







1.43 (m, 7H),







1.40-1.29







(m, 3H), 1.29-







1.20 (m,







2H), 1.20-







1.15 (m, 1H).





1-397
SO


embedded image


Me
H

1H NMR











(500 MHz,







DMSO-d6) δ







12.38 (s,







1H), 8.33 (dd,







J = 7.5, 6.0







Hz, 1H), 7.59







(d, J = 7.5







Hz, 1H),







5.87-5.76 (m,







1H), 5.08-







4.93 (m, 2H),







2.82 (t, J =







8.0 Hz, 2H),







2.46 (s, 3H),







2.34-2.26







(m, 2H).





1-398
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s,








1H), 8.38 (dd,







J = 7.5, 6.0







Hz, 1H), 7.60







(d, J = 7.5







Hz, 1H), 5.55







2H), 3.45-







3.34 (m, 2H),







2.46 (s, 3H),







1.65-1.60







(m, 3H).





1-399
SO


embedded image


Me
H






1-400
SO


embedded image


Me
H






1-401
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s,








1H), 8.34 (dd,







J = 7.5, 6.0







Hz, 1H), 7.59







(d, J = 7.5







Hz, 1H), 3.05







(t, J = 3.0 Hz,







1H), 2.95 (t,







J = 8.0 Hz,







2H), 2.46 (s,







3H), 2.37-







2.26 (m, 2H).





1-402
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s,








1H), 8.32 (dd,







J = 7.5, 6.0







Hz, 1H), 7.59







(d, J = 7.5







Hz, 1H), 3.47







(q, J = 2.0







Hz, 2H), 2.46







(s, 3H), 1.77







(t, J = 2.0 Hz,







3H).





1-403
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s,








1H), 8.33 (dd,







J = 7.5, 6.0







Hz, 1H), 7.59







(d, J = 7.5







Hz, 1H), 4.35







(t, J = 7.5 Hz,







1H), 4.25 (t,







J = 7.5 Hz,







1H), 2.76 (t,







J = 5.5 Hz,







2H), 2.46 (s,







3H), 1.90-







1.76 (m, 2H).





1-404
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s,








1H), 8.28







(dd, J = 7.5,







6.0 Hz, 1H),







7.59 (d, J =







7.5 Hz, 1H),







5.20-5.11







(m, 1H),







3.04-2.93 (m,







1H), 2.79-







2.68 (m, 1H),







2.40 (s, 3H),







1.41 (dd, J =







25.0, 7.0 Hz,







3H).





1-405
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s, 1H), 8.34 (dd, J = 7.5, 6.0








Hz, 1H), 7.59







(d, J = 7.5







Hz, 1H), 5.37







(t, J = 7.0 Hz,







1H), 2.76 (t,







J = 8.5 Hz,







2H), 2.46 (s,







3H), 1.99-







1.88 (m, 2H).





1-406
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s, 1H), 8.33 (dd,








J = 7.5, 6.0







Hz, 1H), 7.59







(d, J = 7.5







Hz,







1H), 3.45-







3.32 (m, 2H),







2.46 (s, 3H),







1.63-1.51 (m,







3H).





1-407
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s,








1H), 8.32 (dd,







J = 7.5, 6.0







Hz, 1H), 7.57







(d, J = 7.5







Hz, 1H), 2.45







(s, 3H).





1-408
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s, 1H), 8.31 (dd, Hz, 1H), 7.59








(d, J = 7.5







Hz, 1H), 2.45







(s, 3H).





1-409
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s, 1H), 8.36 (dd, J = 7.5, 6.0








Hz, 1H), 7.61







(d, J = 7.5







Hz, 1H), 2.46







(s, 3H).





1-410
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s, 1H), 8.35 (dd, J = 7.5, 6.0 Hz, 1H), 7.59








(d, J = 7.5







Hz, 1H), 2.45







(s, 3H).





1-411
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s,








1H), 8.34 (dd,







J = 7.5, 6.0







Hz, 1H), 7.61







(d, J = 7.5







Hz, 1H), 2.76







(t, J = 8.0 Hz,







2H), 2.52-







2.40 (m, 5H),







1.38-1.27 (m,







2H).





1-412
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s, 1H), 8.42 (dd, J = 7.5, 6.0








Hz, 1H), 7.60







(d, J = 7.5







Hz, 1H), 2.76







(t, J = 8.5 Hz,







2H), 2.46 (s,







3H), 1.93-







1.82 (m, 2H).





1-413
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s, 1H), 8.37 (dd, J = 7.5, 6.0








Hz, 1H), 7.59







(d, J = 7.5







Hz, 1H), 2.76







(t, J = 8.0 Hz,







2H), 2.46 (s,







3H), 1.71 (dt,







J = 25.0, 8.0







Hz, 2H).





1-414
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s,








1H), 8.33 (dd,







J = 7.5, 6.0







Hz, 1H), 7.59







(d, J = 7.5







Hz, 1H), 3.57







(t, J = 7.5







Hz, 2H), 2.76







(t, J = 5.5







Hz, 2H), 2.46







(s, 3H), 1.91-







1.80 (m, 2H).





1-415
SO


embedded image


Me
H
1H NMR (500 MHz, DMSO-d6) δ 12.38 (s, 1H), 8.33 (dd,







J = 7.5, 6.0







Hz, 1H), 7.59







(d, J = 7.5







Hz, 1H), 4.76-







4.64 (m,







1H), 3.13







(dd, J = 12.5,







7.0 Hz, 1H),







2.88 (dd, J =







12.5, 7.0 Hz,







1H), 2.46 (s,







3H), 1.55 (d,







J = 7.0 Hz,







3H).





1-416
SO


embedded image


Me
H






1-417
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s, 1H), 8.33 (dd, J = 7.5, 6.0








Hz, 1H), 7.56







(d, J = 7.5







Hz, 1H), 6.01







(t, J = 6.0 Hz,







1H), 3.45 (d,







J = 6.0 Hz,







2H), 2.46 (s,







3H).





1-418
SO


embedded image


Me
H






1-419
SO


embedded image


Me
H






1-420
SO


embedded image


Me
H






1-421
SO


embedded image


Me
H






1-422
SO


embedded image


Me
H






1-423
SO


embedded image


Me
H






1-424
SO


embedded image


Me
H






1-425
SO


embedded image


Me
H






1-426
SO


embedded image


Me
H






1-427
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s,








1H), 8.35 (dd,







J = 7.5, 6.0







Hz, 1H), 7.60







(d, J = 7.5







Hz, 1H), 3.15







(t, J = 8.0







Hz, 2H), 2.55







(t, J = 8.0







Hz, 2H), 2.46







(s, 3H).





1-428
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s,








1H), 8.34 (dd,







J = 7.5, 6.0







Hz, 1H), 7.59







(d, J = 7.5







Hz, 1H), 2.76







(t, J = 5.0







Hz, 2H), 2.46







(s, 3H), 2.14







(t, J = 5.5







Hz, 2H), 2.00







(1), J = 5.5







Hz, 2H).





1-429
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s,








1H), 8.33 (dd,







J = 7.5, 6.0







Hz, 1H), 7.60







(d, J = 7.5







Hz, 1H), 4.27







(t, J = 5.0 Hz,







1H), 3.87-







3.72 (m, 2H),







2.97 (t, J =







4.0 Hz, 2H),







2.46 (s, 3H).





1-430
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s,








1H), 8.34 (dd,







J = 7.5, 6.0







Hz, 1H), 7.59







(d, J = 7.5







Hz, 1H), 4.34







(t, J = 5.0 Hz,







1H), 3.50 (q,







J = 5.0 Hz,







2H), 2.76 (t,







J = 8.0 Hz,







2H), 2.46 (s,







3H), 1.82-







1.71 (m, 2H).





1-431
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s, 1H), 8.34 (dd,








J = 7.5, 6.0







Hz, 1H), 7.60







(d, J = 7.5







Hz, 1H),







5.24-5.15 (m,







1H), 4.34 (d,







J = 5.0 Hz,







1H), 4.41 (d,







J = 5.0 Hz,







2H), 3.12 (d,







J = 7.0 Hz,







2H), 2.46 (s,







3H).





1-432
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s,








1H), 8.33 (dd,







J = 7.5, 6.0







Hz, 1H), 7.61







(d, J = 7.5







Hz, 1H), 3.08-







2.93 (m,







4H), 3.01-







2.95 (m, 2H),







2.60 (s, 2H),







2.46 (s, 3H).





1-433
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s,








1H), 8.35 (dd,







J = 7.5, 6.0







Hz, 1H), 7.61







(d, J = 7.5







Hz, 1H), 4.96







(s, 1H), 2.81







(q, J = 8.0







Hz, 2H), 2.46







(s, 3H), 0.87







(t, J = 8.0







Hz, 3H).





1-434
SO


embedded image


Me
H






1-435
SO


embedded image


Me
H






1-436
SO


embedded image


Me
H






1-437
SO


embedded image


Me
H






1-438
SO


embedded image


Me
H






1-439
SO


embedded image


Me
H






1-440
SO


embedded image


Me
H






1-441
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s,








1H), 8.34 (dd,







J = 7.5, 6.0







Hz, 1H), 7.59







(d, J = 7.5







Hz, 1H),







4.04-3.92 (m,







2H), 3.85-







3.72 (m, 2H),







2.46 (s, 3H),







2.32 (s, 3H),







1.97 (s, 1H).





1-442
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s,








1H), 8.34 (dd,







J = 7.5, 6.0







Hz, 1H), 7.60







(d, J = 7.5







Hz, 1H), 3.57







(q, J = 8.0







Hz, 2H), 2.46







(s, 3H), 1.15







(t, J = 8.0 Hz,







3H).





1-443
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s,








1H), 8.32 (dd,







J = 7.5, 6.0







Hz, 1H), 7.61-







7.55 (m,







1H), 4.86-







4.73 (m, 2H),







3.21 (s, 3H),







2.46 (s, 3H).





1-444
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s,








1H), 8.34 (dd,







J = 7.5, 6.0







Hz, 1H), 7.61







(d, J = 7.5







Hz, 1H), 3.71







(t, J = 7.5







Hz, 1H), 3.43







(q, J = 8.0







Hz, 2H), 2.95







(t, J = 7.5







Hz, 1H), 2.45







(s, 3H), 1.08







(t, J = 8.0







Hz, 3H).





1-445
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) 12.41 (s, 1H), 8.12 (dd, J = 8.0,








7.0 Hz, 1H),







7.83 (d, J =







8.0 Hz, 1H),







4.35-4.24 (m,







1H), 3.32 (s,







3H), 2.50 (s,







3H), 1.45 (d,







J = 7.5 Hz,







3H)





1-446
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s,








1H), 8.32 (dd,







J = 7.5, 6.0







Hz, 1H), 7.58







(d, J = 7.5







Hz, 1H),







4.86-4.73 (m,







2H), 4.56-







4.43 (m, 2H),







3.46 (q, J =







8.0 Hz, 2H),







2.46 (s, 3H),







1.03 (t, J =







8.0 Hz, 3H).





1-447
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s, 1H), 8.34 (dd,








J = 7.5, 6.0







Hz, 1H), 7.64-







7.58 (m,







1H), 3.70-







3.61 (m, 1H),







3.22 (s, 3H),







3.02 (dd, J =







12.0, 7.0 Hz,







1H), 2.77







(dd, J = 12.0,







7.0 Hz, 1H),







2.46 (s, 3H),







1.18 (d, J =







7.0 Hz, 3H).





1-448
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s,








1H), 8.33 (dd,







J = 7.5, 6.0







Hz, 1H), 7.59







(d, J = 7.5







Hz, 1H), 3.34







(t, J = 7.5







Hz, 2H), 3.18







(s, 3H), 2.76







(t, J = 5.5







Hz, 2H), 2.46







(s, 3H), 1.80-







1.71 (m, 2H).





1-449
SO


embedded image


Me
H






1-450
SO


embedded image


Me
H






1-451
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.34 (s,








1H), 8.07-







8.95 (m,







1H), 7.59 (d,







J = 8.0 Hz,







1H), 3.89-







3.80 (m,







1H), 3.02-







2.95 (m,







1H), 2.81-







2.72 (m,







2H), 2.47 (s,







3H), 2.44-







2.39 (m,







1H).





1-452
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s, 1H), 7.78 (dd, J = 7.5, 6.0 Hz, 1H), 7.60








(d, J = 7.5







Hz, 1H), 4.75







(dd, J = 7.0







6.0 Hz, 2H),







4.51 (dd, J =







7.0, 6.0 Hz,







2H), 3.28-







3.17 (m, 1H),







2.70 (d, J =







7.0 Hz, 2H),







2.45 (s, 3H).





1-453
SO


embedded image


Me
H






1-454
SO


embedded image


Me
H






1-455
SO


embedded image


Me
H






1-456
SO


embedded image


Me
H






1-457
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.01 (s,








1H), 8.23-







8.10 (m,







1H), 7.93 (d,







J = 8.0 Hz,







1H), 7.65-







7.46 (m,







5H), 2.48 (s,







3H).





1-458
SO


embedded image


Me
H






1-459
SO


embedded image


Me
H






1-460
SO


embedded image


Me
H






1-461
SO


embedded image


Me
H






1-462
SO


embedded image


Me
H






1-463
SO


embedded image


Me
H






1-464
SO


embedded image


Me
H






1-465
SO


embedded image


Me
H






1-466
SO


embedded image


Me
H






1-467
SO


embedded image


Me
H






1-468
SO


embedded image


Me
H






1-469
SO


embedded image


Me
H






1-470
SO


embedded image


Me
H






1-471
SO


embedded image


Me
H






1-472
SO


embedded image


Me
H






1-473
SO


embedded image


Me
H






1-474
SO


embedded image


Me
H






1-475
SO


embedded image


Me
H






1-476
SO


embedded image


Me
H






1-477
SO


embedded image


Me
H






1-478
SO


embedded image


Me
H






1-479
SO


embedded image


Me
H






1-480
SO


embedded image


Me
H






1-481
SO


embedded image


Me
H






1-482
SO


embedded image


Me
H






1-483
SO


embedded image


Me
H






1-484
SO


embedded image


Me
H






1-485
SO


embedded image


Me
H






1-486
SO


embedded image


Me
H






1-487
SO


embedded image


Me
H






1-488
SO


embedded image


Me
H






1-489
SO


embedded image


Me
H






1-490
SO


embedded image


Me
H






1-491
SO


embedded image


Me
H






1-492
SO


embedded image


Me
H






1-493
SO


embedded image


Me
H






1-494
SO


embedded image


Me
H






1-495
SO


embedded image


Me
H






1-496
SO


embedded image


Me
H






1-497
SO


embedded image


Me
H






1-498
SO


embedded image


Me
H






1-499
SO


embedded image


Me
H






1-500
SO


embedded image


Me
H






1-501
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.59 (s, 1H) 8.10- 7.91 (m,








4H), 7.17 (d,







J = 6.5 Hz,







2H), 2.47 (s,







3H).





1-502
SO


embedded image


Me
H






1-503
SO


embedded image


Me
H






1-504
SO


embedded image


Me
H






1-505
SO


embedded image


Me
H






1-506
SO


embedded image


Me
H






1-507
SO


embedded image


Me
H






1-508
SO


embedded image


Me
H






1-509
SO


embedded image


Me
H






1-510
SO


embedded image


Me
H






1-511
SO


embedded image


Me
H






1-512
SO


embedded image


Me
H






1-513
SO


embedded image


Me
H






1-514
SO


embedded image


Me
H






1-515
SO


embedded image


Me
H






1-516
SO


embedded image


Me
H






1-517
SO


embedded image


Me
H






1-518
SO


embedded image


Me
H






1-519
SO


embedded image


Me
H






1-520
SO


embedded image


Me
H






1-521
SO


embedded image


Me
H






1-522
SO


embedded image


Me
H






1-523
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s, 1H), 8.27








(dd, J = 7.5,







6.0 Hz, 1H),







7.58 (d, J =







7.5 Hz, 1H),







7.15 (t, J =







50.0 Hz, 1H),







3.71 (t, J =







8.0 Hz, 2H),







2.95 (t, J =







8.0 Hz, 2H),







2.40 (s, 3H).





1-524
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s,








1H), 8.34 (dd,







J = 7.5, 6.0







Hz, 1H), 7.59







(d, J = 7.5







Hz, 1H),







3.71.-3.62







(m, 2H), 2.95







(t, J = 8.0







Hz, 2H), 2.46







(s, 3H).





1 -525
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s, 1H), 8.33 (dd,








J = 7.5, 6.0







Hz, 1H), 7.59







(d, J = 7.5







Hz, 1H),







3.87-3.75 (m,







2H), 2.97 (t,







J = 4.5 Hz,







2H), 2.46 (s,







3H), 2.42 (s,







6H).





1-526
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s, 1H), 8.34 (dd, J = 7.5, 6.0








Hz, 1H), 7.59







(d, J = 7.5







Hz, 1H), 2.48-







2.40 (m,







2H), 1.26 (t,







J = 8.0 Hz,







3H).





1-527
SO


embedded image


Me
H






1-528
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s, 1H), 8.34 (dd,








J = 7.5, 6.0







Hz, 1H), 7.59







(d, J = 7.5







Hz, 1H), 2.92







(q, J = 45.0







Hz, 2H), 2.45







(s, 3H).





1-529
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s, 1H), 8.10- 8.03 (m, 2H), 7.79 (dd, J =








7.5, 6.0 Hz,







1H), 7.67-







7.54 (m, 1H),







7.61-7.51







(m, 3H), 2.45







(s, 3H).





1-530
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s, 1H), 8.35 (dd, J = 7.5, 6.0








Hz, 1H), 7.84







(d, J = 7.5







Hz, 1H), 7.60







(dd, J = 7.5







Hz, 1H), 7.52







(dd, J = 7.5,







1.5 Hz, 1H),







6.74 (t, J =







7.5 Hz, 1H),







2.46 (s, 3H).





1-531
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s, 1H), 8.35 (dd, J = 7.5, 6.0 Hz, 1H), 8.24 (s, 1H), 7.60








(d, J = 7.5







Hz, 1H), 3.81







(s, 3H), 2.60







(s, 3H), 2.46







(s, 3H).





1-532
SO


embedded image


Me
H






1-533
SO


embedded image


Me
H






1-534
SO


embedded image


Me
H






1-535
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s, 1H), 8.34 (dd, J = 7.5, 6.0








Hz, 1H), 7.59







(d, J = 7.5







Hz, 1H), 3.06







(s, 6H), 2.45







(s, 3H).





1-536
SO


embedded image


Me
H






1-537
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s, 1H), 8.06 (dd, J = 7.5, 6.0








Hz, 1H), 7.59







(d, J = 7.5







Hz, 1H), 3.67







(s, 2H), 2.91







(s, 6H), 2.46







(s, 3H).





1-538
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s, 1H), 7.77 (dd,








J = 7.5, 6.0







Hz, 1H), 7.60-







7.55 (m,







1H), 4.73 (s,







2H), 3.06 (s,







9H), 2.45 (s,







3H).





1-539
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.67 (s, 1H), 8.16-








8.05 (m,







1H), 7.78 (d,







J = 8.0 Hz,







1H), 7.30-







7.16 (m,







5H), 4.78-







4.63 (m,







2H), 2.47 (s,







3H).





1-540
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.55 (s, 1H), 8.10- 8.01 (m,








1H), 7.87 (d,







J = 8.0 Hz,







1H), 7.35-







7.26 (m,







4H), 7.27-







7.20 (m,







1H), 3.88-







3.77 (m,







1H), 3.48-







3.40 (m,







1H), 3.18-







3.08 (m,







1H), 3.02-







2.92 (m,







1H), 2.48 (s,







3H).





1-541
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.59 (s, 1H), 8.14-








8.02 (m,







1H), 7.87-







7.82 (m,







1H), 7.62-







7.59 (m,







1H), 6.39-







6.34 (m,







2H), 4.97-







4.86 (m,







1H), 4.84-







4.75 (m,







1H), 2.47 (s,







3H).





1-542
SO


embedded image


Me
H






1-543
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s, 1H), 8.34 (dd, J = 7.5, 6.0 Hz, 1H), 7.60








(d, J = 7.5







Hz, 1H), 6.88







(s, 1H), 4.70







(s, 2H), 3.72







(s, 3H), 2.46







(s, 3H), 2.29







(s, 3H).





1-544
SO


embedded image


Me
H






1-545
SO


embedded image


Me
H






1-546
SO


embedded image


Me
H






1-547
SO


embedded image


Me
H






1-548
SO


embedded image


Me
H






1-549
SO


embedded image


Me
H






1-550
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s,








1H), 9.72 (t,







J = 6.0 Hz,







1H), 8.39







(dd, J = 7.5,







6.0 Hz, 1H),







7.60 (d, J =







7.5 Hz, 1H),







3.89-3.78 (m,







2H), 2.46 (s,







3H).





1-551
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ








12.38 (s,







1H), 9.90 (t,







J = 6.0 Hz,







1H), 8.34







(dd, J = 7.5,







6.0 Hz, 1H),







7.61 (d, J =







7.5 Hz, 1H),







3.11-3.01 (m,







2H), 2.74-







2.61 (m, 2H),







2.46 (s, 3H).





1-552
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s, 1H), 8.34








(dd, J = 7.5,







6.0 Hz, 1H),







7.57 (d, J =







7.5 Hz, 1H),







3.94-3.83 (m,







2H), 2.45 (s,







3H), 2.16 (s,







3H).





1-553
SO


embedded image


Me
H






1-554
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.41 (s, 1H), 12.38 (s,








1H), 8.18







(dd, J = 7.5,







6.0 Hz, 1H),







7.61 (d, J =







7.5 Hz, 1H),







3.72-3.63 (m,







2H), 2.46 (s,







3H).





1-555
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s,








1H), 8.33 (dd,







J = 7.5, 6.0







Hz, 1H), 7.61







(d, J = 7.5







Hz, 1H),







4.31-4.23 (m,







2H), 3.73 (s,







3H), 2.47 (s,







3H).





1-556
SO


embedded image


Me
H






1-557
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s, 1H), 8.35 (dd, J = 7.5, 6.0 Hz, 1H), 7.60 (d, J = 7.5 Hz, 1H), 4.31-4.22 (m,








2H), 2.46 (s,







3H), 1.39 (s,







9H).





1-558
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s, 1H), 8.33 (dd, J = 7.5, 6.0 Hz, 1H), 7.63-7.57 (m, 1H), 4.31-4.22 (m,








2H), 4.02-







3.86 (m, 4H),







4.17 (q, J =







8.0 Hz, 2H),







2.46 (s, 3H),







1.12 (t, J =







8.0 Hz, 3H).





1-559
SO


embedded image


Me
H






1-560
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s, 1H), 8.35 (dd, J = 7.5,








6.0 Hz, 1H),







7.60 (d, J =







7.5 Hz, 1H),







4.31-4.22 (m,







2H), 2.46 (s,







3H), 1.39 (s,







9H).





1-561
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s,








1H), 8.29







(dd, J = 7.5,







6.0 Hz, 1H),







7.59 (d, J =







7.5 Hz, 1H),







3.93-3.82 (m,







2H), 2.45 (s,







3H), 2.21 (s,







3H).





1-562
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s,








1H), 8.34







(dd, J = 7.5,







6.0 Hz, 1H),







7.60 (d, J =







7.5 Hz, 1H),







3.15 (t, J =







8.0 Hz, 2H),







2.67 (t, J =







8.0 Hz, 2H),







2.46 (s, 3H),







2.07 (s, 3H)





1-563
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s, 1H), 8.24








(dd, J = 7.5,







6.0 Hz, 1H),







7.56 (d, J =







7.5 Hz, 1H),







4.06-3.91 (m,







2H), 2.53 (s,







3H), 2.45 (s,







3H).





1-564
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s, 1H), 8.03








(dd, J =







7.5, 6.0 Hz,







1H), 7.62 (d,







J = 7.5 Hz,







1H), 2.63 (s,







3H), 0.08 (s,







9H).





1-565
SO


embedded image


Me
H






1-566
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s, 1H), 8.32








(dd, J = 7.5,







6.0 Hz, 1H),







7.59 (d, J =







7.5 Hz, 1H),







4.13-4.01 (m,







2H), 3.02 (t,







J = 3.5 Hz,







2H), 2.46 (s,







3H), 1.03 (s,







9H), 0.21 (s,







6H).





1-567
SO


embedded image


Me
H

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s, 1H), 8.33








(dd, J = 7.5,







6.0 Hz, 1H),







7.59 (dd, J =







7.5 Hz, 1H),







7.36-7.25







(m, 5H), 4.86







(s, 2H), 4.68







(s, 2H), 2.48







(s, 3H).


1-568
SO
Et
Me
Me

1H NMR








(500 MHz,







DMSO-d6) δ







7.96 (dd, J =







7.5, 6.0 Hz,







1H), 7.57 (d,







J = 7.5 Hz,







1H), 3.25 (s,







3H), 2.82 (q,







J = 8.0 Hz,







2H), 2.45 (s,







3H), 1.33 (t,







J = 8.0 Hz,







3H).


1-569
SO
Et
Me
Et






1-570
SO
Et
Me


embedded image








1-571
SO
Et
Me


embedded image



1H NMR (500 MHz, DMSO-d6) δ 7.79 (dd, J = 7.5, 6.0 Hz, 1H), 7.54 (d,








J = 7.5 Hz,







1H), 5.93-







5.85 (m,







1H), 5.10-







5.01 (m,







1H), 4.89-







4.79 (m,







1H), 4.47-







4.43 (m,







2H), 2.85 (q,







J = 8.0 Hz,







2H), 2.46 (s,







3H), 1.31 (t,







J = 8.0 Hz,







3H).





1-572
SO
Et
Me


embedded image



1H NMR (500 MHz, DMSO-d6) δ 7.81 (dd, J = 7.5, 6.0 Hz, 1H), 7.57 (d, J = 7.5 Hz,








1H), 3.94 (d,







J = 3.0 Hz,







2H), 3.29 (t,







J = 3.0 Hz,







1H), 2.84 (q,







J = 8.0 Hz,







2H), 2.46 (s,







3H), 1.32 (t,







J = 8.0 Hz,







3H).





1-573
SO
Et
Me


embedded image








1-574
SO
Et
Me


embedded image



1H NMR (500 MHz, DMSO-d6) δ 7.66 (dd, J =








7.5, 6.0 Hz,







1H), 7.55-







7.49 (m, 1H),







2.88 (q, J =







8.0 Hz, 2H),







2.46 (s, 3H),







2.22 (s, 3H),







1.34 (t, J =







8.0 Hz, 3H).





1-575
SO
Et
Me


embedded image



1H NMR (500 MHz, DMSO-d6) δ 8.10 (dd, J = 7.5, 6.0 Hz, 1H), 7.91-








7.84 (m, 2H),







7.63-7.56







(m, 2H), 7.52







(t, J = 7.5







Hz, 2H), 2.81







(q, J = 8.0







Hz, 2H), 2.33







(s, 3H), 1.32







(t, J = 8.0







Hz, 3H).





1-576
SO
Et
Me


embedded image








1-577
SO
Et
Me


embedded image








1-578
SO
Et
Me


embedded image








1-579
SO
Et
Me


embedded image








1-580
SO
Et
Me


embedded image








1-581
SO
Et
Me


embedded image



1H NMR (500 MHz, DMSO-d6) δ 8.03 (dd, J = 7.5, 6.0 Hz, 1H), 7.62 (d, J = 7.5 Hz, 1H), 7.50 (s, 1H), 3.64 (s,








3H), 2.83 (q,







J = 8.0 Hz,







2H), 2.63 (s,







3H), 2.46 (s,







3H), 1.17 (t,







J = 8.0 Hz,







3H).





1-582
SO
Et
Me


embedded image








1-583
SO
Et
Me


embedded image








1-584
SO
Et
Me


embedded image








1-585
SO
Et
Me


embedded image








1-586
SO
Et
Me


embedded image








1-587
SO
Et
Me


embedded image








1-588
SO
Et
Me


embedded image



1H NMR (500 MHz, DMSO-d6) δ 8.11 (dd, J =








7.5, 6.0 Hz,







1H), 7.61 (d,







J = 7.5 Hz,







1H), 3.71 (s,







3H), 2.84 (q,







J = 8.0 Hz,







2H), 2.46 (s,







3H), 1.33 (t,







J = 8.0 Hz,







3H).





1-589
SO
Et
Me


embedded image








1-590
SO
Et
Me


embedded image








1-591
SO
Et
Me


embedded image








1-592
SO
Et
Me


embedded image








1-593
SO
Et
Me


embedded image








1-594
SO
Et
Me


embedded image








1-595
SO
Et
Me


embedded image








1-596
SO
Et
Me


embedded image



1H NMR (500 MHz, DMSO-d6) δ 8.11 (dd, J = 7.5, 6.0 Hz, 1H), 7.62 (d,








J = 7.5 Hz,







1H), 3.52 (t,







J = 4.5 Hz,







4H), 3.12 (t,







J = 4.5 Hz,







4H), 2.85 (q,







J = 8.0 Hz,







2H), 2.44 (s,







3H), 1.30 (t,







J = 8.0 Hz,







3H).





1-597
SO
Et
Me


embedded image



1H NMR (500 MHz, DMSO-d6) δ 7.94 (dd, J =








7.5, 6.0 Hz,







1H), 7.57 (d,







J = 7.5 Hz,







1H), 3.72 (q,







J = 9.0 Hz,







2H), 2.82 (q,







J = 8.0 Hz,







2H), 2.46 (s,







3H), 1.31 (t,







J = 8.0 Hz,







3H).





1-598
SO
Et
Me


embedded image



1H NMR (500 MHz, DMSO-d6) δ 7.90 (dd, J =








7.5, 6.0 Hz,







1H), 7.61 (d,







J = 7.5 Hz,







1H), 4.32 (s,







2H), 2.83 (q,







J = 8.0 Hz,







2H), 2.47 (s,







3H), 1.31 (t,







J = 8.0 Hz,







3H).





1-599
SO
Et
Me


embedded image



1H NMR (500 MHz, DMSO-d6) δ 7.67 (dd, J = 7.5, 6.0 Hz, 1H), 7.40 (d, J = 7.5 Hz,








1H), 7.28-







7.19 (m, 5H),







5.03 (s, 2H),







2.85 (q, J =







8.0 Hz, 2H),







2.47 (s, 3H),







1.27 (t, J =







8.0 Hz, 3H).





1-600
SO
Et
Me


embedded image








1-601
SO
Et
Me


embedded image








1-602
SO
Et
Me


embedded image








1-603
SO
Et
Me


embedded image








1-604
SO
Et
Me


embedded image



1H NMR (500 MHz, DMSO-d6) δ 7.87 (dd, J = 7.5, 6.0 Hz, 1H), 7.66 (d,








J = 7.5 Hz,







1H), 6.28 (q,







J = 7.5 Hz,







1H), 3.81 (s,







3H), 2.83 (q,







J = 8.0 Hz,







2H), 2.46 (s,







3H), 1.64 (d,







J = 7.0 Hz,







3H), 1.31 (t,







J = 8.0 Hz,







3H).





1-605
SO


embedded image


Me
Me






1-606
SO


embedded image


Me


embedded image








1-607
SO


embedded image


Me


embedded image








1-608
SO


embedded image


Me


embedded image








1-609
SO


embedded image


Me


embedded image








1-610
SO


embedded image


Me


embedded image








1-611
SO


embedded image


Me


embedded image








1-612
SO


embedded image


Me


embedded image








1-613
SO


embedded image


Me


embedded image








1-614
SO


embedded image


Me


embedded image








1-615
SO


embedded image


Me


embedded image








1-616
SO


embedded image


Me


embedded image








1-617
SO


embedded image


Me


embedded image



1H NMR (500 MHz, DMSO-d6) δ 7.82 (dd, J = 7.5, 6.0 Hz,








1H), 7.56 (d,







J = 7.5 Hz,







1H), 6.31 (q,







J = 7.0 Hz,







1H), 4.70-







4.53 (m, 2H),







3.50 (td, J =







12.5, 3.0 Hz,







1H), 3.24 (td,







J = 12.5, 3.0







Hz, 1H), 2.56-







2.42 (m,







1H), 2.36 (s,







3H), 1.67-







1.52 (m, 4H),







1.32 (t, J =







8.0 Hz, 3H),







0.88 (t, J =







8.0 Hz, 3H).





1-618
SO


embedded image


Me


embedded image








1-619
SO


embedded image


Me


embedded image








1-620
SO


embedded image


Me


embedded image








1-621
SO


embedded image


Me


embedded image








1-622
SO


embedded image


Me


embedded image








1-623
SO


embedded image


Me


embedded image








1-624
SO


embedded image


Me


embedded image








1-625
SO


embedded image


Me


embedded image








1-626
SO


embedded image


Me


embedded image








1-627
SO


embedded image


Me


embedded image








1-628
SO


embedded image


Me


embedded image








1-629
SO


embedded image


Me


embedded image








1-630
SO


embedded image


Me


embedded image








1-631
SO


embedded image


Me


embedded image








1-632
SO


embedded image


Me


embedded image








1-633
SO


embedded image


Me


embedded image








1-634
SO


embedded image


Me


embedded image








1-635
SO


embedded image


Me


embedded image








1-636
SO


embedded image


Me


embedded image








1-637
SO


embedded image


Me


embedded image








1-638
SO


embedded image


Me


embedded image








1-639
SO


embedded image


Me


embedded image








1-640
SO


embedded image


Me


embedded image








1-641
SO


embedded image


Me


embedded image








1-642
SO


embedded image


Me


embedded image








1-643
SO


embedded image


Me


embedded image








1-644
SO


embedded image


Me


embedded image








1-645
SO


embedded image


Me


embedded image








1-646
SO


embedded image


Me


embedded image








1-647
SO


embedded image


Me


embedded image








1-648
SO


embedded image


Me


embedded image








1-649
SO


embedded image


Me


embedded image








1-650
SO


embedded image


Me


embedded image








1-651
SO


embedded image


Me
OMe






1-652
SO


embedded image


Me


embedded image








1-653
SO


embedded image


Me


embedded image








1-654
SO


embedded image


Me


embedded image








1-655
SO


embedded image


Me


embedded image








1-656
SO


embedded image


Me


embedded image








1-657
SO


embedded image


Me


embedded image








1-658
SO


embedded image


Me


embedded image








1-659
SO


embedded image


Me


embedded image








1-660
SO


embedded image


Me


embedded image








1-661
SO


embedded image


Me


embedded image











Table A2 is constructed in the same manner as Table A1 except that the fourth column (i.e., “Z” column) are replaced by the corresponding “Z” column shown below. Accordingly, the first column in Table A2 is the number of compound (Compound No.), i.e., Compound 2-1 (wherein, X is S, Y is Me, Z is Et, and M is H), followed by Compound 2-2, Compound 2-3, and Compound 2-4, the last number of compound is Compound 2-661.
















Table
“Z”









A2 
Et



A3 
H







A4 


embedded image









A5 
I







A6 


embedded image









A7 
Br







A8 


embedded image









A9 
F







A10 


embedded image









A11 


embedded image









A12 


embedded image









A13 


embedded image









A14 


embedded image









A15 


embedded image









A16 
Cl







A17 


embedded image









A18 
CN







A19 


embedded image









A20 
CF3







A21 


embedded image









A22 


embedded image









A23 


embedded image









A24 


embedded image









A25 


embedded image









A26 


embedded image









A27 


embedded image









A28 


embedded image









A29 


embedded image









A30 


embedded image









A31 


embedded image









A32 


embedded image









A33 


embedded image









A34 


embedded image









A35 


embedded image









A36 


embedded image









A37 


embedded image









A38 


embedded image









A39 


embedded image









A40 


embedded image









A41 


embedded image









A42 


embedded image









A43 


embedded image









A44 


embedded image









A45 


embedded image









A46 


embedded image









A47 


embedded image









A48 


embedded image









A49 


embedded image









A50 


embedded image









A51 


embedded image









A52 


embedded image









A53 


embedded image









A54 


embedded image









A55 


embedded image









A56 


embedded image









A57 


embedded image









A58 


embedded image









A59 


embedded image









A60 


embedded image









A61 


embedded image









A62 


embedded image









A63 


embedded image









A64 


embedded image









A65 


embedded image









A66 


embedded image









A67 


embedded image









A68 


embedded image









A69 


embedded image









A70 


embedded image









A71 


embedded image









A72 


embedded image









A73 


embedded image









A74 


embedded image









A75 


embedded image









A76 


embedded image









A77 


embedded image









A78 


embedded image









A79 


embedded image









A80 


embedded image









A81 


embedded image









A82 


embedded image









A83 


embedded image









A84 


embedded image









A85 


embedded image









A86 


embedded image









A87 


embedded image









A88 


embedded image









A89 


embedded image









A90 


embedded image









A91 


embedded image









A92 


embedded image









A93 


embedded image









A94 


embedded image









A95 


embedded image









A96 
CHF2







A97 


embedded image









A98 


embedded image









A99 
CH2F







A100


embedded image









A101


embedded image









A102


embedded image









A103


embedded image









A104
SMe







A105


embedded image









A106
SO2Me



A107
SOMe







A108


embedded image









A109


embedded image









A110
COOEt







A111


embedded image









A112


embedded image









A113


embedded image









A114


embedded image









A115


embedded image









A116


embedded image









A117


embedded image









A118


embedded image









A119


embedded image









A120


embedded image









A121


embedded image









A122


embedded image









A123


embedded image









A124


embedded image









A125


embedded image









A126


embedded image









A127


embedded image









A128


embedded image









A129


embedded image









A130


embedded image









A131


embedded image









A132


embedded image









A133


embedded image









A134


embedded image









A135


embedded image









A136


embedded image









A137


embedded image









A138
NH2







A139


embedded image









A140


embedded image









A141


embedded image









A142


embedded image









A143


embedded image









A144


embedded image









A145


embedded image









A146


embedded image









A147


embedded image









A148


embedded image









A149


embedded image









A150


embedded image









A151


embedded image









A152


embedded image












The 1H NMR data of some of the compounds in the above tables are shown in Table 1:









TABLE 1








1H NMR data of compounds









Compound



No.

1HNMR






2-3

1HNMR (500 MHz, DMSO-d6) 12.37 (s, 1 H), 8.23 (dd, J = 8.0, 7.0 Hz, 1 H), 7.98 (d, J = 8.0 Hz,




1 H), 3.45 (s, 3 H), 2.63 (q, J = 8.0 Hz, 2 H), 1.32 (t, J = 8.0 Hz, 3 H)


2-4

1H NMR (500 MHz, DMSO-d6) 12.38 (s, 1 H), 7.88 (dd, J = 8.0, 7.0 Hz, 1 H), 7.78 (d, J = 8.0 Hz,




1 H), 2.98 (q, J = 7.5 Hz, 2 H), 2.71 (q, J = 7.0 Hz, 2 H), 1.15 (t, J = 7.5 Hz, 3 H), 1.10 (t, J = 7.5 Hz,



3 H).


2-8

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s, 1 H),8.24 (dd, J = 7.5, 6.0 Hz, 1 H), 7.65 (d, J = 7.5 Hz,




1 H), 2.76 (t, J = 5.0 Hz, 2 H), 2.59 (q, J = 8.0 Hz, 2 H), 1.47-1.38 (m, 2 H), 1.13 (t, J = 8.0 Hz, 3 H),



0.94 (t, J = 8.0 Hz, 3 H).


3-4

1H NMR (500 MHz, DMSO-d6) δ 12.68 (s, 1 H), 9.06 (s, 1 H), 7.89-7.83 (m, 1 H), 7.76 (d, J =




8.0 Hz, 1 H), 3.00-2.92 (m, 2 H), 1.13 (t, J = 7.5 Hz, 3 H).


3-5

1H NMR (500 MHz, DMSO-d6) δ 12.72 (s, 1 H), 9.06 (s, 1 H), 8.18-8.04 (m, 1 H), 7.86 (d, J =




8.0 Hz, 1 H), 3.51-3.44 (m, 1 H), 3.29-3.22 (m, 1 H), 1.17 (t, J = 7.5 Hz, 3 H).


3-8

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s, 1 H),8.24 (dd, J = 7.5, 6.0 Hz, 1 H), 7.71 (s, 1 H), 7.65




(d, J = 7.5 Hz, 1 H), 2.76 (t, J = 5.0 Hz, 2 H), 1.47-1.44 (m, 2 H), 0.95 (t, J = 8.0 Hz, 3 H).


3-11

1H NMR (500 MHz, DMSO-d6) δ 12.58 (s, 1 H), 9.03 (s, 1 H), 8.19-8.08 (m, 1 H), 7.59 (d, J =




8.0 Hz, 1 H), 3.86-3.74 (m, 1 H), 1.43 -1.09 (m, 6 H).


3-14

1H NMR (500 MHz, DMSO-d6) δ 12.78 (s, 1 H), 9.07 (s, 1 H), 8.14-8.06 (m, 1 H), 7.76 (d, J =




8.0 Hz, 1 H), 3.58-3.47 (m, 1 H), 3.20 ? 3.10 (m, 1 H), 1.73-1.51 (m, 2 H), 1.50-1.35(m, 2 H),



0.88 (t, J = 7.5 Hz, 3 H).


3-17

1H NMR (500 MHz, DMSO-d6) δ 12.61 (s, 1 H), 9.08 (s, 1 H), 8.01-7.92 (m, 1 H), 7.59 (d, J =




8.0 Hz, 1 H), 2.75-2.68 (m, 1 H), 1.78-1.69 (m, 2 H), 1.40 (d, J = 7.0 Hz, 3 H), 0.94 (t, J = 8.0



Hz, 3 H).


3-20

1H NMR (500 MHz, DMSO-d6) δ 12.77 (s, 1 H), 9.02 (s, 1 H), 8.13-8.03 (m, 1 H), 7.86 (d, J




8.0 Hz, 1 H), 3.59-3.48 (m, 1 H), 2.90-2.81 (m, 1 H), 2.19-2.04 (m, 1 H), 1.11-0.99 (m, 6 H).


3-52

1H NMR (500 MHz, DMSO-d6) δ 12.67 (s, 1 H), 9.05 (s, 1 H), 8.27-8.18 (m, 1 H), 7.92 (d J =




8.0 Hz, 1 H), 2.76-2.62 (m, 2 H), 2.15-2.05 (m, 2 H).


3-54

1H NMR (500 MHz, DMSO-d6) δ 12.71 (s, 1 H), 9.01 (s, 1 H), 8.03-7.93 (m, 1 H), 7.82 (d, J




8.0 Hz, 1 H), 3.78 (t, J = 8.0 Hz, 2 H), 3.07 (t, J = 8.0 Hz, 2 H).


3-57

1H NMR (500 MHz, DMSO-d6) δ 8.67 (s, 1 H), 8.08-7.97 (m, 1 H), 7.74 (d, J = 8.0 Hz, 1 H),




3.81-3.71 (m, 1 H), 3.69-3.60 (m, 2 H), 3.42-3.35 (m, 1 H), 3.23 (s, 3 H).


4-4

1H NMR (500 MHz, DMSO-d6) 12.40 (s, 1 H), 7.89 (dd, J = 8.0, 7.0 Hz, 1 H), 7.79 (d, J = 8.0 Hz,




1 H), 2.99 (q, J = 7.5 Hz, 2 H), 2.77 (t, J = 7.5 Hz, 2 H), 1.37-1.32 (m, 2 H), 1.15 (t, J = 7.5 Hz, 3 H),



1.06 (t, J = 7.0 Hz, 3 H).


4-8

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s, 1 H),8.32 (dd, J = 7.5, 6.0 Hz, 1 H), 7.67 (d, J = 7.5 Hz,




1 H), 2.76 (t, J = 8.0 Hz, 2 H), 2.53 (t, J = 8.0 Hz, 2 H), 1.61-1.55 (m, 2 H), 1.47-1.33 (m, 2 H), 0.87-



0.83 (m, 6 H).


6-4

1H NMR (500 MHz, DMSO-d6) 12.42 (s, 1 H), 7.91 (dd, J = 8.0, 7.0 Hz, 1 H), 7.80 (d, J = 8.0 Hz,




1 H), 3.01 (q, J = 7.5 Hz, 2 H), 2.97 (hept., J = 7.0 Hz, 1 H), 1.15 (t, J = 7.5 Hz, 3 H), 1.13 (d, J = 7.0



Hz, 6 H).


6-8

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s, 1 H), 8.30 (dd, J = 7.5, 6.0 Hz, 1 H), 7.68 (d, J = 7.5 Hz,




1 H), 3.08 (p,J = 6.8 Hz, 1 H), 2.76 (t,J = 8.1 Hz, 2 H), 1.47-.33(m, 2 H), 1.26 (d,J = 6.8 Hz, 6 H),



0.89 (t,J = 8.0 Hz, 3 H).


8-4

1H NMR (500 MHz, DMSO-d6) 12.40 (s, 1 H), 7.92 (dd, J = 8.0, 7.0 Hz, 1 H), 7.81 (d, J = 8.0 Hz,




1 H), 3.00 (q, J = 7.5 Hz, 2 H), 1.16 (t, J = 7.5 Hz, 3 H), 1.14 (s, 9 H).


8-8

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s, 1 H),8.24 (dd, J = 7.5, 6.0 Hz, 1 H), 7.65 (d, J = 7.5 Hz,




1 H), 2.76 (t, J = 5.0 Hz, 2 H), 1.47-1.43 (m, 2 H), 1.25 (s, 9H), 0.94 (t, J = 8.0 Hz, 3 H).


10-4

1H NMR (500 MHz, DMSO-d6) 12.40 (s, 1 H), 7.91 (dd, J = 8.0, 7.0 Hz, 1 H), 7.80 (d, J = 8.0 Hz,




1 H), 3.01 (q, J = 7.5 Hz, 2 H), 2.30- 2.20 (m, 1 H), 1.15 (t, J = 7.5 Hz, 3 H), 1.10 - 0.94 (m, 4H)


10-8

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s, 1 H),8.11 (dd, J = 7.5, 6.0 Hz, 1 H), 7.53 (d, J = 7.5 Hz,




1 H), 2.76 (t, J = 7.0 Hz, 2 H), 1.55 - 1.41 (m, 3 H), 0.97 (t, J = 8.0 Hz, 3 H), 0.89 - 0.78 (m, 2 H),



0.71-0.61 (m, 2 H).


12-8

1H NMR (500 MHz, Chloroform-a) δ 8.19 (s, 1 H), 7.79 (dd, J = 7.5, 6.0 Hz, 1 H), 7.68 (d, J = 7.5




Hz, 1 H), 3.77 (s, 3 H), 2.76 (t, J = 8.0 Hz, 2 H), 1.67-1.58 (m, 2 H), 0.91 (t, J = 8.0 Hz, 3 H).


14-4

1HNMR (500 MHz, DMSO-d6) 12.36 (s, 1 H), 7.90 (dd, J = 8.0, 7.0 Hz, 1 H), 7.80 (d, J = 8.0 Hz,




1 H),4.78 (s, 2 H), 3.21 (s, 3 H), 2.97 (q, J = 7.5 Hz, 2 H), 1.14 (t, J = 7.5 Hz, 3 H).


14-8

1H NMR (500 MHz, Chloroform-a) δ 8.20 (s, 1 H), 7.79 (dd, J = 7.5, 6.0 Hz, 1 H), 7.67 (d, J = 7.5




Hz, 1 H), 4.63 (s, 2 H), 3.35 (s, 3 H), 2.76 (t, J = 5.0 Hz, 2 H), 1.67 (qt, J = 8.0, 5.0 Hz, 2 H), 0.93 (t, J =



8.0 Hz, 3 H).


16-8

1H NMR (500 MHz, Chloroform-a) δ 8.23 (s, 1 H), 8.19 (dd, J = 7.5, 6.0 Hz, 1 H), 7.42 (d, J = 7.5




Hz, 1 H), 2.76 (t, J = 5.0 Hz, 2 H), 1.67 (qt, J = 8.0, 5.0 Hz, 2 H), 0.95 (t, J = 8.0 Hz, 3 H).


17-4

1H NMR (500 MHz, DMSO-d6) 12.40 (s, 1 H), 7.92 (dd, J = 8.0, 7.0 Hz, 1 H), 7.81 (d, J = 8.0 Hz,




1 H), 3.59 (t, J = 8.5 Hz, 2 H), 3.32 (s, 3 H), 3.00 (q, J = 7.5 Hz, 2 H), 2.77 (t, J = 8.5 Hz, 2 H), 1.16 (t,



J = 7.5 Hz, 3 H).


17-5

1H NMR (500 MHz, DMSO-d6) 12.40 (s, 1 H), 8.12 (dd, J = 8.0, 7.0 Hz, 1 H), 8.01 (d, J = 8.0 Hz,




1 H), 3.59 (t, J = 8.5 Hz, 2 H), 3.32 (s, 3 H), 3.20 (q, J = 7.5 Hz, 2 H), 2.77 (t, J = 8.5 Hz, 2 H), 1.23 (t,



J = 7.5 Hz, 3 H).


17-8

1H NMR (500 MHz, Chloroform-a) δ 8.21 (s, 1 H), 7.80 (dd, J = 7.5, 6.0 Hz, 1 H), 7.67 (d, J = 7.5




Hz, 1 H),3.55 (t, J = 8.0 Hz, 2 H), 3.25 (s, 3 H), 2.74-2.65 (m, 4H), 1.67-1.58 (m, 2 H), 0.91 (t, J =



8.0 Hz, 3 H).


18-4

1H NMR (500 MHz, DMSO-d6) 12.59 (s, 1 H), 8.03 (dd, J = 8.0, 7.0 Hz, 1 H), 7.95 (d, J = 8.0 Hz,




1 H), 3.09 (q, J = 7.5 Hz, 2 H), 1.19 (t, J = 7.5 Hz, 3 H)


18-8

1H NMR (500 MHz, Chloroform-a) δ 8.77 (s, 1 H), 8.32 (dd, J = 7.5, 6.0 Hz, 1 H), 7.68 (d, J = 7.5




Hz, 1 H), 2.76 (t, J = 5.0 Hz, 2 H), 1.67 (qt, J = 8.0, 5.0 Hz, 2 H), 0.97 (t, J = 8.0 Hz, 3 H).


20-2

1H NMR (500 MHz, DMSO-d6) 12.53 (s, 1 H), 8.09 (dd, J = 8.0, 7.0 Hz, 1 H), 7.82 (d, J = 8.0 Hz,




1 H), 3.37 (s, 3 H)


20-4

1H NMR (500 MHz, DMSO-d6) 12.51 (s, 1 H), 7.96 (dd, J = 8.0, 7.0 Hz, 1 H), 7.88 (d, J = 8.0 Hz,




1 H), 3.07 (q, J = 7.5 Hz, 2 H), 1.17 (t, J = 7.5 Hz, 3 H)


20-8

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s, 1 H), 8.33 (dd, J = 7.5, 6.0 Hz, 1 H), 7.68 - 7.63 (m,




1 H), 2.76 (t, J = 5.5 Hz, 2 H), 1.47-1.38 (m, 2 H), 0.95 (t, J = 8.0 Hz, 3 H).


21-4

1H NMR (500 MHz, DMSO-d6) 12.41 (s, 1 H), 7.95 (dd, J = 8.0, 7.0 Hz, 1 H), 7.84 (d, J = 8.0 Hz,




1 H), 3.21 -3.17 (m, 1 H), 3.01 (q, J = 7.5 Hz, 2 H), 2.05 - 1.75 (m, 6 H), 1.17 (t, J = 7.5 Hz, 3 H).


21-5

1H NMR (500 MHz, DMSO-d6) 12.41 (s, 1 H), 8.15 (dd, J = 8.0, 7.0 Hz, 1 H), 8.04 (d, J = 8.0 Hz,




1 H), 3.21 -3.17 (m, 1 H), 3.21 (q, J = 7.5 Hz, 2 H), 2.05 - 1.75 (m, 6 H), 1.24 (t, J = 7.5 Hz, 3 H).


21-8

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s, 1 H), 8.11 (dd, J = 7.5, 6.0 Hz, 1 H), 7.53 (dd, J = 7.5,




1.0 Hz, 1 H), 3.24 (p, J = 7.0 Hz, 1 H), 2.76 (t, J = 7.0 Hz, 2 H), 2.38-2.29 (m, 2 H), 2.18 -2.08 (m,



2 H), 2.04 - 1.86 (m, 2 H), 1.47-1.38 (m, 2 H), 0.97 (t, J = 8.0 Hz, 3 H).


22-4

1H NMR (500 MHz, DMSO-d6) 12.43 (s, 1 H), 7.93 (dd, J = 8.0, 7.0 Hz, 1 H), 7.79 (d, J = 8.0 Hz,




1 H), 3.03 (q, J = 7.5 Hz, 2 H), 2.51 (t, J = 7.5 Hz, 2 H), 2.21 -2.10 (m, 2 H), 1.15 (t, J = 7.5 Hz, 3 H)


22-8

1H NMR (500 MHz, Chloroform-a) δ 8.23 (s, 1 H), 7.80 (dd, J = 7.5, 6.0 Hz, 1 H), 7.68 (d, J = 7.5




Hz, 1 H), 2.76 (t, J = 8.0 Hz, 2 H), 2.53 (t, J = 8.5 Hz, 2 H), 2.14-2.05 (m, 2 H), 1.67-1.55 (m, 2 H),



0.92 (t, J = 8.0 Hz, 3 H).


23-8

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s, 1 H), 8.32 (dd, J = 7.5, 6.0 Hz, 1 H), 7.66 (d, J = 7.5 Hz,




1 H), 3.02 (p, J = 7.0 Hz, 1 H), 2.76 (t, J = 8.0 Hz, 2 H), 1.87- 1.76 (m, 2 H), 1.72- 1.61 (m, 2 H),



1.59 - 1.36 (m, 6 H), 0.90 (t, J = 8.0 Hz, 3 H).


24-4

1H NMR (500 MHz, DMSO-d6) 12.46 (s, 1 H), 7.90 (dd, J = 8.0, 7.0 Hz, 1 H), 7.88 - 7,81 (m, 2 H),




7.78 (d, J = 8.0 Hz, 1 H), 7.27 - 7.19 (m, 3 H), 3.03 (q, J = 7.5 Hz, 2 H), 1.14 (t, J = 7.5 Hz, 3 H)


26-4

1H NMR (500 MHz, DMSO-d6) δ 12.45 (s, 1 H), 7.90-7.81 (m, 1 H), 7.79-7.72 (m, 1 H), 7.40-




7.24 (m, 5H), 4.26 (s, 2 H) , 3.01 (q, J = 7.5 Hz, 2 H), 1.15 (t, J = 7.5 Hz, 3 H).


29-4

1H NMR (500 MHz, DMSO-d6) δ 12.73 (s, 1 H), 8.06-7.99 (m, 1 H), 7.94-7.87 (m, 1 H), 7.83-




7.78 (m, 1 H), 7.31-7.26 (m, 1 H), 6.83-6.77 (m, 1 H), 3.00 (q, J = 7.5 Hz, 2 H), 1.16 (t, J = 7.5



Hz, 3 H).


96-4

1H NMR (500 MHz, DMSO-d6) 12.42 (s, 1 H), 7.99 (dd, J = 8.0, 7.0 Hz, 1 H), 7.88 (d, J = 8.0 Hz,




1 H), 6.50 (t, J = 72.5 Hz, 1 H), 3.03 (q, J = 7.5 Hz, 2 H), 1.18 (t, J = 7.5 Hz, 3 H).


96-5

1H NMR (500 MHz, DMSO-d6) 12.42 (s, 1 H), 8.19 (dd, J = 8.0, 7.0 Hz, 1 H), 8.08 (d, J = 8.0 Hz,




1 H), 6.50 (t, J = 72.5 Hz, 1 H), 3.23 (q, J = 7.5 Hz, 2 H), 1.23 (t, J = 7.5 Hz, 3 H).


96-8

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s, 1 H), 7.84 (dd, J = 7.5, 6.0 Hz, 1 H), 7.64 (d, J = 7.5 Hz,




1 H), 6.61 (s, 1 H), 2.76 (t,J = 5.5 Hz, 2 H), 1.47-1.38 (m, 2 H), 0.94 (t, J = 8.0 Hz, 6 H).


101-4

1HNMR (500 MHz, DMSO-d6) 12.41 (s, 1 H), 7.94 (dd, J = 8.0, 7.0 Hz, 1 H), 7.86 (d, J = 8.0 Hz,




1 H), 6.71-6.60 (m, 1 H), 5.81-5.72 (m, 1 H), 5.53-5.45 (m, 1 H), 3.02 (q, J - 7.5 hz, 2 H), 1.17



(t, J = 7.5 Hz, 3 H).


101-5

1H NMR (500 MHz, DMSO-d6) 12.41 (s, 1 H), 8.14 (dd, J = 8.0, 7.0 Hz, 1 H), 8.06 (d, J = 8.0 Hz,




1 H), 6.71-6.60 (m, 1 H), 5.81-5.72 (m, 1 H), 5.53-5.45 (m, 1 H), 3.22 (q, J - 7.5 hz, 2 H), 1.23



(t, J = 7.5 Hz, 3 H).


101-8

1HNMR (500 MHz, DMSO-d6) δ 12.38 (s, 1 H), 7.84 (dd, J = 7.5, 6.0 Hz, 1 H), 7.64 (d, J = 7.5 Hz,




1 H), 6.37 (dd, J = 16.5, 10.0 Hz, 1 H), 5.73 (dd, J = 14.0, 10.0 Hz, 1 H), 5.48 (dd, J = 16.5, 14.0 Hz,



1 H), 2.76 (t, J = 5.5 Hz, 2 H), 1.47-1.38 (m, 2 H), 0.94 (t, J = 8.0 Hz, 3 H).


103-4

1HNMR (500 MHz, DMSO-d6) 12.41 (s, 1 H), 7.94 (dd, J = 8.0, 7.0 Hz, 1 H), 7.86 (d, J = 8.0 Hz,




1 H), 4.13 (s, 1 H), 3.02 (q, J = 7.5 Hz, 2 H), 1.17 (t, J = 7.5 Hz, 3 H).


103-5

1H NMR (500 MHz, DMSO-d6) 12.41 (s, 1 H), 8.14 (dd, J = 8.0, 7.0 Hz, 1 H), 8.05 (d, J = 8.0 Hz,




1 H), 4.13 (s, 1 H), 3.22 (q, J = 7.5 Hz, 2 H), 1.22 (t, J = 7.5 Hz, 3 H).


103-8

1H NMR (500 MHz, DMSO-d6) δ 12.38 (s, 1 H), 7.82 (dd, J = 7.5, 6.0 Hz, 1 H), 7.66 (dd, J = 7.5,




1.0 Hz, 1 H), 4.28 (s, 1 H), 2.76 (t, J = 5.5 Hz, 2 H), 1.47-1.42 (m, 2 H), 0.94 (t,J = 8.0 Hz, 3 H).


148-8

1HNMR (500 MHz, DMSO-d6) δ 12.38 (s, 1 H), 8.11 (dd, J = 7.5, 6.0 Hz, 1 H), 7.53 (d, J+327.5, 1.0




Hz, 1 H), 2.76 (t, J = 7.0 Hz, 2 H), 1.56 ? 1.41 (m, 4H), 0.97 (t, J = 8.0 Hz, 3 H), 0.87 (d, J = 6.6 Hz,



3 H), 0.63-0.54 (m, 1 H), 0.38-0.29 (m, 1 H).


149-8

1HNMR (500 MHz, Chloroform-a) δ 8.23 (s, 1 H),8.08 (dd, J = 7.5, 6.0 Hz, 1 H), 7.52 (d, J = 7.5




Hz, 1 H), 6.60 (q, J = 7.0 Hz, 1 H), 6.50 (q, J = 7.0 Hz, 1 H), 2.76 (t, J = 7.0 Hz, 2 H), 2.05-1.91 (m,



1 H), 1.73 ? 1.61 (m, 1 H), 1.08-0.92 (m, 1 H), 0.95 (t, J = 8.0 Hz, 3 H), 0.82-0.73 (m, 1 H).


150-8

1HNMR (500 MHz, Chloroform-a) δ 8.23 (s, 1 H),8.08 (dd, J = 7.5, 6.0 Hz, 1 H), 7.52 (d, J = 7.5




Hz, 1 H), 2.76 (t, J = 7.0 Hz, 2 H), 2.60 -2.51(m, 1 H), 1.73 ? 1.61 (m, 2 H), 1.51-1.40 (m, 1 H), 1.26-



1.13 (m, 1 H), 0.95 (t, J = 8.0 Hz, 3 H).


151-8

1HNMR (500 MHz, Chloroform-a) δ 8.23 (s, 1 H), 8.08 (dd, J = 7.5, 6.0 Hz, 1 H), 7.52 (d,J = 7.5




Hz, 1 H), 7.37-7.32 (m, 2 H), 7.25-7.14 (m, 3 H), 3.51 (t, J = 7.0 Hz, 1 H), 2.76 (t, J = 7.0 Hz, 2 H),



2.45 (q, J = 7.0 Hz, 1 H), 1.73 ? 1.61 (m, 2 H), 1.50-1.41 (m, 1 H), 1.25-1.16 (m, 1 H), 0.95 (t, J = 8.0



Hz, 3 H).


152-4

1H NMR (500 MHz, DMSO-d6) δ 12.60 (s, 1 H), 8.18-7.95 (m, 3 H), 7.52-7.35 (m, 2 H), 3.02




(q, J = 7.5 Hz, 2 H), 1.19 (t, J = 7.5 Hz, 3 H).









The method for preparing the compound of the invention will be explained in detail in the following program and embodiment. The material is commercial available or prepared through known method reported in the literature or shown in the route. Those skilled in the art should understand that the compound of the invention can also be synthesized by other synthetic route. Although the detailed material and reaction condition in the synthetic route have been explicated in the following text, it is still easy to be replaced by other similar material and condition. Isomer of the compound, for example, that produced with the variation of the preparation method of the present invention is included in the scope of the present invention. In addition, the following preparation method can be further modified according to the disclosures of the present invention by using common chemical method known to those skilled in the art, for example, protection of suitable group in the process of the reaction, etc.


The following method of application can be used to improve further understanding of the preparation method of the present invention. The specific material, class and condition have been determined to be further explication of the present invention, not to be any limit of the reasonable scope thereof. Reagents of the following synthetic compound showed in the table can either be purchased from the market or easily prepared by those skilled in the art.


Examples of representative compounds are as follows:


1. Synthesis of Compound 1-4




embedded image


(1) Compound II (3 g, 16 mmol, 1.0 eq), NaOH (0.72 g, 18 mmol, 1.1 eq) were added sequentially into 30 ml of DMF, and then compound a (1.07 g, 1.2 mmol, 1.05 eq) was added dropwise at 0° C., and the reaction solution was stirred at 0° C. for 1 hour. When LCMS test showed that the reaction of starting materials was basically completed, there was one major new peak. The reaction solution was poured into 30 ml of water, and the mixture was separated, and the aqueous phase was extracted once with 50 ml of ethyl acetate, and the resultant organic phase was washed three times with saturated saline solution (50 ml), dried, evaporated to dryness under reduced pressure and separated by column chromatography to obtain compound b (3.4 g, 92% yield) (colorless oil).




embedded image


(2) Compound b (3 g, 13 mmol, 1.0 eq) was added to 30 ml of THF, then n-BuLi (6.42 ml, 2.5 M, 16 mmol, 1.2 eq) was slowly added at −78° C., then the reaction solution was stirred at −78° C. for 0.5 hour, and slowly fed with CO2 for 10 minutes, then the reaction solution was slowly warmed to room temperature. The product was detected by LCMS. 20 ml of water was poured into the reaction solution, the mixture was separated, the aqueous phase was extracted once with 30 ml of ethyl acetate, and the resultant aqueous phase was gradually adjusted to pH=4-5 with concentrated hydrochloric acid, filtered and dried to give compound c (3 g, 83.6% yield) (white solid).




embedded image


(3) Compound c (3 g, 11 mmol, 1.0 eq), compound d (1.66 g, 16.8 mmol, 1.5 eq), DMAP (0.13 g, 1.1 mmol, 0.1 eq) were sequentially added to 30 ml of pyridine. Then, SOCl2 (2.0 g, 16.8 mmol, 1.5 eq) was slowly added at 0° C., and the reaction solution was stirred at room temperature for 3 hours. The product was detected by LCMS. Pyridine was removed by concentration, then 30 ml of water was poured into the reaction solution, and the mixture was separated. The aqueous phase was extracted three times with 30 ml of ethyl acetate, and the resultant organic phase was washed three times with saturated saline solution (50 ml), dried, and evaporated to dryness under reduced pressure and separated by column chromatography to to obtain Compound 1-4 (2.5 g, 64% yield) (white solid).


2. Synthesis of Compound 1-5




embedded image


Compound 1-4 (1 g, 2.8 mmol, 1.0 eq) and compound e (0.54 g, 3.1 mmol, 1.1 eq) were added sequentially in 10 mL of dichloromethane. The reaction solution was then stirred at room temperature for 1 hour. The product was detected by LCMS, and the reaction of raw materials was basically completed. The reaction solution was poured into 10 ml of water, the reaction was quenched with sodium hydrogen sulfite, and the mixture was separated. The aqueous phase was extracted three times with 30 ml of dichloromethane, and the resultant organic phase was washed once with saturated saline solution (30 ml), dried, and evaporated to dryness under reduced pressure, and separated by column chromatography to give Compound 1-5 (0.8 g, 76.5% yield) (greyish white solid).


3. Synthesis of Compound 1-6




embedded image


Compound 1-4 (1 g, 2.8 mmol, 1.0 eq) and compound e (1.24 g, 7.2 mmol, 2.5 eq) were added sequentially in 10 mL of dichloromethane. The reaction solution was then stirred at room temperature for 24 hours. The product was detected by LCMS and the reaction of raw materials was basically completed. The reaction solution was filtrated, the filtrate was quenched with sodium hydrogen sulfite, concentrated and separated by column chromatography to give Compound 1-6 (0.5 g, 45.8% yield) (greyish white solid).


4. Synthesis of Compound 1-69




embedded image


(1) Compound 1-136 was prepared by using the above method for synthesis of Compound 1-4, and then Compound 1-136 (0.34 g, 1.0 mmol, 1.0 eq) was added to 5 ml of TFA, and then the reaction solution was stirred at 90° C. for 16 hours. The product was detected by LCMS, and evaporated to dryness under reduced pressure to give compound A (0.29 g) (yellow oil, crude).




embedded image


(2) Compound A (0.32 g, 1.0 mmol, 1.0 eq), K2CO3 (0.28 g, 2 mmol, 2.0 eq) and compound B (0.13 g, 1.1 mmol, 1.1 eq) were sequentially added in 10 ml of DMF, then the reaction solution was stirred at 25° C. for 2 hours. The product was detected by LCMS. The reaction solution was poured into 20 ml of water, and the mixture was separated, the aqueous phase was extracted three times with 20 ml of ethyl acetate, and the resultant organic phase was washed three times with saturated saline solution (20 ml), dried, and evaporated to dryness under reduced pressure, and separated by column chromatography to give Compound 1-69 (0.25 g, 69% yield) (white solid).


5. Synthesis of Compound 1-112




embedded image


Compound 1-4 (500 mg, 1.4 mmol), Compound C (367 mg, 2.1 mmol), potassium carbonate (595 mg, 2.8 mmol) and acetonitrile 10 mL were placed in a round bottom flask, and stirred at 80° C. for 12 hours. The completion of the reaction was detected by high performance liquid chromatography, then the temperature of the reaction solution was lowered to 20° C., and the remaining potassium carbonate solid was filtered off, and the mother liquid was directly separated by prep-HPLC to obtain Compound 1-112 (160 mg, 25% yield, white solid).


6. Synthesis of Compound 1-118




embedded image


Compound 1-4 (500 mg, 1.4 mmol), a catalytic amount of 4-dimethylaminopyridine (10 mg) and 5 mL of pyridine were placed in a round bottom flask, heated to 60° C., and Compound D (1.1 g, 7.0 mmol) was slowly added dropwise under the protection of nitrogen atmosphere. The completion of the reaction was detected by high performance liquid chromatography, the temperature of the reaction solution was lowered to 20° C., and the reaction system was concentrated and separated by prep-HPLC to give Compound 1-118 (150 mg, 22% yield, yellow solid).


7. Synthesis of Compound 1-127




embedded image


(1) Compound II (3 g, 16 mmol, 1.0 eq), NaOH (0.72 g, 18 mmol, 1.1 eq) were sequentially added to 30 ml of DMF, then compound f (0.8 g, 17 mmol, 1.05 eq) was added dropwise at 0° C., then the reaction solution was stirred at 0° C. for 1 hour. When LCMS detection showed the reaction of starting materials were basically completed, there was one major new peak. The reaction solution was poured into 30 ml of water, and the mixture was separated, and the aqueous phase was extracted once with 50 ml of ethyl acetate, and the resultant organic phase was washed three times with saturated saline solution (50 ml), dried, evaporated to dryness under reduced pressure, and separated by column chromatography to give compound g (3.0 g, 90% yield) (colorless oil).




embedded image


(2) Compound g (2.8 g, 13 mmol, 1.0 eq) was added to 30 ml of THF, then n-BuLi (6.42 ml, 2.5 M, 16 mmol, 1.2 eq) was slowly added at −78° C., then the reaction solution was stirred at −78° C. for 0.5 hour, and then slowly fed with CO2 for 10 minutes, the reaction solution was slowly warmed to room temperature. The product was detected by LCMS. 20 ml of water was poured into the reaction solution, and the mixture was separated. The aqueous phase was extracted once with 30 ml of ethyl acetate, and the resultant aqueous phase was gradually adjusted to pH=4 to 5 with concentrated hydrochloric acid, filtered and dried to give compound h (2.7 g, 85% yield) (white solid).




embedded image


(3) Compound h (2.7 g, 11 mmol, 1.0 eq), compound d (1.66 g, 16.8 mmol, 1.5 eq), DMAP (0.13 g, 1.1 mmol, 0.1 eq) were added sequentially to 30 ml of pyridine. Then, SOCl2 (2.0 g, 16.8 mmol, 1.5 eq) was slowly added at 0° C., and then the reaction solution was stirred at room temperature for 3 hours. The product was detected by LCMS. Pyridine was removed by concentration, then 30 ml of water was poured into the reaction solution, and the mixture was separated. The aqueous phase was extracted three times with 30 ml of ethyl acetate, and the resultant organic phase was washed three times with saturated saline solution (50 ml), dried, and evaporated to dryness under reduced pressure, and separated by column chromatography to give Compound 1-127 (2.3 g, 63% yield) (white solid).


8. Synthesis of Compound 1-132




embedded image


(1) Compound II (3 g, 16 mmol, 1.0 eq), NaOH (0.72 g, 18 mmol, 1.1 eq) were added to 30 ml of DMF, then compound i (17 ml, 1M in THE, 17 mmol, 1.05 eq) was added dropwise at 0° C., then the reaction solution was stirred at 0° C. for 1 hour. When LCMS detection showed that the reaction of starting materials was basically completed, there was one major new peak. The reaction solution was poured into 30 ml of water, and the mixture was separated. The aqueous phase was extracted once with 50 ml of ethyl acetate, and the resultant organic phase was washed three times with saturated saline solution (50 ml), dried, evaporated to dryness under reduced pressure, and separated by column chromatography to give compound j (3.1 g, 92% yield) (colorless oil).




embedded image


(2) Compound j (2.75 g, 13 mmol, 1.0 eq) was added to 30 ml of THF, then n-BuLi (6.42 ml, 2.5 M, 16 mmol, 1.2 eq) was slowly added at −78° C., then the reaction solution was stirred at −78° C. for 0.5 hour, and then slowly fed with CO2 for 10 minutes, the reaction solution was slowly warmed to room temperature. The product was detected by LCMS. 20 ml of water was poured into the reaction solution, the mixture was separated. The aqueous phase was extracted once with 30 ml of ethyl acetate, and the resultant aqueous phase was gradually adjusted with concentrated hydrochloric acid to pH=4 to 5, filtered and dried to obtain compound k (2.5 g, 80% yield) (white solid).




embedded image


(3) Compound k (2.5 g, 11 mmol, 1.0 eq), compound d (1.66 g, 16.8 mmol, 1.5 eq), DMAP (0.13 g, 1.1 mmol, 0.1 eq) were sequentially added to 30 ml of pyridine. Then, SOCl2 (2.0 g, 16.8 mmol, 1.5 eq) was slowly added at 0° C., and then the reaction solution was stirred at room temperature for 3 hours. The product was detected by LCMS. Pyridine was removed by concentration, then 30 ml of water was poured into the reaction solution, and the mixture was separated. The aqueous phase was extracted three times with 30 ml of ethyl acetate, and the resultant organic phase was washed three times with saturated saline solution (50 ml), dried, evaporated to dryness under reduced pressure, and separated by column chromatography to give Compound 1-132 (2.1 g, 61% yield) was obtained (white solid).


9. Synthesis of Compound 1-8 (R-Configuration)


Compound 1-8 was prepared according to the method for the preparation of the above Compound 1-5, and then Compound 1-8 (0.5 g, 98% purity) was passed through chiral HPLC (Column: CHIRALPAK IG; Column Size: 3 cm×25 cm, 5 um; Injection: 3.0 ml; Mobile phase: Hex (0.2% FA): IPA=50:50; Flow rate: 28 ml/min; Wavelength: UV 254 nm; Temperature: 25° C.; Sample solution: 70 mg/ml in EtOH/DCM; Run time=60 minutes) for separation, and then concentrated to obtain Compound 1-8 (R-configuration) (0.16 g, Rt=10.51 min, 100% ee, purity 98%) and Compound 1-8 (S-configuration) (0.13 g, Rt=30.81 min, 99.8% ee, purity 96%) in white solids, which were confirmed by single crystal diffraction.




embedded image


Biological Activity Evaluation:


The activity level criteria for plant damage (i.e., growth control rate) are as follows:


Level 5: growth control rate is above 85%;


Level 4: growth control rate is greater than or equal to 60% and less than 85%;


Level 3: growth control rate is greater than or equal to 40% and less than 60%;


Level 2: growth control rate is greater than or equal to 20% and less than 40%;


Level 1: growth control rate is greater than or equal to 5% and less than 20%;


Level 0: growth control rate is less than 5%.


The above growth control rates are fresh weight control rates.


Experiment on weeding effect in post-emergence stage: monocotyledonous and dicotyledonous weed seeds (Descurainia sophia, Capsella bursa-pastoris, Abutilon theophrasti, Galium aparine, Stellaria media, Lithospermum arvense, rorippa indica, Alopecurus aequalis, Beckmannia syzigachne, Sclerochloa dura, Phleum paniculatum, Bromus japonicus, Aegilops tauschii, Phalaris arundinacea, Amaranthus retroflexus, Chenopodiaceae, Commelina communis, Sonchus arvensis, convolvulus arvensis, Cirsium setosum, Solanum nigrum, Acalypha australis, Digitaria sanguinalis, Echinochloa crusgalli, Setaria viridis, Setaria glauca, Leptochloa chinensis, Monochoria vaginalis, Sagittaria trifolia, Scirpus juncoides, Cyperus rotundus, Cyperus iria, Cyperus difformis, Fimbristylis, Portulaca oleracea, Xanthium sibiricum, Pharbitis nil) and major crop seeds (wheat, corn, rice, soybean, cotton, oilseed rape, millet, sorghum, potato, sesame, ricinus) were placed in plastic pots filled with soil, then covered with 0.5-2 cm of soil, allowed to grow in a good greenhouse environment. After 2 weeks of sowing, the test plants were treated in the 2 to 3 leaf stage. The tested compounds of the present invention were respectively dissolved in acetone, then added with Tween 80 and 1.5 liter/ha of emulsifiable concentrate of methyl oleate as synergist, diluted with a certain amount of water to obtain a solution with a certain concentration, and sprayed with a spray tower onto the plants. After the application, the plants were cultured for 3 weeks in the greenhouse, and then the experimental results of the weeding were counted. The doses of the used compounds were 500, 250, 125, 60, 15 g a.i./ha, and the averages were obtained by repeating for three times. Representative data are listed in Table 2.









TABLE 2







Results on weeding effect in post-emergence stage













Compound

Echinochloa


Digitaria


Abutilion


Amaranthus


Stellaria

Dose (g


No.

crusgah


sanguinalis


theophrasti


retroflexus


media

a.i./ha)





1-1 
4
4
4
4
4
500


1-1 
4
3
4
4
4
250


1-1 
4
2
4
4
4
125


1-1 
2
1
2
4
3
 60


1-2 
4
4
4
4
4
500


1-2 
4
4
4
4
4
250


1-2 
4
3
4
4
3
125


1-2 
3
3
4
4
3
 60


1-4 
5
5
5
5
5
250


1-4 
5
5
5
5
5
125


1-5 
5
5
5
5
5
125


1-5 
5
5
5
5
5
 60


1-6 
5
5
5
5
5
250


1-6 
5
5
5
5
5
125


1-7 
5
5
5
5
5
500


1-7 
5
5
5
5
5
250


1-8 
5
5
5
5
5
125


1-8 
5
5
5
5
5
 60


1-9 
5
5
5
5
5
250


1-9 
5
5
5
5
5
125


1-10 
5
N
5
5
5
250


1-11 
5
5
5
5
5
250


1-12 
5
5
5
5
5
250


1-13 
5
5
5
5
5
250


1-14 
5
5
5
5
5
125


1-15 
N
N
5
5
5
250


1-20 
5
5
5
5
5
250


1-29 
5
5
5
5
5
500


1-40 
5
5
N
5
N
500


1-43 
5
N
N
N
N
500


1-48 
5
5
N
N
N
500


1-49 
5
5
5
5
5
500


1-50 
5
5
5
5
5
500


1-51 
5
5
5
5
5
500


1-52 
5
5
5
5
5
500


1-53 
5
5
5
5
5
500


1-54 
5
5
N
N
N
500


1-57 
5
5
5
5
5
500


1-59 
5
5
5
5
5
500


1-68 
5
N
N
N
N
500


1-69 
5
N
N
N
N
500


1-70 
5
N
N
N
N
500


1-82 
5
5
5
5
5
500


1-137
5
5
5
5
5
500


1-138
5
5
N
N
N
500


1-143
5
N
5
5
5
500


1-144
5
N
5
5
5
500


1-392
5
5
5
5
5
500


1-394
5
N
N
N
N
500


1-395
5
5
5
5
N
500


1-397
5
5
5
5
5
500


1-398
5
5
5
5
5
500


1-401
5
5
5
5
N
250


1-402
5
5
5
5
N
250


1-403
5
5
5
5
N
125


1-404
5
5
5
5
N
125


1-411
5
5
5
5
N
250


1-412
5
5
5
5
N
250


1-413
5
5
N
5
N
500


1-414
5
5
5
5
N
250


1-427
5
5
5
5
N
500


1-428
5
5
5
5
N
500


1-429
5
5
5
N
N
500


1-430
5
5
5
N
N
500


1-441
5
5
5
5
5
500


1-443
5
5
5
5
5
500


1-444
5
N
N
N
N
500


1-446
5
5
5
5
5
250


1-447
5
5
5
5
5
500


1-448
5
5
5
5
5
500


1-452
5
5
5
5
5
250


1-457
5
5
N
N
N
500


1-525
5
N
N
N
N
500


1-537
5
N
N
N
N
500


1-541
5
N
5
5
N
500


1-543
5
5
5
5
5
500


1-552
5
5
5
N
5
250


1-558
5
N
N
N
N
500


1-560
5
N
5
N
N
500


1-563
5
5
5
5
5
500


1-566
5
N
N
N
N
500


1-617
5
5
N
N
N
500


2-4 
5
5
5
5
5
500


3-4 
5
5
5
5
5
500


3-5 
5
5
5
5
5
500


3-8 
5
5
5
5
5
500


3-11 
5
5
5
5
5
500


3-14 
5
5
5
5
5
500


3-17 
5
5
5
5
5
500


3-20 
5
N
N
N
N
500


3-52 
5
5
5
5
5
500


3-54 
5
5
5
5
5
500


3-57 
5
5
5
5
5
500


Control
0
1
N
1
0
500


Compound A





Note:


Control compound A: embedded image
N indicates partial data were unavailable.














TABLE 3







Results on weeding effect in post-emergence stage














Echinochloa


Abutilon


Digitaria





Compound No.

crusgali


theophrasti


sanguinahs


Setaria viridis

Dose (g a.i./ha)















1-1
N
4
2
2
120


1-1
2
2
1
1
60


1-1
2
N
1
1
30


1-1
1
N
0
0
15


1-1
0
N
0
0
7.5


1-2 (R-
4
N
4
3
60


configuration)







1-2 (R-
3
N
3
3
30


configuration)







1-2 (R-
1
N
1
2
15


configuration)







1-2 (R-
0
N
0
0
7.5


configuration)







1-2
3
4
3
3
60


1-4
N
5
5
5
60


1-5 (R-
5
N
5
5
60


configuration)







1-5 (R-
5
N
5
5
30


configuration)







1-5 (R-
5
N
5
5
15


configuration)







1-5 (R-
5
N
4
4
7.5


configuration)







1-5 (R-
4
N
3
3
3.75


configuration)







1-5
5
5
5
5
60


1-8 (R-
5
N
5
5
60


configuration)







1-8 (R-
5
N
5
5
30


configuration)







1-8 (R-
5
N
5
5
15


configuration)







1-8 (R-
5
N
5
4
7.5


configuration)







1-8 (R-
5
N
4
2
3.75


configuration)







1-8
5
5
5
5
60


1-14 (R-configuration)
5
N
5
5
60


1-14 (R-configuration)
5
N
5
5
30


1-14 (R-configuration)
5
N
5
4
15


1-14 (R-configuration)
5
N
4
4
7.5


1-14
N
5
5
5
60


1-17
N
5
5
5
60


1-20
N
5
5
5
60


1-52
N
5
5
5
60


1-57 (R-configuration)
5
N
5
5
125


1-82 (R-configuration)
5
N
5
5
125


1-392 (R-configuration)
5
N
5
5
500


1-395 (R-configuration)
5
N
5
5
500


1-397 (R-configuration)
5
N
5
5
125


1-398 (R-configuration)
5
N
5
5
250


1-401 (R-configuration)
5
N
5
5
500


1-402 (R-configuration)
5
N
5
5
500


1-403 (R-configuration)
5
N
5
5
60


1-404 (R-configuration)
5
N
5
5
60


1-405 (R-configuration)
5
N
5
5
125


1-411 (R-configuration)
5
N
5
5
250


1-412 (R-configuration)
5
N
5
5
500


1-413 (R-configuration)
5
N
5
5
500


1-414 (R-configuration)
5
N
5
5
500


1-427 (R-configuration)
5
N
5
5
500


1-428 (R-configuration)
5
N
5
5
500


1-429 (R-configuration)
5
N
5
5
500


1-430 (R-configuration)
5
N
5
5
500


1-431 (R-configuration)
5
N
5
5
500


1-432 (R-configuration)
5
N
5
5
500


1-441 (R-configuration)
5
N
5
5
500


1-443 (R-configuration)
5
N
5
5
500


1-444 (R-configuration)
5
N
5
5
500


1-446 (R-configuration)
5
N
5
5
500


1-447 (R-configuration)
5
N
5
5
500


1-448 (R-configuration)
5
N
5
5
500


1-523 (R-configuration)
5
N
5
5
500


1-525 (R-configuration)
5
N
5
5
500


1-552 (R-configuration)
5
N
5
5
125


1-563 (R-configuration)
5
N
N
N
125


1-617 (R-configuration)
5
N
5
5
60


2-8 (R-
5
N
5
5
250


configuration)







3-4
5
N
5
5
250


3-5 (R-
5
N
5
5
120


configuration)







3-8 (R-
5
N
5
5
60


configuration)







3-11 (R-configuration)
5
N
5
5
125


3-14 (R-configuration)
5
N
5
5
60


3-17 (R-configuration)
5
N
5
5
125


3-20 (R-configuration)
5
N
5
5
125


3-52 (R-configuration)
5
N
5
5
125


3-54
5
N
5
5
250


3-57 (R-configuration)
5
N
5
5
125


6-8 (R-
5
N
5
5
250


configuration)







Control
N
3
1
1
120


Compound A









It was found that when the group Y in the compound of the formula of the present invention was changed from methyl to ethyl or C3-C8 alkyl, the herbicidal activity and herbicidal spectrum thereof were significally improved. Especially at low doses, the activity on the gramineous weed (such as the main gramineous weed Echinochloa crusgali, Leptochloa chinensis or Digitaria sanguinalis) of Compound 1-4 was higher by more than 2 times than Compound 1-1, the activity of Compound 1-5 was higher by more than 2 times than and Compound 1-2, Compound 1-8 was much more higher than Compound 1-2; when the carbon number exceeded 8, the activity was significantly decreased; while the change of carbon atom number in other groups in the formula had no significant effect on the activity.


Comparative Experiments:









TABLE 4







Safety test results of control experiments (the herbicide selection index


between rice and Echinochloa crusgali was calculated by dividing the average dose of


causing 10% phytotoxicity to rice by the average dose of causing 90% control efficiency to



Echinochloa crusgali, which was an important index for safety evaluation of rice field



herbicides. When a herbicide had a selection index of less than 2, its risk was relatively


higher and it had no commercial value.)















Selection index



Indica rice
Japonica rice

between rice and


Compound No.
(Huanghuazhan)
(Huaidao No. 5)
Dose

Echinochloa crusgali















1-5  
0
0
250 g a.i./ha
>5


1-6  
0
0
250 g a.i./ha
>5


1-7  
0
0
250 g a.i./ha
>5


1-8  
0
0
250 g a.i./ha
>5


1-9  
0
0
250 g a.i./ha
>5


1-13 
0
0
250 g a.i./ha
>5


1-14 
0
0
250 g a.i./ha
>5


1-20 
0
0
250 g a.i./ha
>5


1-52 
0
0
250 g a.i./ha
>5


1-57 
0
0
250 g a.i./ha
>5


1-82 
0
0
250 g a.i./ha
>5


1-134
0
0
250 g a.i./ha
>5


Control
4
3
250 g a.i./ha
0.8


Compound B






Control
3
3
125 g a.i./ha
0.8


Compound B






Control
5
4
125 g a.i./ha
1.1


Compound C






Control
5
5
 60 g a.i./ha
1


Compound D









Note:


Control Compound B: embedded image
Control Compound C: embedded image
Control compound D: embedded image







From Table 4, it was understood that the compounds of the present invention had very high safety and selectivity for rice, while the control compounds were unsafe for rice, which produced unacceptable phytotoxicity for both indica rice and japonica rice.


In summary, the compounds of the present invention were very safe to rice, and their selection indexes were much greater than 2, and could effectively prevent gramineous weeds such as Echinochloa crusgali, Digitaria sanguinalis, Setaria viridis, and various broad-leaved weeds, and thus were ideal herbicides for rice fields.


Experiment on weeding effect in post-emergence stage: after 3-4 weeks of sowing, the test plants were treated in the 1.5-2 leaf stage of the directly sowed rice Longyang 16, and the 4-5 leaf stage of weeds. After the application of the compounds of the present invention, the plants were cultured for 25 days in the greenhouse, and then the experimental results of the weeding were counted. The test results were shown in Tables 5-6.









TABLE 5







Control experiment results of R configuration compound activity


(inhibition rate, %)













Digitaria



Leptochloa


Ablation





sanguinalis (30 g

Green Setaria

chinensis


theophrasti (30



Compound No.
a.i./ha)

viridis (60 g a.i./ha)

(60 g a.i./ha)
g a.i./ha)





1-8 (R-configuration)
100%
100%
85%
100%


1-8 (S-configuration)
 0%
 15%
 0%
  0%


1-8
 80%
 90%
30%
 90%


1-2
 0%
 20%
 0%
 60%
















TABLE 6







Control experiment results of R configuration compound activity


(inhibition rate, %)












Green

Leptochloa







Setaria


chinensis

Rice
Rice




viridis (30

(125
(Longyang 16)
(Longyang 16)


Compound No.
g a.i./ha)
g a.i./ha)
(250 g a.i./ha)
(500 g a.i./ha)





1-8 (R-
75%
100%
 0%
 0%


configuration)






1-8 (S-
 0%
 10%
15%
25%


configuration)






1-8
10%
 80%
 5%
15%









Longyang 16 is a representative and important long-grain fragrant rice in Northeast China. Long-grain fragrant rice is more sensitive to herbicides, especially to HPPD herbicides such as Mesotrione, Benzobicylon and the like, which are prone to causing phytotoxicity. Unexpectedly, compound 1-8 (R-configuration) had high safety on rice (Longyang 16) and had better activity against key weed Leptochloa chinensis, while the S-configuration was not safe for rice, i.e., had severe phytotoxicity on crops, and had lower activity on key weeds, even had no activity at low dose. It was inconsistent with our well-known structure-activity relationships about aryloxyphenoxypropionic acid herbicides and phenoxypropionic acid herbicides that their active isomers had high activity and heavy phytotoxicity while their inactive isomers had almost no activity.


Experiment on weed effect in pre-emergence stage:


Seeds of monocotyledonous and dicotyledonous weeds and main crops (e.g. wheat, corn, rice, soybean, cotton, oilseed rape, millet and sorghum) were put into a plastic pot loaded with soil and covered with 0.5-2 cm soil. The test compounds of the present invention was dissolved with acetone, then added with tween 80, diluted by a certain amount of water to reach a certain concentration, and sprayed immediately after sowing. The obtained seeds were incubated for 4 weeks in the greenhouse after spraying. The test results were observed 4 weeks later. It was observed that the herbicide mostly had excellent effect at the application rate of 250 g a.i./ha, especially to weeds such as Echinochloa crusgali, Digitaria sanguinalis and Abutilon theophrasti, etc. And many compounds had good selectivity for corn, wheat, rice, soybean, oilseed rape, etc.


It is indicated from the experiment that the compound of the present invention generally have good weed control efficacy, especially for major grass weeds such as echinochloa crusgali, Digitaria sanguinalis and Setaria viridis, etc. and major broad-leaved weeds such as Abutilon theophrasti, rorippa indica and Bidens pilosa, which are widely occurred in corn, rice and wheat fields, and have excellent commercial value. Above all, it is noted that the compound of the invention have extremely high activity to broad-leaved weeds, which are resistant to ALS inhibitor, like rorippa indica, Descurainia sophia, Capsella bursa-pastoris, Lithospermum arvense, Galium aparine and Stellaria media, etc.


Transplanted rice safety evaluation and weed control effect evaluation in rice field:


Rice field soil was loaded into a 1/1,000,000 ha pot. The seeds of echinochloa crusgali, scirpus juncoides, Bidens tripartita, Sagittaria trifolia, Monochoria vaginalis and Leptochloa chinensis were sowed and gently covered with soil, then left to stand still in greenhouse in the state of 0.5-1 cm of water storage. The tuber of Sagittaria trifolia was planted in the next day or 2 days later. It was kept at 3-4 cm of water storage thereafter. The weeds were treated by dripping the WP or SC water diluents prepared according to the common preparation method of the compounds of the present invention with pipette homogeneously to achieve specified effective amount when echinochloa crusgali, scirpus juncoides, Bidens tripartita, Monochoria vaginalis and Leptochloa chinensis reached 0.5 leaf stage and Sagittaria trifolia reached the time point of primary leaf stage.


In addition, the rice field soil that loaded into the 1/1,000,000 ha pot was leveled to keep water storage at 3-4 cm depth. The 3 leaf stage rice (japonica rice/Indica rice) was transplanted at 3 cm of transplanting depth the next day. The compound of the present invention was treated by the same way after 5 days of transplantation.


The fertility condition of echinochloa crusgali, scirpus juncoides, Bidens tripartita, Leptochloa chinensis, Sagittaria trifolia and Monochoria vaginalis 14 days after the treatment of the compound of the invention and the fertility condition of rice 21 days after the treatment of the compound of the invention respectively with the naked eye. Evaluate the weed control effect with 0-5 activity standard level. Many compounds show excellent activity and selectivity.









TABLE 7







Experimental results of activity and safety (dose: 125 g a.i./ha)













Echinochloa



Monochoria




Compound No.

crusgali


Scirpus juncoides


vaginalis

Rice





1-4
5
5
5
0


1-5
5
5
5
0


1-6
5
5
5
0


1-8
5
5
5
0


1-11
5
5
5
0


1-14
5
5
5
0


1-57
5
5
5
0


1-76
5
5
5
0
















TABLE 8







Herbicidal effects of compounds (the dose of the compounds of the present invention: 60 g a.i./ha)














Echinochloa


Leptochloa


Sagittaria


Monochoria




Compound No.

crusgali


chinensis


trifolia


vaginalis

Rice





1-8 (R-configuration)
5
5
5
5
0


1-14 (R-configuration)
5
5
5
5
0


1-20 (R-configuration)
5
5
5
5
0


1-82 (R-configuration)
5
5
5
5
0


1-403 (R-configuration)
5
5
5
5
0


1-414 (R-configuration)
5
5
5
5
0


Penoxsulam (30 g a.i./ha)
0
1
0
1
1





Note:


The seeds of Echinochloa crusgali, Scirpus juncoides, Bidens tripartita, Sagittariatrifolia and Monochoria vaginalis were collected from Heilongjiang Province of China. The tests indicated that the weeds were resistant to the common doses of Pyrazosulfuron-ethyland Penoxsulam.






It could be seen from the present experiment that the compound of the present invention had excellent activity against weeds having an anti-ALS inhibiting mechanism and being a serious challenge in production, and thus could solve the increasingly serious resistance problem.


In addition, the present invention further relates to a herbicidal composition comprising herbicidally effective amounts of active ingredient (i) (such as the compound represented by Formula I) and active ingredient (ii), wherein the herbicidal composition may further comprise one or more safeners and/or agrochemically acceptable formulation auxiliaries, and the like.


Wherein, the actual weed control effects of the mixtures of the above active ingredients (i) and (ii) were determined by stem-leaf treatment method, i.e., the weeds in the 3-4 leaf stage were sprayed evenly on stems and leaves by a hand sprayer, in which the added-water amount was 30 kg/667 m2. The investigation was carried out after 20 days of treatment, and the theoretical fresh weight inhibition rate (calculation formula: E0=X+Y−X*Y/100) of each mixture in the treatment was calculated by Gowing method, and then compared with the measured inhibition rate (E), and the type of combined effect on weeds for the two ingredients in the mixture was evaluated, in which if E-E0 value is greater than 10%, the type of combined effect was synergism; if E-E0 value is less than −10%, the type of combined effect was antagonism; if E-E0 value is between −10% and 10%, the type of combined effect was additive effect. According to the actual control effect and the property of the herbicides, the balance of the formula and other factors, the optimal ratio was determined. In the calculation formula: X represents the fresh weight inhibition rate when the active ingredient (i) is used in an amount of P; and Y represents the fresh weight inhibition rate when the active ingredient (ii) is used in an amount of Q. The statistical results are shown in Tables 9-11 below.









TABLE 9







Evaluation of actual control effects and combined effects of the mixtures


of active ingredients (i) and (ii) in weeds (Gowing method)















Active



Control effect
Control effect





Ingredient
Active
(i) + (ii)

of (i) alone
of (ii) alone





(i)/Comp.
Ingredient
g

at corresponding
at corresponding
E
E0
E − E0


No.
(ii)
a.i./mu
Weed type
dose (%)
dose (%)
(%)
(%)
(%)


















1-1
Florpyrauxifen-

3 + 0.6


Echinochloa

43.1
21.5
78.1
55.33
22.77



benzyl


phyllopogon








1-1
Florpyrauxifen-
1 + 3

Echinochloa

8.3
70.5
87.9
72.95
14.95



benzyl


phyllopogon








1-1
Fluroxypyr
15 + 3 

Monochoria

23.9
60.3
83.2
69.79
13.41






vaginalis








1-1
Fluroxypyr
5 + 5

Monochoria

9.6
73.4
90.5
75.95
14.55






vaginalis








1-1
MCPA
15 + 3 

Monochoria

23.9
28.2
62.1
45.36
16.74






vaginalis








1-1
MCPA
5 + 3

Monochoria

9.6
28.2
51.2
35.09
16.11






vaginalis








1-1
2,4-D butyric
15 + 3 

Monochoria

23.9
23.5
56.7
41.78
14.92



acid


vaginalis








1-1
2,4-D butyric
 5 + 15

Monochoria

9.6
65.3
80.8
68.63
12.17



acid


vaginalis








1-1
Dicamba
5 + 3

Monochoria

9.6
50.9
70.5
55.61
14.89






vaginalis








1-1
Dicamba
5 + 5

Monochoria

9.6
70.2
86.2
73.06
13.14






vaginalis








1-1
Quinclorac
2 + 3

Echinochloa

18.7
35.2
62.5
47.32
15.18






phyllopogon








1-1
Quinclorac
 3 + 15

Echinochloa

43.1
52.9
92.2
73.20
19.00






phyllopogon








1-1
Quintrione
1 + 3

Echinochloa

8.3
15.8
45.5
22.79
22.71






phyllopogon








1-1
Quintrione
 3 + 30

Echinochloa

43.1
66.7
94.6
81.05
13.55






phyllopogon








1-1
Clopyralid
5 + 1

Monochoria

9.6
49.6
77.3
54.44
22.86






vaginalis








1-1
Simetryn

3 + 0.6


Echinochloa

43.1
20.8
72.6
54.94
17.66






phyllopogon








1-1
Simetryn
 1 + 15

Echinochloa

8.3
45.3
68.2
49.84
18.36






phyllopogon








1-1
Prometryn

3 + 0.6


Echinochloa

43.1
21.5
72.6
55.33
17.27






phyllopogon








1-1
Prometryn
 1 + 20

Echinochloa

8.3
68.2
85.6
70.84
14.76






phyllopogon








1-1
Pyraclonil
 5 + 15

Sagittaria

33.5
72.5
99.6
81.71
17.89






trifolia








1-1
Bromoxynil
1 + 3

Sagittaria

10.9
12.5
38.3
22.04
16.26



octanoate


trifolia








1-1
Carfentrazone-

1 + 0.2


Echinochloa

8.3
5.3
30.2
13.16
17.04



ethyl


phyllopogon








1-1
Carfentrazone-
2 + 8

Echinochloa

18.7
73.6
93.6
78.54
15.06



ethyl


phyllopogon








1-1
Amicarbazone
15 + 3 

Monochoria

23.9
23.3
67.2
41.63
25.57






vaginalis








1-1
Amicarbazone
 5 + 10

Monochoria

9.6
51.6
76.1
56.25
19.85






vaginalis








1-1
Atrazine
 3 + 15

Echinochloa

43.1
30.6
78.6
60.51
18.09






phyllopogon








1-1
Isoproturon

3 + 0.6


Echinochloa

43.1
20.3
70.6
54.65
15.95






phyllopogon








1-1
Isoproturon
3 + 3

Echinochloa

43.1
40.2
84.1
65.97
18.13






phyllopogon








1-1
Bromacil
3 + 3

Echinochloa

43.1
12.8
70.2
50.38
19.82






phyllopogon








1-1
Pyridate
 5 + 15

Cyperus

30.6
53.2
86.7
67.52
19.18






difformis








1-1
Propanil
 5 + 15

Cyperus

30.6
46.2
80.1
62.66
17.44






difformis








1-1
Oxadiazon
3 + 3

Echinochloa

43.1
14.3
72.5
51.24
21.26






phyllopogon








1-1
Oxadiazon
 3 + 15

Echinochloa

43.1
41.3
79.6
66.60
13.00






phyllopogon








1-1
Oxadiargyl

3 + 0.6


Echinochloa

43.1
3.4
60.3
45.03
15.27






phyllopogon








1-1
Oxadiargyl
 3 + 15

Echinochloa

43.1
35.3
78.6
63.19
15.41






phyllopogon








1-1
Bentazone
5 + 9

Cyperus

30.6
40.4
76.5
58.64
17.86






difformis








1-1
Oxyfluorfen

2 + 0.2


Echinochloa

18.7
6.7
46.7
24.15
22.55






phyllopogon








1-1
Oxyfluorfen
2 + 8

Echinochloa

18.7
76.5
98.6
80.89
17.71






phyllopogon








1-1
Pentoxazone
7.5 + 10 

Monochoria

15.1
43.6
66.5
52.12
14.38






vaginalis








1-1
Metribuzin
2 + 3

Echinochloa

18.7
32.3
60.6
44.96
15.64






phyllopogon








1-1
Terbuthylazine
 3 + 15

Echinochloa

43.1
18.6
71.6
53.68
17.92






phyllopogon








1-1
Chlortoluron

3 + 0.6


Echinochloa

43.1
18.3
70.6
53.51
17.09






phyllopogon








1-1
Chlortoluron
 3 + 15

Echinochloa

43.1
57.6
93.8
75.87
17.93






phyllopogon








1-1
Fluorochloridone
3 + 3

Echinochloa

43.1
9.1
60.3
48.28
12.02






phyllopogon








1-1
Beflubutamid
7.5 + 5

Monochoria

15.1
40.3
65.2
49.31
15.89






vaginalis








1-1
Pyrazosulfuron-
7.5 + 1

Monochoria

15.1
75.6
93.6
79.28
14.32



ethyl


vaginalis








1-1
Penoxsulam
1 + 1

Cyperus

6.2
66.4
83.2
68.48
14.72






difformis








1-1
Bispyribac-
5 + 1

Cyperus

30.6
70.4
93.7
79.46
14.24



sodium


difformis








1-1
Metazosulfuron
7.5 + 1

Monochoria

15.1
25.6
50.5
36.83
13.67






vaginalis








1-1
Propyrisulfuron

1 + 1.5


Cyperus

6.2
46.3
63.8
49.63
14.17






difformis








1-1
Triafamone
 15 + 0.5

Monochoria

23.9
16.3
70.2
36.30
33.90






vaginalis








1-1
Triafamone
15 + 1 

Monochoria

23.9
29.6
69.5
46.43
23.07






vaginalis








1-1
Butralin
1 + 3

Cyperus

6.2
16.4
38.5
21.58
16.92






difformis








1-1
Pendimethalin
 5 + 30

Cyperus

30.6
40.3
79.5
58.57
20.93






difformis








1-1
Sanzuohuangcaotong
5 + 3

Monochoria

9.6
21.5
46.6
29.04
17.56



( custom-character  )


vaginalis








1-1
Shuangzuocaotong

3 + 0.6


Echinochloa

43.1
7.8
70.5
47.54
22.96



( custom-character  )


phyllopogon








1-1
Shuangzuocaotong
2 + 8

Echinochloa

18.7
70.9
95.6
76.34
19.26



( custom-character  )


phyllopogon








1-1
Huanbifucaotong
 15 + 0.5

Leptochloa

20.3
9.2
46.7
27.63
19.07



( custom-character   custom-character  )


chinensis








1-1
Mesotrione
5 + 1

Cyperus

30.6
50.4
85.7
65.58
20.12






difformis








1-1
Benzobicylon
5 + 3

Leptochloa

3.8
26.8
46.3
29.58
16.72






chinensis








1-1
Benzobicylon
 5 + 15

Leptochloa

3.8
68.2
88.5
69.41
19.09






chinensis








1-1
Tefuryltrione
1 + 1

Cyperus

6.2
37.4
55.9
41.28
14.62






difformis








1-1
Molinate
3 + 3

Echinochloa

43.1
7.8
63.5
47.54
15.96






phyllopogon








1-1
Benthiocarb
5 + 3

Cyperus

30.6
15.2
60.9
41.15
19.75






difformis








1-1
Butachlor
 3 + 15

Echinochloa

43.1
19.3
72.3
54.08
18.22






phyllopogon








1-1
Pretilachlor
3 + 3

Echinochloa

43.1
15.2
70.5
51.75
18.75






phyllopogon








1-1
Pretilachlor
 3 + 15

Echinochloa

43.1
43.2
85.5
67.68
17.82






phyllopogon








1-1
Mefenacet
2 + 3

Echinochloa

18.7
19.2
56.3
34.31
21.99






phyllopogon








1-1
Mefenacet
 3 + 15

Echinochloa

43.1
46.7
90.1
69.67
20.43






phyllopogon








1-1
Fentrazamide
15 + 3 

Monochoria

23.9
30.2
62.5
46.88
15.62






vaginalis








1-1
Metolachlor
3 + 3

Echinochloa

43.1
7.8
67.5
47.54
19.96






phyllopogon








1-1
Anilofos
15 + 3 

Leptochloa

20.3
30.8
70.2
44.85
25.35






chinensis








1-1
Piperophos
15 + 3 

Monochoria

23.9
9.9
50.6
31.43
19.17






vaginalis








1-1
Pyroxasulfone
6 + 9

Monochoria

12.3
34.5
60.5
42.56
17.94






vaginalis








1-1
Cyhalofop-
3 + 3

Echinochloa

43.1
12.2
70.3
50.04
20.26



butyl


phyllopogon








1-1
Metamifop

3 + 0.6


Echinochloa

43.1
6.8
70.5
46.97
23.53






phyllopogon








1-1
Metamifop
2 + 8

Echinochloa

18.7
60.9
82.6
68.21
14.39






phyllopogon








1-1
Clomazone
15 + 15

Leptochloa

20.3
53.6
82.6
63.02
19.58






chinensis








1-1
Cinmethylin
3 + 3

Echinochloa

43.1
13.2
68.3
50.61
17.69






phyllopogon








1-1
Indanofan
5 + 5

Monochoria

9.6
20.8
50.9
28.40
22.50






vaginalis








1-1
Oxaziclomefone

3 + 0.6


Echinochloa

43.1
12.5
70.1
50.21
19.89






phyllopogon








1-1
Oxaziclomefone
1 + 1

Echinochloa

8.3
18.7
46.2
25.45
20.75






phyllopogon






Note:


mu is a unit of land area in China, fifteen mus equal one hectare, i.e., 1 mu = 1/15 ha.













TABLE 10







Evaluation of actual control effects and combined effects of the mixtures


of active ingredients (i) and (ii) in weeds (Gowing method)















Active



Control effect
Control effect





Ingredient
Active
(i) + (ii)

of (i)alone
of (ii) alone





(i)/Comp.
Ingredient
g

at corresponding
at corresponding
E
E0
E − E0


No.
(ii)
a.i./mu
Weed type
dose (%)
dose (%)
(%)
(%)
(%)


















1-2
Florpyrauxifen-

3 + 0.6


Echinochloa

53.7
21.5
80.1
63.65
16.45



benzyl


phyllopogon








1-2
Florpyrauxifen-
1 + 3

Echinochloa

12.6
70.5
88.5
74.22
14.28



benzyl


phyllopogon








1-2
Fluroxypyr
15 + 3 

Monochoria

30.9
60.3
85.3
72.57
12.73






vaginalis








1-2
Fluroxypyr
5 + 5

Monochoria

7.8
73.4
93.5
75.47
18.03






vaginalis








1-2
MCPA
15 + 3 

Monochoria

30.9
28.2
70.3
50.39
19.91






vaginalis








1-2
MCPA
5 + 3

Monochoria

7.8
28.2
51.2
33.80
17.40






vaginalis








1-2
2,4-D butyric
15 + 3 

Monochoria

30.9
23.5
66.7
47.14
19.56



acid


vaginalis








1-2
2,4-D butyric
 3 + 15

Monochoria

7.8
65.3
83.8
68.01
15.79



acid


vaginalis








1-2
Dicamba
5 + 3

Monochoria

7.8
50.9
71.3
54.73
16.57






vaginalis








1-2
Dicamba
5 + 5

Monochoria

7.8
70.2
87.9
72.52
15.38






vaginalis








1-2
Quinclorac
2 + 3

Echinochloa

26.8
35.2
69.5
52.57
16.93






phyllopogon








1-2
Quinclorac
 3 + 15

Echinochloa

53.7
52.9
93.6
78.19
15.41






phyllopogon








1-2
Quintrione
1 + 3

Digitaria

18.2
15.2
46.9
30.63
16.27






sanguinalis








1-2
Clopyralid
5 + 1

Monochoria

7.8
49.6
70.5
53.53
16.97






vaginalis








1-2
Simetryn

3 + 0.6


Echinochloa

53.7
20.8
77.6
63.33
14.27






phyllopogon








1-2
Simetryn
 1 + 15

Echinochloa

12.6
45.3
65.2
52.19
13.01






phyllopogon








1-2
Prometryn

3 + 0.6


Echinochloa

53.7
21.5
78.6
63.65
14.95






phyllopogon








1-2
Prometryn
 1 + 20

Echinochloa

12.6
68.2
87.3
72.21
15.09






phyllopogon








1-2
Pyraclonil
 3 + 15

Sagittaria

50.3
72.5
99.6
86.33
13.27






trifolia L.








1-2
Bromoxynil
1 + 3

Sagittaria

19.7
12.5
49.3
29.74
19.56



octanoate


trifolia L.








1-2
Carfentrazone-

1 + 0.2


Echinochloa

12.6
5.3
34.2
17.23
16.97



ethyl


phyllopogon








1-2
Carfentrazone-
2 + 8

Echinochloa

26.8
73.6
95.6
80.68
14.92



ethyl


phyllopogon








1-2
Amicarbazone
15 + 3 

Monochoria

30.9
23.3
65.2
47.00
18.20






vaginalis








1-2
Amicarbazone
 5 + 10

Monochoria

7.8
51.6
75.1
55.38
19.72






vaginalis








1-2
Atrazine
 3 + 15

Echinochloa

53.7
30.6
83.6
67.87
15.73






phyllopogon








1-2
Isoproturon

3 + 0.6


Echinochloa

53.7
20.3
79.6
63.10
16.50






phyllopogon








1-2
Isoproturon
3 + 3

Echinochloa

53.7
40.2
86.1
72.31
13.79






phyllopogon








1-2
Bromacil
3 + 3

Echinochloa

53.7
12.8
75.1
59.63
15.47






phyllopogon








1-2
Pyridate
 5 + 15

Cyperus

36.5
53.2
88.2
70.28
17.92






difformis








1-2
Propanil
 5 + 15

Cyperus

36.5
46.2
81.1
65.84
15.26






difformis








1-2
Oxadiazon
3 + 3

Echinochloa

53.7
14.3
76.5
60.32
16.18






phyllopogon








1-2
Oxadiazon
 3 + 15

Echinochloa

53.7
41.3
87.6
72.82
14.78






phyllopogon








1-2
Oxadiargyl

3 + 0.6


Echinochloa

53.7
3.4
72.3
55.27
17.03






phyllopogon








1-2
Bentazone
5 + 9

Cyperus

36.5
40.4
76.5
62.15
14.35






difformis








1-2
Oxyfluorfen
2 + 8

Echinochloa

26.8
76.5
96.6
82.80
13.80






phyllopogon








1-2
Pentoxazone
 5 + 10

Monochoria

7.8
43.6
63.5
48.00
15.50






vaginalis








1-2
Metribuzin
2 + 3

Echinochloa

26.8
32.3
67.6
50.44
17.16






phyllopogon








1-2
Terbuthylazine
 3 + 15

Echinochloa

53.7
18.6
78.6
62.31
16.29






phyllopogon








1-2
Chlortoluron

3 + 0.6


Echinochloa

53.7
18.3
79.6
62.17
17.43






phyllopogon








1-2
Chlortoluron
 3 + 15

Echinochloa

53.7
57.6
92.8
80.37
12.43






phyllopogon








1-2
Fluorochloridone
3 + 3

Echinochloa

53.7
9.1
72.3
57.91
14.39






phyllopogon








1-2
Beflubutamid
5 + 5

Monochoria

7.8
40.3
60.2
44.96
15.24






vaginalis








1-2
Pyrazosulfuron-
5 + 1

Monochoria

7.8
75.6
90.6
77.50
13.10



ethyl


vaginalis








1-2
Penoxsulam
1 + 1

Cyperus

7.8
66.4
85.2
69.02
16.18






difformis








1-2
Bispyribac-
5 + 1

Cyperus

36.5
70.4
95.6
81.20
14.40



sodium


difformis








1-2
Metazosulfuron
5 + 1

Monochoria

7.8
25.6
49.5
31.40
18.10






vaginalis








1-2
Propyrisulfuron

1 + 1.5


Cyperus

7.8
46.3
65.8
50.49
15.31






difformis








1-2
Triafamone
15 + 1 

Monochoria

30.9
29.6
67.5
51.35
16.15






vaginalis








1-2
Butralin
1 + 3

Cyperus

7.8
16.4
44.5
22.92
21.58






difformis








1-2
Pendimethalin
 5 + 30

Cyperus

36.5
40.3
78.5
62.09
16.41






difformis








1-2
Sanzuohuangcaotong
5 + 3

Monochoria

7.8
21.5
43.6
27.62
15.98



( custom-character  )


vaginalis








1-2
Shuangzuocaotong
2 + 8

Digitaria

40.6
75.1
98.6
85.21
13.39



( custom-character  )


sanguinalis








1-2
Huanbifucaotong
1 + 3

Digitaria

18.2
6.2
40.7
23.27
17.43



( custom-character  )


sanguinalis








1-2
Mesotrione
5 + 1

Cyperus

36.5
50.4
82.7
68.50
14.20






difformis








1-2
Benzobicylon
5 + 3

Leptochloa

6.5
26.8
44.3
31.56
12.74






chinensis








1-2
Benzobicylon
 5 + 15

Leptochloa

6.5
68.2
87.2
70.27
16.93






chinensis








1-2
Tefuryltrione
1 + 1

Cyperus

7.8
37.4
58.9
42.28
16.62






difformis








1-2
Molinate
3 + 3

Echinochloa

53.7
7.8
73.8
57.31
16.49






phyllopogon








1-2
Benthiocarb
5 + 3

Cyperus

36.5
15.2
63.9
46.15
17.75






difformis








1-2
Butachlor
 3 + 15

Echinochloa

53.7
19.3
77.3
62.64
14.66






phyllopogon








1-2
Pretilachlor
3 + 3

Echinochloa

53.7
15.2
76.2
60.74
15.46






phyllopogon








1-2
Pretilachlor
 3 + 15

Echinochloa

53.7
43.2
87.6
73.70
13.90






phyllopogon








1-2
Mefenacet
2 + 3

Echinochloa

26.8
19.2
59.3
40.85
18.45






phyllopogon








1-2
Mefenacet
 3 + 15

Echinochloa

53.7
46.7
95.1
75.32
19.78






phyllopogon








1-2
Fentrazamide
15 + 3 

Monochoria

30.9
30.2
69.5
51.77
17.73






vaginalis








1-2
Metolachlor
3 + 3

Digitaria

65.3
15.3
89.5
70.61
18.89






sanguinalis








1-2
Anilofos
15 + 3 

Leptochloa

30.6
30.8
79.2
51.98
27.22






chinensis








1-2
Piperophos
15 + 3 

Monochoria

30.9
9.9
53.6
37.74
15.86






vaginalis








1-2
Cyhalofop-
3 + 3

Echinochloa

53.7
12.2
76.3
59.35
16.95



butyl


phyllopogon








1-2
Metamifop

3 + 0.6


Echinochloa

53.7
6.8
75.9
56.85
19.05






phyllopogon








1-2
Metamifop
2 + 8

Echinochloa

26.8
60.9
87.6
71.38
16.22






phyllopogon








1-2
Clomazone
15 + 15

Leptochloa

30.6
53.6
85.8
67.80
18.00






chinensis








1-2
Cinmethylin
3 + 3

Echinochloa

53.7
13.2
75.3
59.81
15.49






phyllopogon








1-2
Indanofan
5 + 5

Monochoria

7.8
20.8
48.9
26.98
21.92






vaginalis








1-2
Oxaziclomefone

3 + 0.6


Echinochloa

53.7
12.5
79.1
59.49
19.61






phyllopogon








1-2
Oxaziclomefone
1 + 1

Echinochloa

12.6
18.7
50.2
28.94
21.26






phyllopogon






Note:


mu is a unit of land area in China, fifteen mus equal one hectare, i.e., 1 mu = 1/15 ha.













TABLE 11







Evaluation of actual control effects and combined effects of the mixtures


of activity ingredient (i) and (ii) in weeds (Gowing method)















Activity



Control effect
Control effect





Ingredient
Activity
(i) + (ii)

of (i)alone
of (ii) alone





(i)/Comp.
Ingredient
g

at corresponding
at corresponding
E
E0
E − E0


No.
(ii)
a.i./mu
Weed type
dose (%)
dose (%)
(%)
(%)
(%)


















1-4
Florpyrauxifen-

3 + 0.6


Echinochloa

60.2
21.5
89.1
68.8
20.3



benzyl


phyllopogon








1-4
Florpyrauxifen-
0.6 + 3

Echinochloa

20.5
70.5
100
76.5
23.5



benzyl


phyllopogon








1-4
Fluroxypyr
15 + 3 

Monochoria

40.5
60.3
98
76.4
21.6






vaginalis








1-4
Fluroxypyr
0.8 + 4

Monochoria

5.8
70.4
100
72.1
27.9






vaginalis








1-4
MCPA
15 + 3 

Monochoria

40.5
28.2
80.6
57.3
23.3






vaginalis








1-4
MCPA
3 + 3

Monochoria

12.7
28.2
64.5
37.3
27.2






vaginalis








1-4
2,4-D butyric
15 + 3 

Monochoria

40.5
23.5
75
54.5
20.5



acid


vaginalis








1-4
2,4-D butyric
 3 + 15

Monochoria

12.7
65.3
86
69.7
16.3



acid


vaginalis








1-4
Dicamba
3 + 3

Monochoria

12.7
50.9
84.5
57.1
27.4






vaginalis








1-4
Dicamba
1 + 5

Monochoria

6.2
70.2
98
72.0
26.0






vaginalis








1-4
Quinclorac
3 + 3

Echinochloa

60.2
35.2
96.3
74.2
22.1






phyllopogon








1-4
Quinclorac
 3 + 15

Echinochloa

60.2
52.9
100
81.3
18.7






phyllopogon








1-4
Quintrione
3 + 3

Echinochloa

60.2
15.8
90.5
66.5
24.0






phyllopogon








1-4
Quintrione
1.5 + 30 

Echinochloa

41.5
66.7
92.6
80.5
12.1






phyllopogon








1-4
Clopyralid

6 + 1.2


Monochoria

28.6
56.3
83.5
68.8
14.7






vaginalis








1-4
Clopyralid
1 + 1

Monochoria

6.2
49.6
75.5
52.7
22.8






vaginalis








1-4
Simetryn

3 + 0.6


Echinochloa

60.2
20.8
85.6
68.5
17.1






phyllopogon








1-4
Simetryn
 3 + 15

Echinochloa

60.2
45.3
93.1
78.2
14.9






phyllopogon








1-4
Prometryn

3 + 0.6


Echinochloa

60.2
21.5
90.6
68.8
21.8






phyllopogon








1-4
Prometryn
 1 + 20

Echinochloa

36.6
68.2
96.6
79.8
16.8






phyllopogon








1-4
Pyraclonil

3 + 0.6


Sagittaria

60.3
9.3
90.6
64.0
26.6






trifolia L.








1-4
Pyraclonil
0.75 + 15

Sagittaria

16.3
72.5
92.6
77.0
15.6






trifolia L.








1-4
Bromoxynil

3 + 0.6


Sagittaria

60.3
6.4
86.9
62.8
24.1



octanoate


trifolia L.








1-4
Bromoxynil
3 + 3

Sagittaria

60.3
12.5
92.3
65.3
27.0



octanoate


trifolia L.








1-4
Carfentrazone-

3 + 0.2


Echinochloa

60.2
5.3
82.2
62.3
19.9



ethyl


phyllopogon








1-4
Carfentrazone-
0.7 + 8

Echinochloa

25.1
73.6
93
80.2
12.8



ethyl


phyllopogon








1-4
Amicarbazone
15 + 3 

Monochoria

40.5
23.3
80.6
54.4
26.2






vaginalis








1-4
Amicarbazone
3.5 + 10 

Monochoria

13.3
51.6
80.1
58.0
22.1






vaginalis








1-4
Atrazine

3 + 0.6


Echinochloa

60.2
2.3
83.6
61.1
22.5






phyllopogon








1-4
Atrazine
0.75 + 15

Echinochloa

30.3
30.6
70.6
51.6
19.0






phyllopogon








1-4
Isoproturon

3 + 0.6


Echinochloa

60.2
20.3
90.6
68.3
22.3






phyllopogon








1-4
Isoproturon
3 + 3

Echinochloa

60.2
40.2
94.3
76.2
18.1






phyllopogon








1-4
Bromacil
3 + 3

Echinochloa

60.2
12.8
87.6
65.3
22.3






phyllopogon








1-4
Bromacil
1.5 + 30 

Echinochloa

41.5
59.7
93.7
76.4
17.3






phyllopogon








1-4
Pyridate

9 + 1.8


Cyperus

32.1
12.9
68.6
40.9
27.7






difformis








1-4
Pyridate
 3 + 15

Cyperus

15.2
53.2
83.5
60.3
23.2






difformis








1-4
Propanil

9 + 1.8


Cyperus

32.1
9.2
63.6
38.3
25.3






difformis








1-4
Propanil
 3 + 15

Cyperus

15.2
46.2
73.5
54.4
19.1






difformis








1-4
Oxadiazon
3 + 3

Echinochloa

60.2
14.3
90.5
65.9
24.6






phyllopogon








1-4
Oxadiazon
0.75 + 15

Echinochloa

30.3
41.3
86.6
59.1
27.5






phyllopogon








1-4
Oxadiargyl

3 + 0.6


Echinochloa

60.2
3.4
83.3
61.6
21.7






phyllopogon








1-4
Oxadiargyl
0.75 + 15

Echinochloa

30.3
35.3
78.6
54.9
23.7






phyllopogon








1-4
Bentazone

9 + 1.8


Cyperus

32.1
18.2
65.6
44.5
21.1






difformis








1-4
Bentazone
9 + 9

Cyperus

32.1
40.4
80.5
59.5
21.0






difformis








1-4
Oxyfluorfen

3 + 0.2


Echinochloa

60.2
6.7
86.7
62.9
23.8






phyllopogon








1-4
Oxyfluorfen
0.7 + 8

Echinochloa

25.1
76.5
95.4
82.4
13.0






phyllopogon








1-4
Pentoxazone
 15 + 0.5

Monochoria

40.5
6.4
73.6
44.3
29.3






vaginalis








1-4
Pentoxazone
10 + 10

Monochoria

31.7
43.6
90.5
61.5
29.0






vaginalis








1-4
Metribuzin

3 + 0.6


Echinochloa

60.2
9.1
86.9
63.8
23.1






phyllopogon








1-4
Metribuzin
3 + 3

Echinochloa

60.2
32.3
90.6
73.1
17.5






phyllopogon








1-4
Terbuthylazine

3 + 0.6


Echinochloa

60.2
0.95
80.2
60.6
19.6






phyllopogon








1-4
Terbuthylazine
 3 + 15

Echinochloa

60.2
18.6
91.4
67.6
23.8






phyllopogon








1-4
Chlortoluron

3 + 0.6


Echinochloa

60.2
18.3
85.6
67.5
18.1






phyllopogon








1-4
Chlortoluron
0.75 + 15

Echinochloa

30.3
57.6
91.5
70.4
21.1






phyllopogon








1-4
Fluorochloridone
3 + 3

Echinochloa

60.2
9.1
90.3
63.8
26.5






phyllopogon








1-4
Fluorochloridone
1.5 + 30 

Echinochloa

41.5
52.3
87.7
72.1
15.6






phyllopogon








1-4
Beflubutamid
 15 + 1.5

Monochoria

40.5
15.3
73.6
49.6
24.0






vaginalis








1-4
Beflubutamid
5 + 5

Monochoria

19.6
40.3
80.3
52.0
28.3






vaginalis








1-4
Pyrazosulfuron-

3 + 0.6


Monochoria

12.7
54.5
83.1
60.3
22.8



ethyl


vaginalis








1-4
Pyrazosulfuron-
1 + 1

Monochoria

6.2
75.6
90.6
77.1
13.5



ethyl


vaginalis








1-4
Penoxsulam

9 + 1.8


Cyperus

32.1
80.2
100
86.6
13.4






difformis








1-4
Penoxsulam
1 + 1

Cyperus

6.3
66.4
85.7
68.5
17.2






difformis








1-4
Bispyribac-

9 + 0.6


Cyperus

32.1
39.5
77.3
58.9
18.4



sodium


difformis








1-4
Bispyribac-
1 + 1

Cyperus

6.3
70.4
88.6
72.3
16.3



sodium


difformis








1-4
Metazosulfuron

6 + 1.2


Monochoria

28.6
30.3
81.5
68.8
12.7






vaginalis








1-4
Metazosulfuron
1 + 1

Monochoria

6.2
25.6
76.5
52.7
23.8






vaginalis








1-4
Propyrisulfuron

9 + 0.6


Cyperus

32.1
19.5
57.3
45.3
12.0






difformis








1-4
Propyrisulfuron
0.3 + 1.5

Cyperus

4.1
46.3
63.5
48.5
15.0






difformis








1-4
Triafamone
 15 + 0.5

Monochoria

40.5
16.3
70.6
50.2
20.4






vaginalis








1-4
Triafamone
1 + 1

Monochoria

6.2
29.6
60.5
34.0
26.5






vaginalis








1-4
Butralin
3 + 3

Cyperus

15.2
16.4
58.5
29.1
29.4






difformis








1-4
Butralin
1.5 + 30 

Cyperus

9.2
46.8
75.3
51.7
23.6






difformis








1-4
Pendimethalin

9 + 1.8


Cyperus

32.1
6.3
62.6
36.4
26.2






difformis








1-4
Pendimethalin
 6 + 30

Cyperus

25.6
40.3
76.5
55.6
20.9






difformis








1-4
Sanzuohuangcaotong
15 + 3 

Monochoria

40.5
21.5
79.6
53.3
26.3



( custom-character  )


vaginalis








1-4
Sanzuohuangcaotong
6 + 6

Monochoria

28.6
40.1
83
57.2
25.8



( custom-character  )


vaginalis








1-4
Shuangzuocaotong

3 + 0.6


Echinochloa

60.2
7.8
83.5
63.3
20.2



( custom-character  )


phyllopogon








1-4
Shuangzuocaotong
1.6 + 8

Echinochloa

45.3
70.9
98.6
84.1
14.5



( custom-character  )


phyllopogon








1-4
Huanbifucaotong
 15 + 0.5

Leptochloa

45.6
9.2
68.7
50.6
18.1



( custom-character   custom-character  )


chinensis








1-4
Huanbifucaotong
 3 + 15

Leptochloa

18.6
76.2
100
80.6
19.4



( custom-character   custom-character  )


chinensis








1-4
Mesotrione

9 + 0.6


Cyperus

32.1
29.5
67.3
52.1
15.2






difformis








1-4
Mesotrione
1 + 1

Cyperus

6.3
50.4
68.6
53.5
15.1






difformis








1-4
Benzobicylon
15 + 3 

Leptochloa

45.6
26.8
76.3
60.2
16.1






chinensis








1-4
Benzobicylon
 3 + 15

Leptochloa

18.6
68.2
98.6
74.1
24.5






chinensis








1-4
Tefuryltrione

9 + 1.8


Cyperus

32.1
63.2
89.6
75.0
14.6






difformis








1-4
Tefuryltrione
1 + 1

Cyperus

6.3
37.4
58.7
41.3
17.4






difformis








1-4
Molinate
3 + 3

Echinochloa

60.2
7.8
76.5
63.3
13.2






phyllopogon








1-4
Molinate
1.5 + 30 

Echinochloa

41.5
40.6
78.5
65.3
13.2






phyllopogon








1-4
Benthiocarb
3 + 3

Cyperus

15.2
15.2
53.5
28.1
25.4






difformis








1-4
Benthiocarb
1.5 + 30 

Cyperus

9.2
50.3
70.3
54.9
15.4






difformis








1-4
Butachlor
 3 + 15

Echinochloa

60.2
19.3
85.5
67.9
17.6






phyllopogon








1-4
Butachlor
0.6 + 30 

Echinochloa

20.5
39.7
65.2
52.1
13.1






phyllopogon








1-4
Pretilachlor
3 + 3

Echinochloa

60.2
15.2
85.3
66.2
19.1






phyllopogon








1-4
Pretilachlor
0.75 + 15

Echinochloa

30.3
43.2
80.5
60.4
20.1






phyllopogon








1-4
Mefenacet
3 + 3

Echinochloa

60.2
19.2
80.3
67.8
12.5






phyllopogon








1-4
Mefenacet
 3 + 15

Echinochloa

60.2
46.7
96.1
78.8
17.3






phyllopogon








1-4
Fentrazamide
 15 + 1.5

Monochoria

40.5
18.3
65.6
51.4
14.2






vaginalis








1-4
Fentrazamide
15 + 3 

Monochoria

40.5
30.2
73.5
58.5
15.0






vaginalis








1-4
Metolachlor
3 + 3

Echinochloa

60.2
7.8
80.5
63.3
17.2






phyllopogon








1-4
Metolachlor
 3 + 15

Echinochloa

60.2
15.3
87.5
66.3
21.2






phyllopogon








1-4
Anilofos
15 + 3 

Leptochloa

45.6
30.8
100
62.4
37.6






chinensis








1-4
Anilofos
 3 + 30

Leptochloa

18.6
62.6
100
69.6
30.4






chinensis








1-4
Piperophos
15 + 3 

Monochoria

40.5
9.9
65.6
46.4
19.2






vaginalis








1-4
Piperophos
 1 + 30

Monochoria

6.2
41.2
68.2
44.8
23.4






vaginalis








1-4
Pyroxasulfone
 15 + 0.5

Monochoria

40.5
6.3
66.4
44.2
22.2






vaginalis








1-4
Pyroxasulfone
1.8 + 9

Monochoria

8.6
34.5
63.5
40.1
23.4






vaginalis








1-4
Cyhalofop-
3 + 3

Echinochloa

60.2
12.2
80.3
65.1
15.2



butyl


phyllopogon








1-4
Cyhalofop-
0.75 + 15

Echinochloa

30.3
45.1
80.9
61.7
19.2



butyl


phyllopogon








1-4
Metamifop

3 + 0.6


Echinochloa

60.2
6.8
83.5
62.9
20.6






phyllopogon








1-4
Metamifop
1.6 + 8

Echinochloa

45.3
60.9
96.6
78.6
18.0






phyllopogon








1-4
Clomazone
15 + 3 

Leptochloa

45.6
16.8
80.6
54.7
25.9






chinensis








1-4
Clomazone
 3 + 15

Leptochloa

18.6
53.6
90.4
62.2
28.2






chinensis








1-4
Cinmethylin
3 + 3

Echinochloa

60.2
13.2
82.3
65.5
16.8






phyllopogon








1-4
Cinmethylin
0.75 + 15

Echinochloa

30.3
54.5
85.7
68.3
17.4






phyllopogon








1-4
Indanofan
5 + 5

Monochoria

19.6
20.8
60.3
36.3
24.0






vaginalis








1-4
Indanofan
2.4 + 12 

Monochoria

10.2
63.1
80
66.9
13.1






vaginalis








1-4
Oxaziclomefone

3 + 0.6


Echinochloa

60.2
12.5
83.1
65.2
17.9






phyllopogon








1-4
Oxaziclomefone
1 + 1

Echinochloa

36.6
18.7
70.6
48.5
22.1






phyllopogon






Note:


mu is a unit of land area in China, fifteen mus equal one hectare, i.e., 1 mu = 1/15 ha.






In addition, Table B1 lists specific combinations of other activity ingredients (i) and (ii), further illustrating the compositions of the present invention. The compounds in the column “activity Ingredient (i)/Compound No.” are listed in the index Table A1. The second column of Table B1 lists compounds of the particular activity ingredient (ii) (e.g., “Pyrazosulfuron-ethyl” in the first row). The remaining rows of Table B1 are constructed similarly.









TABLE B1







List of ingredients in the compositions










Activity Ingredient (i)/




Compound. No.
Activity Ingredient (ii)







1-3
Pyrazosulfuron-ethyl



1-3
Penoxsulam



1-3
Bispyribac-sodium



1-3
Pyriminob ac-methyl



1-3
Metazosulfuron



1-3
Propyrisulfuron



1-3
Triafamone



1-3
Cyhalofop-butyl



1-3
Metamifop



1-3
Quinclorac



1-3
MCPA



1-3
2,4-D



1-3
2,4-D butyric acid



1-3
Fluroxypyr



1-3
Florpyrauxifen-benzyl



1-3
MCPA butyric acid



1-3
Dicamba



1-3
Quintrione



1-3
Clopyralid



1-3
Trichlopyr



1-3
Pendimethalin



1-3
Butralin



1-3
Benthiocarb



1-3
Molinate



1-3
Sanzuohuangcaotong custom-character



1-3
Shuangzuocaotong custom-character



1-3
Huanbifucaotong custom-character



1-3
Mesotrione



1-3
Benzobicylon



1-3
Tefuryltrione



1-3
Diflufenican



1-3
Fluorochloridone



1-3
Beflubutamid



1-3
Carfentrazone-ethyl



1-3
Pyraclonil



1-3
Oxadiazon



1-3
Oxadiargyl



1-3
Oxyfluorfen



1-3
Pentoxazone



1-3
Butachlor



1-3
Pretilachlor



1-3
Mefenacet



1-3
Anilofos



1-3
Fentrazamide



1-3
Metolachlor



1-3
Piperophos



1-3
Pyroxasulfone



1-3
Simetryn



1-3
Prometryn



1-3
Amicarbazone



1-3
Isoproturon



1-3
Bromacil



1-3
Pyridate



1-3
Chlortoluron



1-3
Bentazone



1-3
Prop anil



1-3
Metribuzin



1-3
Atrazine



1-3
Bromoxynil



1-3
Bromoxynil octanoate



1-3
Terbuthylazine



1-3
Clomazone



1-3
Oxaziclomefone



1-3
Cinmethylin



1-3
Indanofan










Table B2 is constructed in the same manner as the above Table B1, except that the first column “Activity Ingredient (i)/Comp. No.” are replaced by the corresponding “Activity Ingredient (i)/Comp. No.” column as shown below. The compounds in the “Activity Ingredient (i)/Comp. No.” column are listed in the Tables A1-A152. Accordingly, for example, in Table B2, the “Activity Ingredient (i)/Comp. No.” of the first column are all “1-5” (i.e., Compound 1-5 identified in the Table A1), and the first row below the column heading of Table B2 specifically discloses a mixture of Compound 1-5 and “Pyrazosulfuron-ethyl”. Tables B3 to B167 are similarly constructed.




















“Activity

“Activity

“Activity

“Activity



Ingredient

Ingredient

Ingredient

Ingredient



(i)/Comp.

(i)/Comp.

(i)/Comp.

(i)/Comp.


Table
No.”
Table
No.”
Table
No.”
Table
No.”







B2
1-5 
B3
1-6 
B4
1-7 
B5
1-8 


B6
1-9 
B7
1-10
B8
1-11
B9
1-12


B10
1-13
B11
1-14
B12
1-15
B13
1-16


B14
1-17
B15
1-18
B16
1-19
B17
1-20


B18
1-21
B19
1-22
B20
1-23
B21
1-24


B22
1-25
B23
1-26
B24
1-27
B25
1-28


B26
1-29
B27
1-30
B28
1-31
B29
1-32


B30
1-33
B31
1-34
B32
1-35
B33
1-36


B34
1-37
B35
1-38
B36
1-39
B37
1-40


B38
1-41
B39
1-42
B40
1-43
B41
1-44


B42
1-45
B43
1-46
B44
1-47
B45
1-48


B46
1-49
B47
1-50
B48
1-51
B49
1-52


B50
1-53
B51
1-54
B52
1-55
B53
1-56


B54
1-57
B55
1-58
B56
1-59
B57
1-60


B58
1-61
B59
1-62
B60
1-63
B61
1-64


B62
1-65
B63
1-66
B64
1-67
B65
1-68


B66
1-69
B67
1-70
B68
1-71
B69
1-72


B70
1-73
B71
1-74
B72
1-75
B73
1-76


B74
1-77
B75
1-78
B76
1-79
B77
1-80


B78
1-81
B79
1-82
B80
1-83
B81
1-84


B82
1-85
B83
1-86
B84
1-87
B85
1-88


B86
1-89
B87
1-90
B88
1-91
B89
1-92


B90
1-93
B91
1-94
B92
1-95
B93
1-96


B94
1-97
B95
1-98
B96
1-99
B97
 1-100


B98
 1-101
B99
 1-102
B100
 1-103
B101
 1-104


B102
 1-105
B103
 1-106
B104
 1-107
B105
 1-108


B106
 1-109
B107
 1-110
B108
 1-111
B109
 1-112


B110
 1-113
B111
 1-114
B112
 1-115
B113
 1-116


B114
 1-117
B115
 1-118
B116
 1-119
B117
 1-120


B118
 1-121
B119
 1-122
B120
 1-123
B121
 1-124


B122
 1-125
B123
 1-126
B124
 1-127
B125
 1-128


B126
 1-129
B127
 1-130
B128
 1-131
B129
 1-132


B130
 1-133
B131
 1-134
B132
 1-135
B133
 1-136


B134
 1-137
B135
 1-138
B136
 1-139
B137
 1-140


B138
 1-141
B139
 1-142
B140
 1-143
B141
 1-144


B142
 1-145
B143
 1-146
B144
 1-147
B145
 1-148


B146
2-3 
B147
2-4 
B148
4-4 
B149
6-4 


B150
8-4 
B151
10-4 
B152
14-4 
B153
17-4 


B154
17-5 
B155
18-4 
B156
20-2 
B157
20-4 


B158
21-4 
B159
21-5 
B160
22-4 
B161
24-4 


B162
96-4 
B163
96-5 
B164
101-4  
B165
101-5  


B166
103-4  
B167
103-5  









At the same time, it is found after several tests that the other mixtures of activity ingredients (i) and (ii) of the present invention could produce similar herbicidal effects. In addition, the compounds and compositions of the present invention have good selectivity to many gramineae grasses such as zoysia japonica, bermuda grass, tall fescue, bluegrass, ryegrass and seashore paspalum etc, and are able to control many important grass weeds and broad-leaved weeds. The compounds also show excellent selectivity and commercial value in the tests on wheat, corn, rice, sugarcane, soybean, cotton, oil sunflower, potato, orchards and vegetables in different herbicide application methods.

Claims
  • 1. An N-(1,3,4-oxadiazol-2-yl)arylcarboxamide compound represented by Formula I or a salt thereof,
  • 2. The N-(1,3,4-oxadiazol-2-yl)arylcarboxamide compound or a salt thereof according to claim 1, wherein X represents O, S, SO, SO2 or NR1;Y represents halogen, cyano, cyano-(C1-C8)alkyl, carboxy, nitro, N(R2)2, —(C1-C8)alkyl-N(R2)2, CON(R2)2, —(C1-C8)alkyl-CON(R2)2, —(C1-C8)alkyl-N(R2)3+I−, hydroxy(C1-C8)alkyl, (C1-C8)alkyl substituted by amino and carboxy, OR3, SR3, —(C1-C8)alkyl-SOR3, —(C1-C8)alkyl-OR3, —(C1-C8)alkyl-SR3, COR3, COOR3, —(C1-C8)alkyl-COR4, —(C1-C8)alkyl-COOR4, —(C1-C8)alkyl-OCOR3, Si(R3)3, —(C1-C8)alkyl-O—Si(R3)3, —(C1-C8)alkyl-O—N═C(R3)2, C1-C8alkyl, halo C1-C8 alkyl; unsubstituted or substituted C2-C8 alkenyl, unsubstituted or substituted C2-C8 alkynyl, unsubstituted or substituted C3-C8 cycloalkyl, unsubstituted or substituted C3-C8 cycloalkyl C1-C8 alkyl, unsubstituted or substituted heterocyclyl, unsubstituted or substituted aryl, unsubstituted or substituted heteroaryl, unsubstituted or substituted heterocyclyl C1-C8 alkyl, unsubstituted or substituted aryl C1-C8 alkyl, unsubstituted or substituted heteroaryl C1-C8 alkyl, wherein the substituted C2-C8 alkenyl or the substituted C2-C8 alkynyl is C2-C8 alkenyl or C2-C8 alkynyl substituted by at least one group selected from the group consisting of halogen, cyano, C3-C8 cycloalkyl, C1-C8 alkylcarbonyl, C1-C8 alkoxycarbonyl, C1-C8 alkoxy, C1-C8 alkylthio, C1-C8 alkylsulfinyl, C1-C8 alkylsulfonyl and tri(C1-C8)alkylsilyl, the substituted C3-C8 cycloalkyl or the substituted (C3-C8)cycloalkyl(C1-C8)alkyl is C3-C8 cycloalkyl or (C3-C8)cycloalkyl(C1-C8)alkyl substituted by at least one group selected from the group consisting of C1-C8 alkyl, halogen and phenyl;or, —X—Y represents
  • 3. The N-(1,3,4-oxadiazol-2-yl)arylcarboxamide compound or a salt thereof according to claim 1, wherein X represents O, S, SO, SO2 or NR1;Y represents halogen, cyano, cyano C1-C6alkyl, carboxy, nitro, N(R2)2, —(C1-C6)alkyl-N(R2)2, CON(R2)2, —(C1-C6)alkyl-CON(R2)2, —(C1-C6)alkyl-N(R2)3+I−, hydroxy C1-C6alkyl, C1-C6alkyl substituted by amino and carboxy, OR3, SR3, —(C1-C6)alkyl-SOR3, —(C1-C6)alkyl-OR3, —(C1-C6)alkyl-SR3, COR3, COOR3, —(C1-C6)alkyl-COR4, —(C1-C6)alkyl-COOR4, —(C1-C6)alkyl-OCOR3, Si(R3)3, —(C1-C6)alkyl-O—Si(R3)3, —(C1-C6)alkyl-O—N═C(R3)2, C1-C6alkyl, haloC1-C6alkyl, unsubstituted or substituted C2-C6 alkenyl, unsubstituted or substituted C2-C6 alkynyl, unsubstituted or substituted C3-C6 cycloalkyl, unsubstituted or substituted C3-C6cycloalkyl unsubstituted or substituted heterocyclyl, unsubstituted or substituted aryl, unsubstituted or substituted heteroaryl, unsubstituted or substituted heterocyclyl C1-C6alkyl, unsubstituted or substituted aryl C1-C6alkyl, unsubstituted or substituted heteroaryl C1-C6alkyl, wherein the substituted C2-C6 alkenyl or the substituted C2-C6 alkynyl is C2-C6 alkenyl or C2-C6 alkynyl substituted by at least one group selected from the group consisting of halogen, cyano, C3-C6 cycloalkyl, C1-C6 alkyl carbonyl, C1-C6 alkoxy carbonyl, C1-C6 alkoxy, C1-C6 alkylthio, C1-C6 alkyl sulfinyl, C1-C6 alkyl sulfonyl and tri(C1-C6)alkylsilyl, the substituted C3-C6 cycloalkyl or the substituted C3-C6cycloalkyl C1-C6alkyl is C3-C6 cycloalkyl or C3-C6cycloalkyl C1-C6alkyl substituted by at least one group selected from the group consisting of C1-C6 alkyl, halogen and phenyl;or, —X—Y represents
  • 4. The N-(1,3,4-oxadiazol-2-yl)arylcarboxamide compound or a salt thereof according to claim 1, wherein X represents O, S, SO, SO2 or NR1;Y represents halogen, cyano, cyano C1-C2 alkyl, carboxy, nitro, N(R2)2, —(C1-C2)alkyl-N(R2)2, CON(R2)2, —(C1-C2)alkyl-CON(R2)2, —(C1-C2)alkyl-N(R2)3+I−, hydroxy C1-C2 alkyl, C1-C2 alkyl substituted by amino and carboxy, OR3, SR3, —(C1-C2)alkyl-SOR3, —(C1-C2)alkyl-OR3, —(C1-C2)alkyl-SR3, COR3, COOR3, —(C1-C2)alkyl-COR4, —(C1-C2)alkyl-COOR4, —(C1-C2)alkyl-OCOR3, Si(R3)3, —(C1-C2)alkyl-O—Si(R3)3, —(C1-C2)alkyl-O—N═C(R3)2, C1-C6 alkyl, halo C1-C6 alkyl; unsubstituted or substituted C2-C6 alkenyl, unsubstituted or substituted C2-C6 alkynyl, unsubstituted or substituted C3-C6 cycloalkyl, unsubstituted or substituted C3-C6 cycloalkyl C1-C2 alkyl, unsubstituted or substituted heterocyclyl, unsubstituted or substituted aryl, unsubstituted or substituted heteroaryl, unsubstituted or substituted heterocyclyl C1-C2 alkyl, unsubstituted or substituted aryl C1-C2 alkyl, or unsubstituted or substituted heteroaryl C1-C2 alkyl, wherein the substituted C2-C6 alkenyl or substituted C2-C6 alkynyl is C2-C6 alkenyl or C2-C6 alkynyl substituted by at least one group selected from halogen, cyano, C3-C6 cycloalkyl, C1-C6 alkyl carbonyl, C1-C6 alkoxy carbonyl, C1-C6 alkoxy, C1-C6 alkylthio, C1-C6 alkylsulfinyl, C1-C6 alkylsulfonyl, and tri(C1-C6)alkylsilyl, the substituted C3-C6 cycloalkyl or the substituted C3-C6 cycloalkyl C1-C2 alkyl is C3-C6 cycloalkyl or C3-C6 cycloalkyl C1-C2 alkyl substituted by at least one group selected from C1-C6 alkyl, halogen and phenyl;or, —X—Y represents
  • 5. The N-(1,3,4-oxadiazol-2-yl)arylcarboxamide compound or a salt thereof according to claim 1, wherein X represents S, SO or SO2;Y represents C2-C8 alkyl, halo C1-C8 alkyl, C2-C8 alkenyl, C2-C8 alkynyl, C1-C8 alkoxy C1-C8 alkyl, hydroxy C1-C8 alkyl, cyano, cyano C1-C8 alkyl, amino C1-C8 alkyl, C1-C8 alkyl amino C1-C8 alkyl, C1-C8 alkyl carbonyl, C3-C8 cycloalkyl, C3-C8 cycloalkyl C1-C8 alkyl, di(C1-C8)alkylamino carbonyl C1-C8 alkyl, C1-C8 alkyl carbonyl C1-C8 alkyl, C1-C8 alkoxy carbonyl C1-C8 alkyl, C1-C8 alkyl carbonyloxy C1-C8 alkyl, C1-C8 alkyl sulfinyl C1-C8 alkyl, tri(C1-C8)alkylsiloxy C1-C8 alkyl, heterocyclyl, heterocyclyl C1-C8 alkyl, phenyl, heteroaryl, heteroaryl C1-C8 alkyl, —(C1-C8)alkyl-O—N═C(R′″)2;wherein the heterocyclyl is
  • 6. The N-(1,3,4-oxadiazol-2-yl)arylcarboxamide compound or a salt thereof according to claim 1, wherein the compound is
  • 7. A method for preparing the N-(1,3,4-oxadiazol-2-yl)arylcarboxamide compound or a salt thereof according to claim 1, wherein a) when X represents Q in the Formula I, the method comprises the following steps:reacting the compound represented by Formula V with a compound represented by VI to obtain a compound represented by Formula I-1, wherein the reaction equation thereof is as follows:
  • 8. A herbicidal composition, in comprising the N-(1,3,4-oxadiazol-2-yl)arylcarboxamide compound represented by Formula I or a salt thereof according to claim 1.
  • 9. A method for controlling a weed comprising: applying at least one of the N-(1,3,4-oxadiazol-2-yl)arylcarboxamide compound or a salt thereof according to claim 1 or a herbicidal composition comprising the N-(1,3,4-oxadiazol-2-yl)arylcarboxamide compound represented by Formula I or a salt thereof according to claim 1 in an herbicidally effective amount on a plant or in a weed area.
  • 10. (canceled)
  • 11. The method according to claim 7, wherein: in a), the reaction is carried out in the presence of a halogenating agent, a catalyst and a solvent, the halogenating agent is SOCl2, the catalyst is 4-dimethylaminopyridine, and the solvent is pyridine, the reaction is conducted at a temperature of 0 to 50° C.;in b), the reaction is carried out in the presence of a base and a solvent, the base is one base or two bases in combination selected from the group consisting of potassium carbonate and sodium carbonate, the solvent is one solvent or more solvents in combination selected from the group consisting of DCM, DCE, ACN, THF, and DMF, the reaction is conducted at a temperature of 0 to 25° C.;in c), the peroxide is
  • 12. The herbicidal composition according to claim 8, wherein the herbicidal composition further comprises one or more additional herbicides and/or safeners.
  • 13. The herbicidal composition according to claim 12, wherein the herbicidal composition further comprises an agrochemically acceptable formulation auxiliary.
  • 14. The herbicidal composition according to claim 12, wherein the additional herbicide is selected from the following compounds or salt or ester derivatives thereof: a) ALS inhibitors: Pyrazosulfuron-ethyl, Penoxsulam, Bispyribac-sodium, Pyriminobac-methyl, Metazosulfuron, Propyrisulfuron, Triafamone;b) ACCase inhibitors: Cyhalofop-butyl, Metamifop;c) hormones inhibitors: Quinclorac, MCPA, 2,4-D, 2,4-D butyric acid, Fluroxypyr, Florpyrauxifen-benzyl, MCPA butyric acid, Dicamba, Quintrione, Clopyralid, Trichlopyr;d) cell division inhibitors: Pendimethalin, Butralin;e) lipid synthesis (non-ACC) inhibitors: Benthiocarb, Molinate;f) HPPD inhibitors: Sanzuohuangcaotong (), Shuangzuocaotong () Huanbifucaotong (), Mesotrione, Benzobicylon, Tefuryltrione;g) PDS inhibitors: Diflufenican, Fluorochloridone, Beflubutamid;h) PPO inhibitors: Carfentrazone-ethyl, Pyraclonil, Oxadiazon, Oxadiargyl, Oxyfluorfen, Pentoxazone;i) Long-chain fatty acid synthesis inhibitors: Butachlor, Pretilachlor, Mefenacet, Anilofos, Fentrazamide, Metolachlor, Piperophos, Pyroxasulfone;j) PSII inhibitors: Simetryn, Prometryn, Amicarbazone, Isoproturon, Bromacil, Pyridate, Chlortoluron, Bentazone, Propanil, Metribuzin, Atrazine, Bromoxynil, Bromoxynil octanoate, Terbuthylazine;k) DOXP inhibitors: Clomazone;l) Others: Oxaziclomefone, Cinmethylin, Indanofan.
  • 15. The herbicidal composition according to claim 8, wherein the herbicidal composition further comprises an agrochemically acceptable formulation auxiliary.
  • 16. The method according to claim 9, wherein the plant is rice, and the weed is a gramineous weed, a broad-leaved weed, or a cyperaceae weed.
  • 17. The method according to claim 16, wherein the rice is indica rice or japonica rice.
  • 18. The method according to claim 16, wherein the weed is Echinochloa phyllopogon, Leptochloa chinensis, Echinochloa crusgali, Digitaria sanguinalis, Setaria viridis, Monochoria vaginalis, Sagittaria trifolia, Abutilon theophrasti, Amaranthus retroflexus, Stellaria media, Cyperus difformis, or Scirpus juncoides.
Priority Claims (2)
Number Date Country Kind
201811455280.X Nov 2018 CN national
201911014193.5 Oct 2019 CN national
PCT Information
Filing Document Filing Date Country Kind
PCT/CN2019/121224 11/27/2019 WO